5,216 results on '"Luo, F"'
Search Results
2. STCF Conceptual Design Report: Volume 1 -- Physics & Detector
- Author
-
Achasov, M., Ai, X. C., Aliberti, R., An, L. P., An, Q., Bai, X. Z., Bai, Y., Bakina, O., Barnyakov, A., Blinov, V., Bobrovnikov, V., Bodrov, D., Bogomyagkov, A., Bondar, A., Boyko, I., Bu, Z. H., Cai, F. M., Cai, H., Cao, J. J., Cao, Q. H., Cao, Z., Chang, Q., Chao, K. T., Chen, D. Y., Chen, H., Chen, H. X., Chen, J. F., Chen, K., Chen, L. L., Chen, P., Chen, S. L., Chen, S. M., Chen, S., Chen, S. P., Chen, W., Chen, X. F., Chen, X., Chen, Y., Chen, Y. Q., Cheng, H. Y., Cheng, J., Cheng, S., Dai, J. P., Dai, L. Y., Dai, X. C., Dedovich, D., Denig, A., Denisenko, I., Ding, D. Z., Dong, L. Y., Dong, W. H., Druzhinin, V., Du, D. S., Du, Y. J., Du, Z. G., Duan, L. M., Epifanov, D., Fan, Y. L., Fang, S. S., Fang, Z. J., Fedotovich, G., Feng, C. Q., Feng, X., Feng, Y. T., Fu, J. L., Gao, J., Ge, P. S., Geng, C. Q., Geng, L. S., Gilman, A., Gong, L., Gong, T., Gradl, W., Gu, J. L., Escalante, A. G., Gui, L. C., Guo, F. K., Guo, J. C., Guo, J., Guo, Y. P., Guo, Z. H., Guskov, A., Han, K. L., Han, L., Han, M., Hao, X. Q., He, J. B., He, S. Q., He, X. G., He, Y. L., He, Z. B., Heng, Z. X., Hou, B. L., Hou, T. J., Hou, Y. R., Hu, C. Y., Hu, H. M., Hu, K., Hu, R. J., Hu, X. H., Hu, Y. C., Hua, J., Huang, G. S., Huang, J. S., Huang, M., Huang, Q. Y., Huang, W. Q., Huang, X. T., Huang, X. J., Huang, Y. B., Huang, Y. S., Hüsken, N., Ivanov, V., Ji, Q. P., Jia, J. J., Jia, S., Jia, Z. K., Jiang, H. B., Jiang, J., Jiang, S. Z., Jiao, J. B., Jiao, Z., Jing, H. J., Kang, X. L., Kang, X. S., Ke, B. C., Kenzie, M., Khoukaz, A., Koop, I., Kravchenko, E., Kuzmin, A., Lei, Y., Levichev, E., Li, C. H., Li, C., Li, D. Y., Li, F., Li, G., Li, H. B., Li, H., Li, H. N., Li, H. J., Li, H. L., Li, J. M., Li, J., Li, L., Li, L. Y., Li, N., Li, P. R., Li, R. H., Li, S., Li, T., Li, W. J., Li, X. H., Li, X. Q., Li, Y., Li, Y. Y., Li, Z. J., Liang, H., Liang, J. H., Liao, G. R., Liao, L. Z., Liao, Y., Lin, C. X., Lin, X. S., Liu, B. J., Liu, C. W., Liu, D., Liu, F., Liu, G. M., Liu, H. B., Liu, J., Liu, J. J., Liu, J. B., Liu, K., Liu, K. Y., Liu, L., Liu, Q., Liu, S. B., Liu, T., Liu, X., Liu, Y. W., Liu, Y., Liu, Y. L., Liu, Z. Q., Liu, Z. Y., Liu, Z. W., Logashenko, I., Long, Y., Lu, C. G., Lu, N., Lü, Q. F., Lu, Y., Lv, Z., Lukin, P., Luo, F. J., Luo, T., Luo, X. F., Lyu, H. J., Lyu, X. R., Ma, J. P., Ma, P., Ma, Y., Maas, F., Malde, S., Matvienko, D., Meng, Z. X., Mitchell, R., Dias, J. M., Nefediev, A., Nefedov, Y., Olsen, S. L., Ouyang, Q., Pakhlov, P., Pakhlova, G., Pan, X., Pan, Y., Passemar, E., Pei, Y. P., Peng, H. P., Peng, L., Peng, X. Y., Peng, X. J., Peters, K., Pivovarov, S., Pyata, E., Qi, B. B., Qi, Y. Q., Qian, W. B., Qian, Y., Qiao, C. F., Qin, J. J., Qin, L. Q., Qin, X. S., Qiu, T. L., Rademacker, J., Redmer, C. F., Sang, H. Y., Saur, M., Shan, W., Shan, X. Y., Shang, L. L., Shao, M., Shekhtman, L., Shen, C. P., Shen, J. M., Shen, Z. T., Shi, H. C., Shi, X. D., Shwartz, B., Sokolov, A., Song, J. J., Song, W. M., Song, Y., Song, Y. X., Sukharev, A., Sun, J. F., Sun, L., Sun, X. M., Sun, Y. J., Sun, Z. P., Tang, J., Tang, S. S., Tang, Z. B., Tian, C. H., Tian, J. S., Tikhonov, Y., Todyshev, K., Uglov, T., Vorobyev, V., Wan, B. D., Wang, B. L., Wang, B., Wang, D. Y., Wang, G. Y., Wang, G. L., Wang, H. L., Wang, J., Wang, J. H., Wang, J. C., Wang, M. L., Wang, R., Wang, S. B., Wang, W., Wang, W. P., Wang, X. C., Wang, X. D., Wang, X. L., Wang, X. P., Wang, X. F., Wang, Y. D., Wang, Y. P., Wang, Y. Q., Wang, Y. L., Wang, Y. G., Wang, Z. Y., Wang, Z. L., Wang, Z. G., Wei, D. H., Wei, X. L., Wei, X. M., Wen, Q. G., Wen, X. J., Wilkinson, G., Wu, B., Wu, J. J., Wu, L., Wu, P. W., Wu, T. W., Wu, Y. S., Xia, L., Xiang, T., Xiao, C. W., Xiao, D., Xiao, M., Xie, Y. H., Xing, Y., Xing, Z. Z., Xiong, X. N., Xu, F. R., Xu, J., Xu, L. L., Xu, Q. N., Xu, X. C., Xu, X. P., Xu, Y. C., Xu, Y. P., Xu, Y., Xu, Z. Z., Xuan, D. W., Xue, F. F., Yan, L., Yan, M. J., Yan, W. B., Yan, W. C., Yan, X. S., Yang, B. F., Yang, C., Yang, H. J., Yang, H. R., Yang, H. T., Yang, J. F., Yang, S. L., Yang, Y. D., Yang, Y. H., Yang, Y. S., Yang, Y. L., Yang, Z. Y., Yao, D. L., Yin, H., Yin, X. H., Yokozaki, N., You, S. Y., You, Z. Y., Yu, C. X., Yu, F. S., Yu, G. L., Yu, H. L., Yu, J. S., Yu, J. Q., Yuan, L., Yuan, X. B., Yue, Y. F., Zeng, M., Zeng, S., Zhang, A. L., Zhang, B. W., Zhang, G. Y., Zhang, G. Q., Zhang, H. J., Zhang, H. B., Zhang, J. Y., Zhang, J. L., Zhang, J., Zhang, L., Zhang, L. M., Zhang, R., Zhang, S. L., Zhang, T., Zhang, X., Zhang, Y., Zhang, Y. X., Zhang, Y. T., Zhang, Y. F., Zhang, Y. C., Zhang, Y. M., Zhang, Y. L., Zhang, Z. H., Zhang, Z. Y., Zhao, H. Y., Zhao, J., Zhao, L., Zhao, M. G., Zhao, Q., Zhao, R. G., Zhao, R. P., Zhao, Z. G., Zhao, Z. X., Zhemchugov, A., Zheng, B., Zheng, L., Zheng, Q. B., Zheng, R., Zheng, Y. H., Zhong, X. H., Zhou, H. J., Zhou, H. Q., Zhou, H., Zhou, S. H., Zhou, X., Zhou, X. K., Zhou, X. R., Zhou, Y. L., Zhou, Y., Zhou, Y. X., Zhou, Z. Y., Zhu, J. Y., Zhu, K., Zhu, R. D., Zhu, R. L., Zhu, S. H., Zhu, Y. C., Zhu, Z. A., Zhukova, V., Zhulanov, V., Zou, B. S., and Zuo, Y. B.
- Subjects
High Energy Physics - Experiment ,High Energy Physics - Phenomenology ,Physics - Instrumentation and Detectors - Abstract
The Super $\tau$-Charm facility (STCF) is an electron-positron collider proposed by the Chinese particle physics community. It is designed to operate in a center-of-mass energy range from 2 to 7 GeV with a peak luminosity of $0.5\times 10^{35}{\rm cm}^{-2}{\rm s}^{-1}$ or higher. The STCF will produce a data sample about a factor of 100 larger than that by the present $\tau$-Charm factory -- the BEPCII, providing a unique platform for exploring the asymmetry of matter-antimatter (charge-parity violation), in-depth studies of the internal structure of hadrons and the nature of non-perturbative strong interactions, as well as searching for exotic hadrons and physics beyond the Standard Model. The STCF project in China is under development with an extensive R\&D program. This document presents the physics opportunities at the STCF, describes conceptual designs of the STCF detector system, and discusses future plans for detector R\&D and physics case studies.
- Published
- 2023
- Full Text
- View/download PDF
3. Effects of Social Support Provided by Disabled Older Adults to Others on Their Own Depressive Symptoms: A Moderated Mediation Model
- Author
-
Fang Y, Jiang Y, Ma L, Chen H, Li Z, Luo F, Jiang W, Cai S, Guo Q, and Yin Z
- Subjects
disabled older adults ,social support ,social exchange ,depressive symptoms ,adl ,Psychology ,BF1-990 ,Industrial psychology ,HF5548.7-5548.85 - Abstract
Yi Fang,1 Yuqi Jiang,2 Linlin Ma,1 Huixian Chen,1 Zhi Li,1 Fen Luo,1 Wen Jiang,1 Shuya Cai,1 Qiaoqiao Guo,3 Zhiqin Yin1,4 1School of Nursing, Wenzhou Medical University, Wenzhou City, Zhejiang Province, People’s Republic of China; 2The First Hospital of Jiaxing City, Jiaxing City, Zhejiang Province, People’s Republic of China; 3College of Renji, Wenzhou Medical University, Wenzhou City, Zhejiang Province, People’s Republic of China; 4Wenzhou Health Promotion Research Center, Wenzhou City, Zhejiang Province, People’s Republic of ChinaCorrespondence: Zhiqin Yin; Qiaoqiao Guo, Email yzq@wmu.edu.cn; 1574612325@qq.comPurpose: While previous studies have extensively examined the impact of receiving positive social support during social support interactions on depressive symptoms among older adults, adverse effects experienced, such as being rejected or ignored, are often overlooked. Moreover, there has been limited discussion on the effects of giving social support to others. Thus, this study investigates the impacts of social support given by disabled older adults to others on their own depressive symptoms, as well as the mediating role of receiving social support (both positive and negative aspects) and the moderating effect of the activity of daily living (ADL).Patients and Methods: This cross-sectional, community-based study was conducted in Wenzhou and Jiaxing City, China, from September 2021 to September 2022, with a total of 255 disabled older adults meeting the inclusion and exclusion criteria. The data were collected face-to-face using a structured questionnaire. The participants were asked to complete the Barthel Index Scale, the Chinese version of the Positive and Negative Social Exchange Scale, the Giving Social Support questionnaire, and the Short Form Chinese Geriatric Depression Scale to measure disability, receiving positive and negative social support, giving social support, and depressive symptoms, respectively. Descriptive statistical analysis, correlation analysis, mediation effect tests, and moderation effect tests were used to analyse the questionnaire data.Results: The social support provided by disabled older adults to others primarily involved companionship and care. The positive aspect of social support received was largely emotional support, while the negative aspect was mainly characterised by failure to obtain help and unsympathetic behaviour. Providing social support was found to be associated with a potential beneficial effect on depressive symptoms, linked to lower severity, with this effect fully mediated by receiving social support. Specifically, receiving emotional support accounted for 56.63% of the effect size, while failure to obtain help and unsympathetic behaviour contributed 21.55%, and rejection and neglect collectively accounted for 21.83%. Additionally, the effect was partially moderated by ADL, with older adults exhibiting lower ADL scores showing a greater benefit from both giving and receiving social support compared to those with higher ADL scores.Conclusion: It is imperative to recognise and encourage disabled older adults to provide social support to others, especially emotional support, while reducing negative feedback, such as neglect and unnecessary blame. This could alleviate their depressive symptoms and promote psycho-social well-being.Keywords: disabled older adults, social support, social exchange, depressive symptoms, ADL
- Published
- 2024
4. Sex Hormones and Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study and Mendelian Randomization Analysis
- Author
-
Du D, Ran B, Xu D, Liu L, Hu X, Zeng T, Shen Y, and Luo F
- Subjects
sex steroid hormones ,chronic obstructive pulmonary disease ,nhanes ,mendelian randomization ,Diseases of the respiratory system ,RC705-779 - Abstract
Dongru Du,1– 3,* Bi Ran,1– 3,* Dan Xu,1– 3 Lian Liu,1– 3 Xueru Hu,1– 3 Tingting Zeng,1– 3 Yongchun Shen,1– 3 Fengming Luo1– 4 1Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 2State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 3Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, West China Hospital, Sichuan University, Chengdu, 610041, People’s Republic of China; 4Laboratory of Pulmonary Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, Sichuan University, Chengdu, 610200, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yongchun Shen; Fengming Luo, Tel +86 28 8542 2350, Fax +86 28 8558 2944, Email shen_yongchun@126.com; fengmingluo@outlook.comBackground: Sex steroid hormones, including testosterone and estradiol, play significant roles in various aspects of pulmonary health and diseases. However, although there were a few studies trying to link sex hormones with COPD, their effect remained limited due to small sample size and insufficient causal results. This study aims to investigate the association between sex hormones and chronic obstructive pulmonary disease (COPD) based on the National Health and Nutrition Examination Survey (NHANES) database and evaluate causality via a two-sample Mendelian randomization (MR).Methods: Data from NHANES 2013– 2016 were enrolled for the cross-sectional study. The association between sex hormones and COPD was evaluated via multivariable logistic regression. Sex-stratified analysis, subgroup analyses and interaction tests were performed to further evaluate the correlation. For MR analysis, data were collected from genome-wide association studies and FinnGen datasets. The inverse-variance-weighted (IVW) approach, along with four other approaches, was applied in the analysis. Further sensitivity analysis was conducted to assess the existence of pleiotropy and heterogeneity.Results: 7,617 eligible participants were enrolled in the cross-sectional analysis. Negative associations were observed in both testosterone-COPD (OR 0.770, 95% CI 0.626, 0.948, p = 0.018) and estradiol-COPD (OR 0.794, 95% CI 0.688, 0.915, p = 0.005) relationships after covariate adjustments. However, the results from IVW-MR analysis showed that no causal relationship was observed in either the testosterone-COPD (OR 0.83, 95% CI 0.53, 1.29, p = 0.407) or estradiol-COPD (OR 0.74, 95% CI 0.23, 2.38, p = 0.616) relationship, which was also supported by the other four approaches (all p values > 0.05).Conclusion: Although a significant negative association was observed between sex hormones and COPD, the results of MR analysis did not support the causality of this relationship. Our study suggested that sex hormones may indirectly rather than directly affect the development of COPD via potential covariates, which warranted further investigations.Keywords: sex steroid hormones, testosterone, estradiol, chronic obstructive pulmonary disease, NHANES, Mendelian randomization
- Published
- 2024
5. Bibliometric Analysis of Cough Variant Asthma from 1993 to 2022
- Author
-
Zhu Z, Wu J, Chen W, Luo F, and Zhao X
- Subjects
citespace ,vosviewer ,hotspots ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Ziyu Zhu,1,2,* Jiabao Wu,1,2,* Wenjun Chen,1– 3 Fei Luo,1,2 Xia Zhao1,2 1Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 2Jiangsu Key Laboratory of Children’s Health and Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China; 3Liyang Branch of Jiangsu Provincial Hospital of Chinese Medicine, Changzhou, People’s Republic of China*These authors contributed equally to this workCorrespondence: Xia Zhao, Jiangsu Key Laboratory of Children’s Health and Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China, Tel +13915994006, Email zhaoxiahy@njucm.edu.cnPurpose: Cough variant asthma (CVA) is a chronic inflammatory disease characterized by recurrent coughing, a prevalent cause of chronic cough in children and adults. As a unique form of asthma, researchers have recently become increasingly interested in developing effective diagnostic and treatment methods. Currently, there has been no bibliometric analysis in CVA. Therefore, this study aims to enrich this knowledge network by examining the current development status, research focal points, and emerging trends in this field.Methods: Articles and reviews on CVA published between 1993 and 2022 were collected from the Web of Science Core Collection (WoSCC) database. Relevant data from the reports were extracted, and collaborative network analysis was performed using CiteSpace and VOSviewer software.Results: 772 articles were included in this study, indicating a significant increase since 2019. The countries with the highest output are China, Japan. The Journal of Asthma and Pulmonary Pharmacology Therapeutics emerged as the most prolific journals in this field. Keyword analysis revealed 22 clusters, highlighting airway inflammation, airway hyperresponsiveness, and eosinophil as the main focus and frontier of research on CVA.Conclusion: From the visual analysis results, the research of CVA is still in the development stage, and there is no unified definition of pathogenesis, diagnostic criteria and treatment strategies. Therefore, researchers and teams should actively carry out cross-institutional and cross-regional cooperation, expand cooperation areas, and carry out high-quality clinical research in the future.Keywords: Citespace, VOSviewer, keywords, hotspots
- Published
- 2024
6. Mesenchymal Stem Cells and Osteoblast Function: Investigating the Involvement of circGLIS2
- Author
-
Huo, Y., Mao, Y., Luo, F., Zhang, F., Xie, L., Zhang, X., Liu, K., Sun, L., Liu, H., Song, L., Wang, H., and Kang, Z.
- Published
- 2023
- Full Text
- View/download PDF
7. Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis
- Author
-
Shi M, Wei Y, Guo R, and Luo F
- Subjects
sepsis ,septic shock ,tgfbi ,prognosis ,biomarker ,Pathology ,RB1-214 ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Mingjie Shi,1,2 Yue Wei,3 Runmin Guo,1,2 Fei Luo1,2 1Key Laboratory of Research in Maternal and Child Medicine and Birth Defects, Guangdong Medical University, Foshan, Guangdong, People’s Republic of China; 2Matenal and Child Research Institute, Shunde Women and Children’s Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Guangdong Medical University, Foshan, People’s Republic of China; 3Department of Ultrasound, Shunde Women and Children’s Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Guangdong Medical University, Foshan, People’s Republic of ChinaCorrespondence: Fei Luo, Shunde Women and Children’s Hospital (Maternity and Child Healthcare Hospital of Shunde Foshan), Guangdong Medical University, Foshan, People’s Republic of China, Email luofei_00@163.comBackground: Sepsis is a major contributor to morbidity and mortality among hospitalized patients. This study aims to identify markers associated with the severity and prognosis of sepsis, providing new approaches for its management and treatment.Methods: Data were mined from the Gene Expression Omnibus (GEO) databases and were analyzed by multiple statistical methods like the Spearman correlation coefficient, Kaplan-Meier analysis, Cox regression analysis, and functional enrichment analysis. Candidate indicator’ associations with immune infiltration and roles in sepsis development were evaluated. Additionally, we employed techniques such as flow cytometry and neutral red staining to evaluate its impact on macrophage functions like polarization and phagocytosis.Results: Twenty-eight genes were identified as being closely linked to the severity of sepsis, among which transforming growth factor beta induced (TGFBI) emerged as a distinct marker for predicting clinical outcomes. Notably, reductions in TGFBI expression during sepsis correlate with poor prognosis and rapid disease progression. Elevated expression of TGFBI has been observed to mitigate abnormalities in sepsis-related immune cell infiltration that are critical to the pathogenesis and prognosis of the disease, including but not limited to type 17 T helper cells and activated CD8 T cells. Moreover, the protein-protein interaction network revealed the top ten genes that interact with TGFBI, showing significant involvement in the regulation of the actin cytoskeleton, extracellular matrix-receptor interactions, and phagosomes. These are pivotal elements in the formation of phagocytic cups by macrophages, squaring the findings of the Human Protein Atlas. Additionally, we discovered that TGFBI expression was significantly higher in M2-like macrophages, and its upregulation was found to inhibit lipopolysaccharide-induced polarization and phagocytosis in M1-like macrophages, thereby playing a role in preventing the onset of inflammation.Conclusion: TGFBI warrants additional exploration as a promising biomarker for assessing illness severity and prognosis in patients with sepsis, considering its significant association with immunological and inflammatory responses in this condition.Keywords: sepsis, septic shock, TGFBI, prognosis, biomarker
- Published
- 2024
8. Study on SiPM performance at low temperatures between $-60^{\circ}$C and $-20^{\circ}$C
- Author
-
Zhong, C., Luo, F. J., Zheng, B., Wang, X. D., Bu, M. Y., Zou, J., and Deng, M. N.
- Subjects
Physics - Instrumentation and Detectors ,Nuclear Experiment - Abstract
Radon is the main background source of dark matter and neutrino experiments. Radon concentration ($\rm mBq/m^3$) measurement by liquid scintillation detector is a highly sensitive method at low temperatures using silicon photomultipliers (SiPMs) arrays. The SiPM performance characteristics are closely related to the lower detection limit of the detector. In this study, we built an automatic and accurate low-temperature measurement system to study the single photoelectron spectrum, SPE resolution, optical crosstalk, and after-pulse of the SiPM at different temperatures. As a result, we obtained the variation trend of the SiPM parameters at different temperatures, and the SiPM optimal working conditions were obtained, which can improve the detector's sensitivity
- Published
- 2022
- Full Text
- View/download PDF
9. Modelling the impact of sediment composition on long-term estuarine morphodynamics
- Author
-
Jiang, C.H., Zhou, Z., Townend, I.H., Guo, L.C., Wei, Y.Z., Luo, F., and Zhang, C.K.
- Published
- 2024
- Full Text
- View/download PDF
10. Analysis of the Risk Factors for Negative Emotions in Patients with Esophageal Cancer During the Peri-Radiotherapy Period and Their Effects on Malnutrition
- Author
-
Luo F, Lu Y, Chen C, Chang D, Jiang W, and Yin R
- Subjects
esophageal cancer ,malnutrition ,negative emotions ,influencing factors ,Medicine (General) ,R5-920 - Abstract
Feng Luo, Yingying Lu, Chen Chen, Dongdong Chang, Wei Jiang, Ronghua Yin Department of Oncology Zone II, Hai’an People’s Hospital, Haian, People’s Republic of ChinaCorrespondence: Ronghua Yin, Department of Oncology Zone II, Hai’an People’s Hospital, No. 17, Zhongba Middle Road, Haian, 226600, People’s Republic of China, Email 13606277858@163.comBackground: Esophageal cancer has a high incidence in China. Many patients also have a heavy psychological burden due to clinical features such as wasting and choking on food. This study analyzed the risk factors of negative emotions in esophageal cancer patients during the peri-radiotherapy period and its effects on malnutrition.Methods: We retrospectively analyzed 339 patients with esophageal cancer during the peri-radiotherapy who received treatment at our hospital from April 2017 to April 2020, and followed up for 3 years. t test and Chi-square test were used to analyze the relationship between patients’ negative emotions and clinical data. Binary logistics regression was performed to analyze the independent risk factors for the occurrence of negative mood and malnutrition in the patients. Kaplan-Meier survival curves were used to analyze survival rates.Results: Our results showed that 18.3% of patients undergoing radiotherapy for esophageal cancer had negative emotions, and 41.9% suffered from malnutrition. The results of the binary logistic regression analysis showed that monthly household income (OR = 0.470, P = 0.022), the TNM stage (OR = 2.030, P = 0.044), concomitant gastrointestinal symptoms (OR = 2.071, P = 0.024), sleep status (OR = 2.540, P = 0.003), swallowing disorders (OR = 1.919, P = 0.048), and post-radiotherapy complications were independent risk factors for the development of negative emotions in patients. Negative emotions (OR = 2.547, P = 0.038) were also a risk factor for malnutrition in patients with esophageal cancer.Conclusion: Many patients with esophageal cancer suffer from anxiety and depression in the peri-radiotherapy period, which might lead to complications such as malnutrition or aggravate and affect the prognosis of patients. Therefore, psychological care should be provided based on conventional care to effectively relieve their psychological pressure, and improve their prognosis and quality of life.Keywords: esophageal cancer, malnutrition, negative emotions, influencing factors
- Published
- 2023
11. STCF conceptual design report (Volume 1): Physics & detector
- Author
-
Achasov, M., Ai, X. C., An, L. P., Aliberti, R., An, Q., Bai, X. Z., Bai, Y., Bakina, O., Barnyakov, A., Blinov, V., Bobrovnikov, V., Bodrov, D., Bogomyagkov, A., Bondar, A., Boyko, I., Bu, Z. H., Cai, F. M., Cai, H., Cao, J. J., Cao, Q. H., Cao, X., Cao, Z., Chang, Q., Chao, K. T., Chen, D. Y., Chen, H., Chen, H. X., Chen, J. F., Chen, K., Chen, L. L., Chen, P., Chen, S. L., Chen, S. M., Chen, S., Chen, S. P., Chen, W., Chen, X., Chen, X. F., Chen, X. R., Chen, Y., Chen, Y. Q., Cheng, H. Y., Cheng, J., Cheng, S., Cheng, T. G., Dai, J. P., Dai, L. Y., Dai, X. C., Dedovich, D., Denig, A., Denisenko, I., Dias, J. M., Ding, D. Z., Dong, L. Y., Dong, W. H., Druzhinin, V., Du, D. S., Du, Y. J., Du, Z. G., Duan, L. M., Epifanov, D., Fan, Y. L., Fang, S. S., Fang, Z. J., Fedotovich, G., Feng, C. Q., Feng, X., Feng, Y. T., Fu, J. L., Gao, J., Gao, Y. N., Ge, P. S., Geng, C. Q., Geng, L. S., Gilman, A., Gong, L., Gong, T., Gou, B., Gradl, W., Gu, J. L., Guevara, A., Gui, L. C., Guo, A. Q., Guo, F. K., Guo, J. C., Guo, J., Guo, Y. P., Guo, Z. H., Guskov, A., Han, K. L., Han, L., Han, M., Hao, X. Q., He, J. B., He, S. Q., He, X. G., He, Y. L., He, Z. B., Heng, Z. X., Hou, B. L., Hou, T. J., Hou, Y. R., Hu, C. Y., Hu, H. M., Hu, K., Hu, R. J., Hu, W. H., Hu, X. H., Hu, Y. C., Hua, J., Huang, G. S., Huang, J. S., Huang, M., Huang, Q. Y., Huang, W. Q., Huang, X. T., Huang, X. J., Huang, Y. B., Huang, Y. S., Hüsken, N., Ivanov, V., Ji, Q. P., Jia, J. J., Jia, S., Jia, Z. K., Jiang, H. B., Jiang, J., Jiang, S. Z., Jiao, J. B., Jiao, Z., Jing, H. J., Kang, X. L., Kang, X. S., Ke, B. C., Kenzie, M., Khoukaz, A., Koop, I., Kravchenko, E., Kuzmin, A., Lei, Y., Levichev, E., Li, C. H., Li, C., Li, D. Y., Li, F., Li, G., Li, G., Li, H. B., Li, H., Li, H. N., Li, H. J., Li, H. L., Li, J. M., Li, J., Li, L., Li, L., Li, L. Y., Li, N., Li, P. R., Li, R. H., Li, S., Li, T., Li, W. J., Li, X., Li, X. H., Li, X. Q., Li, X. H., Li, Y., Li, Y. Y., Li, Z. J., Liang, H., Liang, J. H., Liang, Y. T., Liao, G. R., Liao, L. Z., Liao, Y., Lin, C. X., Lin, D. X., Lin, X. S., Liu, B. J., Liu, C. W., Liu, D., Liu, F., Liu, G. M., Liu, H. B., Liu, J., Liu, J. J., Liu, J. B., Liu, K., Liu, K. Y., Liu, K., Liu, L., Liu, Q., Liu, S. B., Liu, T., Liu, X., Liu, Y. W., Liu, Y., Liu, Y. L., Liu, Z. Q., Liu, Z. Y., Liu, Z. W., Logashenko, I., Long, Y., Lu, C. G., Lu, J. X., Lu, N., Lü, Q. F., Lu, Y., Lu, Y., Lu, Z., Lukin, P., Luo, F. J., Luo, T., Luo, X. F., Lyu, H. J., Lyu, X. R., Ma, J. P., Ma, P., Ma, Y., Ma, Y. M., Maas, F., Malde, S., Matvienko, D., Meng, Z. X., Mitchell, R., Nefediev, A., Nefedov, Y., Olsen, S. L., Ouyang, Q., Pakhlov, P., Pakhlova, G., Pan, X., Pan, Y., Passemar, E., Pei, Y. P., Peng, H. P., Peng, L., Peng, X. Y., Peng, X. J., Peters, K., Pivovarov, S., Pyata, E., Qi, B. B., Qi, Y. Q., Qian, W. B., Qian, Y., Qiao, C. F., Qin, J. J., Qin, J. J., Qin, L. Q., Qin, X. S., Qiu, T. L., Rademacker, J., Redmer, C. F., Sang, H. Y., Saur, M., Shan, W., Shan, X. Y., Shang, L. L., Shao, M., Shekhtman, L., Shen, C. P., Shen, J. M., Shen, Z. T., Shi, H. C., Shi, X. D., Shwartz, B., Sokolov, A., Song, J. J., Song, W. M., Song, Y., Song, Y. X., Sukharev, A., Sun, J. F., Sun, L., Sun, X. M., Sun, Y. J., Sun, Z. P., Tang, J., Tang, S. S., Tang, Z. B., Tian, C. H., Tian, J. S., Tian, Y., Tikhonov, Y., Todyshev, K., Uglov, T., Vorobyev, V., Wan, B. D., Wang, B. L., Wang, B., Wang, D. Y., Wang, G. Y., Wang, G. L., Wang, H. L., Wang, J., Wang, J. H., Wang, J. C., Wang, M. L., Wang, R., Wang, R., Wang, S. B., Wang, W., Wang, W. P., Wang, X. C., Wang, X. D., Wang, X. L., Wang, X. L., Wang, X. P., Wang, X. F., Wang, Y. D., Wang, Y. P., Wang, Y. Q., Wang, Y. L., Wang, Y. G., Wang, Z. Y., Wang, Z. Y., Wang, Z. L., Wang, Z. G., Wei, D. H., Wei, X. L., Wei, X. M., Wen, Q. G., Wen, X. J., Wilkinson, G., Wu, B., Wu, J. J., Wu, L., Wu, P., Wu, T. W., Wu, Y. S., Xia, L., Xiang, T., Xiao, C. W., Xiao, D., Xiao, M., Xie, K. P., Xie, Y. H., Xing, Y., Xing, Z. Z., Xiong, X. N., Xu, F. R., Xu, J., Xu, L. L., Xu, Q. N., Xu, X. C., Xu, X. P., Xu, Y. C., Xu, Y. P., Xu, Y., Xu, Z. Z., Xuan, D. W., Xue, F. F., Yan, L., Yan, M. J., Yan, W. B., Yan, W. C., Yan, X. S., Yang, B. F., Yang, C., Yang, H. J., Yang, H. R., Yang, H. T., Yang, J. F., Yang, S. L., Yang, Y. D., Yang, Y. H., Yang, Y. S., Yang, Y. L., Yang, Z. W., Yang, Z. Y., Yao, D. L., Yin, H., Yin, X. H., Yokozaki, N., You, S. Y., You, Z. Y., Yu, C. X., Yu, F. S., Yu, G. L., Yu, H. L., Yu, J. S., Yu, J. Q., Yuan, L., Yuan, X. B., Yuan, Z. Y., Yue, Y. F., Zeng, M., Zeng, S., Zhang, A. L., Zhang, B. W., Zhang, G. Y., Zhang, G. Q., Zhang, H. J., Zhang, H. B., Zhang, J. Y., Zhang, J. L., Zhang, J., Zhang, L., Zhang, L. M., Zhang, Q. A., Zhang, R., Zhang, S. L., Zhang, T., Zhang, X., Zhang, Y., Zhang, Y. J., Zhang, Y. X., Zhang, Y. T., Zhang, Y. F., Zhang, Y. C., Zhang, Y., Zhang, Y., Zhang, Y. M., Zhang, Y. L., Zhang, Z. H., Zhang, Z. Y., Zhang, Z. Y., Zhao, H. Y., Zhao, J., Zhao, L., Zhao, M. G., Zhao, Q., Zhao, R. G., Zhao, R. P., Zhao, Y. X., Zhao, Z. G., Zhao, Z. X., Zhemchugov, A., Zheng, B., Zheng, L., Zheng, Q. B., Zheng, R., Zheng, Y. H., Zhong, X. H., Zhou, H. J., Zhou, H. Q., Zhou, H., Zhou, S. H., Zhou, X., Zhou, X. K., Zhou, X. P., Zhou, X. R., Zhou, Y. L., Zhou, Y., Zhou, Y. X., Zhou, Z. Y., Zhu, J. Y., Zhu, K., Zhu, R. D., Zhu, R. L., Zhu, S. H., Zhu, Y. C., Zhu, Z. A., Zhukova, V., Zhulanov, V., Zou, B. S., and Zuo, Y. B.
- Published
- 2024
- Full Text
- View/download PDF
12. Network Pharmacology Analysis and Machine-Learning Models Confirmed the Ability of YiShen HuoXue Decoction to Alleviate Renal Fibrosis by Inhibiting Pyroptosis
- Author
-
Feng M, Luo F, Wu H, Chen Y, Zuo J, Weng X, Chen G, and Zhong J
- Subjects
pyroptosis ,yishen huoxue decoction ,renal fibrosis ,molecular docking simulation ,machine-learning ,Therapeutics. Pharmacology ,RM1-950 - Abstract
MinChao Feng,1,* Fang Luo,1,* HuiMin Wu,1 Yushan Chen,1 Jinjin Zuo,1 Xueying Weng,1 Guozhong Chen,2 Jian Zhong3 1The First Clinical Medical College, Guangxi University of Traditional Chinese Medicine, Nannig, People’s Republic of China; 2Department of Gastroenterology, the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, People’s Republic of China; 3Department of Nephrology, the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jian Zhong, Department of Nephrology, the First Affiliated Hospital of Guangxi University of traditional Chinese Medicine, No. 89-9, Dong Ge Lu, Xixiangtang District, Nanning, 530023, People’s Republic of China, Tel +86-18677920877, Email 18922005825@163.comPurpose: YiShen HuoXue decoction (YSHXD) is a formulation that has been used clinically for the treatment of renal fibrosis (RF) for many years. We aimed to clarify therapeutic effects of YSHXD against RF and potential pharmacological mechanisms.Materials and Methods: We used network pharmacology analysis and machine-learning to screen the core components and core targets of YSHXD against RF, followed by molecular docking and molecular dynamics simulations to confirm the reliability of the results. Finally, we validated the network pharmacology analysis experimentally in HK-2 cells and a rat model of RF established by unilateral ureteral ligation (UUO).Results: Quercetin, kaempferol, luteolin, beta-sitosterol, wogonin, stigmasterol, isorhamnetin, baicalein, and dihydrotanshinlactone progesterone were identified as the main active components of YSHXD in the treatment of unilateral ureteral ligation-induced RF, with IL-6, IL1β, TNF, AR, and PTGS2 as core target proteins. Molecular docking and molecular dynamics simulations further confirmed the relationship between compounds and target proteins. The potential molecular mechanism of YSHXD predicted by network pharmacology analysis was confirmed in HK-2 cells and UUO rats. YSHXD downregulated NLRP3, ASC, NF-κBp65, Caspase-1, GSDMD, PTGS2, IL-1β, IL-6, IL-18, TNF-α, α-SMA and upregulated HGF, effectively alleviating the RF process.Conclusion: YSHXD exerts important anti-inflammatory and anti-cellular inflammatory necrosis effects by inhibiting the NLRP3/caspase-1/GSDMD-mediated pyroptosis pathway, indicating that YSHXD represents a new strategy and complementary approach to RF therapy.Graphical Abstract: Keywords: pyroptosis, YiShen HuoXue decoction, renal fibrosis, molecular docking simulation, machine-learning
- Published
- 2023
13. Gain and charge response of 20 inch MCP and dynode PMTs
- Author
-
Zhang, H. Q., Wang, Z. M., Luo, F. J., Yang, A. B., Wu, D. R., Li, Y. C., Qin, Z. H., Yang, C. G., Heng, Y. K., Wang, Y. F., and Chen, H. S.
- Subjects
Physics - Instrumentation and Detectors ,High Energy Physics - Experiment - Abstract
JUNO is a 20-kton liquid scintillator detector aiming to determine the neutrino mass ordering, precisely measure the oscillation parameters, detect the astrophysical neutrinos and search for exotic physics. It is designed to reach an energy resolution of 3% at 1 MeV with the highest ever PMT coverage, using two types of 20 inch phototubes: MCP-PMT from NNVT and dynode-PMT from Hamamatsu. In this article, the gain and charge response of the MCP and dynode PMTs are investigated with the study of JUNO Central Detector prototype. The linearity of the MCP-PMT charge output is measured too to check the effect of a long tail on its charge spectrum.
- Published
- 2021
- Full Text
- View/download PDF
14. The Topics and Publication Trends in Emergence Deliri-Um: A Bibliometric Analysis from 2002 to 2022
- Author
-
Liu T and Luo F
- Subjects
bibliometric analysis ,emergence delirium ,anesthesia ,pediatric anesthesia ,Medicine (General) ,R5-920 - Abstract
Ting Liu, Fang Luo Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Fang Luo, Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095, Jiefang Avenue, Wuhan, People’s Republic of China, Tel +8618872246972, Email luofang0909@hotmail.comBackground: Emergence delirium is an early postoperative behavior change in pediatric patients, posing risks to patient safety and leading to prolonged hospital stays and increased medical costs. As a result, the research on emergence delirium has grown substantially. This study aims to identify the most influential literature, trends, and topics in emergence delirium research, as well as to quantify the fundamental data of academic publications on this topic.Methods: We searched for articles on emergence delirium in the Science Citation Index Expanded databases, covering the period from 2002 to 2022. Bibliographic information, including countries, institutions, journals, authorships, references, and keywords, was collected for further analysis.Results: A total of 739 articles on emergence delirium published between 2002 and 2022 were collected. China emerged as the most prolific publisher in this field, accounting for over 30% of all articles (226 publications), followed by the United States (n = 143) and South Korea (n = 92). The top three productive journals were Pediatric anesthesia (n=78, IF=2.129), Anesthesia and Analgesia (n=28, IF=6.627), and BMC Anesthesiology (n=28, IF=2.583). Yonsei University was the most active institution, with 22 publications related to emergence delirium. Among authors, Kin, Hee-Soo (n = 9) published the most articles in this field, followed by Yao, Yusheng (n = 7), Lee, Ji-Hyun (n = 7). The prominent topics in emergence delirium research during the past two decades were “children”, “emergence delirium” and “propofol”.Conclusion: Through bibliometric analysis, this study provides a comprehensive overview of the trends and developments in the field of emergence delirium over the past two decades. The results demonstrate a significant growth in emergence delirium research worldwide, with China leading in the number of publications. Despite the wealth of literature on strategies for preventing and managing emergence delirium in clinical settings, further basic research is needed to elucidate the underlying mechanisms of emergence delirium.Keywords: bibliometric analysis, emergence delirium, anesthesia, pediatric anesthesia
- Published
- 2023
15. Treatment of Persistent Idiopathic Dentoalveolar Pain with Venlafaxine: A Multicentric Retrospective Study on Its Effectiveness and Safety
- Author
-
Xiao X, Chai G, Wang B, and Luo F
- Subjects
venlafaxine ,persistent idiopathic dentoalveolar pain ,effectiveness ,serotonin-norepinephrine reuptake inhibitors ,pain management ,Medicine (General) ,R5-920 - Abstract
Xiong Xiao,1 Guoliang Chai,2 Baoguo Wang,3 Fang Luo4 1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Imaging Department, Beijing Puhua International Hospital, Beijing, People’s Republic of China; 3Department of Anesthesia, Sanbo Brain Hospital, Beijing, People’s Republic of China; 4Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Fang Luo, Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, #119, West Road of the South Fourth Ring, Fengtai District, Beijing, 100070, People’s Republic of China, Tel/Fax +86 10 59976667, Email 13611326978@163.comPurpose: To determine the effectiveness and safety of venlafaxine in treating persistent idiopathic dentoalveolar pain (PIDP).Patients and Methods: A retrospective analysis was conducted on a cohort comprising 129 patients with a definite diagnosis of PIDP, who were treated with venlafaxine between May 2020 and December 2022 at three different institutions. Baseline characteristics were statistically described, and visual analog scale (VAS) scores before and during treatment were collected. The percentage of pain relief was calculated. Differences in baseline characteristics between responsive and unresponsive patients were evaluated. Additionally, side effects experienced during treatment were also summarized.Results: Among the included patients, 4 suffered immediate side effects following the initial dose of venlafaxine and the treatment was discontinued. 104 (80.6%) patients achieved pain relief. VAS scores of responsive patients at weeks 2, and months 1, 2, and 3 were significantly lower than baseline (p< 0.001). Duration of pain was the only factor related to responsiveness (Wilcoxon rank sum test p< 0.001, logistic regression p=0.001). 64 patients (49.6%) suffered from mild side effects. No serious side effects were observed during the study.Conclusion: Venlafaxine is potentially effective and safe in the management of PIDP. Early application of venlafaxine following the diagnoses of PIDP can result in a higher possibility of pain relief.Keywords: venlafaxine, persistent idiopathic dentoalveolar pain, effectiveness, serotonin-norepinephrine reuptake inhibitors, pain management
- Published
- 2023
16. Transverse Tibial Bone Transfer in the Treatment of Diabetes Foot Ulcer: A Pilot Study
- Author
-
Wen R, Cheng X, Cao H, Zhang L, Luo F, and Shang W
- Subjects
tibial transverse transport ,diabetic foot ulcer ,clinical efficacy ,Specialties of internal medicine ,RC581-951 - Abstract
Rongzhi Wen,* Xinhua Cheng,* Hong Cao, Lei Zhang, Fangcheng Luo, Wei Shang Department of Orthopaedics, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangcheng Luo; Wei Shang, Email fangreng79418583@163.com; weiqiaoshi959193@126.comBackground: The treatment of diabetes-related foot complications is a clinical challenge. The underlying complicating factors of peripheral vascular disease render most diabetic foot ulcers asymptomatic until the ulcer fails to heal and becomes clinically distinct, constituting a significant cause of disability and even death in diabetic patients.Objective: To evaluate the clinical efficacy of tibial transverse transport (TTT) in the treatment of patients with diabetic foot ulcers.Methods: A total of 35 patients who met the inclusion criteria were selected as the study group from patients with diabetic foot ulcers diagnosed and treated at our hospital between August 2019 and March 2021 and were treated with TTT, and 35 patients who also met the inclusion criteria were included in the routine group and were given conventional wound debridement. The primary endpoint of this study was clinical efficacy, including pain condition, trauma condition, ankle-brachial index, and peripheral nerve recovery.Results: Patients receiving TTT showed significantly reduced visual analogue scale (VAS) scores than those with conventional treatment (P< 0.05). TTT resulted in a significant reduction of trabecular area and better trabecular healing versus conventional treatment (P< 0.05). TTT was associated with significantly higher ankle-brachial index (ABI) and lower Michigan neuropathy screening instrument (MNSI) scores in patients versus conventional debridement (P< 0.05).Conclusion: TTT effectively alleviates the pain of diabetic foot ulcer patients, promotes wound healing, and improves ankle-brachial index and peripheral nerve recovery. In the context of the high amputation rate of diabetic foot ulcers treated by internal medicine, TTT contributes positively to the enhancement of patient prognosis and merits clinical promotion.Keywords: tibial transverse transport, diabetic foot ulcer, clinical efficacy
- Published
- 2023
17. Optimization of the JUNO liquid scintillator composition using a Daya Bay antineutrino detector
- Author
-
Bay, Daya, collaborations, JUNO, Abusleme, A., Adam, T., Ahmad, S., Aiello, S., Akram, M., Ali, N., An, F. P., An, G. P., An, Q., Andronico, G., Anfimov, N., Antonelli, V., Antoshkina, T., Asavapibhop, B., de André, J. P. A. M., Babic, A., Balantekin, A. B., Baldini, W., Baldoncini, M., Band, H. R., Barresi, A., Baussan, E., Bellato, M., Bernieri, E., Biare, D., Birkenfeld, T., Bishai, M., Blin, S., Blum, D., Blyth, S., Bordereau, C., Brigatti, A., Brugnera, R., Budano, A., Burgbacher, P., Buscemi, M., Bussino, S., Busto, J., Butorov, I., Cabrera, A., Cai, H., Cai, X., Cai, Y. K., Cai, Z. Y., Cammi, A., Campeny, A., Cao, C. Y., Cao, G. F., Cao, J., Caruso, R., Cerna, C., Chakaberia, I., Chang, J. F., Chang, Y., Chen, H. S., Chen, P. A., Chen, P. P., Chen, S. M., Chen, S. J., Chen, X. R., Chen, Y. W., Chen, Y. X., Chen, Y., Chen, Z., Cheng, J., Cheng, Y. P., Cheng, Z. K., Chepurnov, A., Cherwinka, J. J., Chiarello, F., Chiesa, D., Chimenti, P., Chu, M. C., Chukanov, A., Chuvashova, A., Clementi, ., Clerbaux, B., Di Lorenzo, S. Conforti, Corti, D., Costa, S., Corso, F. D., Cummings, J. P., Dalager, O., De La Taille, C., Deng, F. S., Deng, J. W., Deng, Z., Deng, Z. Y., Depnering, W., Diaz, M., Ding, X. F., Ding, Y. Y., Dirgantara, B., Dmitrievsky, S., Diwan, M. V., Dohnal, T., Donchenko, G., Dong, J. M., Dornic, D., Doroshkevich, E., Dove, J., Dracos, M., Druillole, F., Du, S. X., Dusini, S., Dvorak, M., Dwyer, D. A., Enqvist, T., Enzmann, H., Fabbri, A., Fajt, L., Fan, D. H., Fan, L., Fang, C., Fang, J., Fatkina, A., Fedoseev, D., Fekete, V., Feng, L. C., Feng, Q. C., Fiorentini, G., Ford, R., Formozov, A., Fournier, A., Franke, S., Gallo, J. P., Gan, H. N., Gao, F., Garfagnini, A., Göttel, A., Genster, C., Giammarchi, M., Giaz, A., Giudice, N., Giuliani, F., Gonchar, M., Gong, G. H., Gong, H., Gorchakov, O., Gornushkin, Y., Grassi, M., Grewing, C., Gromov, M., Gromov, V., Gu, M. H., Gu, W. Q., Gu, X. F., Gu, Y., Guan, M. Y., Guardone, N., Gul, M., Guo, C., Guo, J. Y., Guo, L., Guo, W. L., Guo, X. H., Guo, Y. H., Guo, Z., Haacke, M., Hackenburg, R. W., Hackspacher, P., Hagner, C., Han, R., Han, Y., Hans, S., He, M., He, W., Heeger, K. M., Heinz, T., Heng, Y. K., Herrera, R., Higuera, A., Hong, D. J., Hor, Y. K., Hou, S. J., Hsiung, Y. B., Hu, B. Z., Hu, H., Hu, J. R., Hu, J., Hu, S. Y., Hu, T., Hu, Z. J., Huang, C. H., Huang, G. H., Huang, H. X., Huang, Q. H., Huang, W. H., Huang, X. T., Huang, Y. B., Huber, P., Hui, J. Q., Huo, L., Huo, W. J., Huss, C., Hussain, S., Insolia, A., Ioannisian, A., Ioannisyan, D., Isocrate, R., Jaffe, D. E., Jen, K. L., Ji, X. L., Ji, X. P., Ji, X. Z., Jia, H. H., Jia, J. J., Jian, S. Y., Jiang, D., Jiang, X. S., Jin, R. Y., Jing, X. P., Johnson, R. A., Jollet, C., Jones, D., Joutsenvaara, J., Jungthawan, S., Kalousis, L., Kampmann, P., Kang, L., Karagounis, M., Kazarian, N., Kettell, S. H., Khan, A., Khan, W., Khosonthongkee, K., Kinz, P., Kohn, S., Korablev, D., Kouzakov, K., Kramer, M., Krasnoperov, A., Krokhaleva, S., Krumshteyn, Z., Kruth, A., Kutovskiy, N., Kuusiniemi, P., Lachacinski, B., Lachenmaier, T., Langford, T. J., Lee, J., Lee, J. H. C., Lefevre, F., Lei, L., Lei, R., Leitner, R., Leung, J., Li, C., Li, D. M., Li, F., Li, H. T., Li, H. L., Li, J., Li, J. J., Li, J. Q., Li, K. J., Li, M. Z., Li, N., Li, Q. J., Li, R. H., Li, S. C., Li, S. F., Li, S. J., Li, T., Li, W. D., Li, W. G., Li, X. M., Li, X. N., Li, X. L., Li, X. Q., Li, Y., Li, Y. F., Li, Z. B., Li, Z. Y., Liang, H., Liang, J. J., Liebau, D., Limphirat, A., Limpijumnong, S., Lin, C. J., Lin, G. L., Lin, S. X., Lin, T., Lin, Y. H., Ling, J. J., Link, J. M., Lippi, I., Littenberg, L., Littlejohn, B. R., Liu, F., Liu, H., Liu, H. B., Liu, H. D., Liu, H. J., Liu, H. T., Liu, J. C., Liu, J. L., Liu, M., Liu, Q., Liu, R. X., Liu, S. Y., Liu, S. B., Liu, S. L., Liu, X. W., Liu, Y., Lokhov, A., Lombardi, P., Loo, K., Lorenz, S., Lu, C., Lu, H. Q., Lu, J. B., Lu, J. G., Lu, S. X., Lu, X. X., Lubsandorzhiev, B., Lubsandorzhiev, S., Ludhova, L., Luk, K. B., Luo, F. J., Luo, G., Luo, P. W., Luo, S., Luo, W. M., Lyashuk, V., Ma, Q. M., Ma, S., Ma, X. B., Ma, X. Y., Ma, Y. Q., Malyshkin, Y., Mantovani, F., Mao, Y. J., Mari, S. M., Marini, F., Marium, S., Marshall, C., Martellini, C., Martin-Chassard, G., Caicedo, D. A. Martinez, Martini, A., Martino, J., Mayilyan, D., McDonald, K. T., McKeown, R. D., Müller, A., Meng, G., Meng, Y., Meregaglia, A., Meroni, E., Meyhöfer, D., Mezzetto, M., Miller, J., Miramonti, L., Monforte, S., Montini, P., Montuschi, M., Morozov, N., Muralidharan, P., Napolitano, J., Nastasi, M., Naumov, D. V., Naumova, E., Nemchenok, I., Nikolaev, A., Ning, F. P., Ning, Z., Nunokawa, H., Oberauer, L., Ochoa-Ricoux, J. P., Olshevskiy, A., Ortica, F., Pan, H. R., Paoloni, A., Park, J., Parkalian, N., Parmeggiano, S., Patton, S., Payupol, T., Pec, V., Pedretti, D., Pei, Y. T., Pelliccia, N., Peng, A. G., Peng, H. P., Peng, J. C., Perrot, F., Petitjean, P. A., Rico, L. F. Pineres, Popov, A., Poussot, P., Pratumwan, W., Previtali, E., Pun, C. S. J., Qi, F. Z., Qi, M., Qian, S., Qian, X., Qian, X. H., Qiao, H., Qin, Z. H., Qiu, S. K., Rajput, M., Ranucci, G., Raper, N., Re, A., Rebber, H., Rebii, A., Ren, B., Ren, J., Reveco, C. M., Rezinko, T., Ricci, B., Robens, M., Roche, M., Rodphai, N., Rohwer, L., Romani, A., Rosero, R., Roskovec, B., Roth, C., Ruan, X. C., Ruan, X. D., Rujirawat, S., Rybnikov, A., Sadovsky, A., Saggese, P., Salamanna, G., Sangka, A., Sanguansak, N., Sawangwit, U., Sawatzki, J., Sawy, F., Schever, M., Schuler, J., Schwab, C., Schweizer, K., Selivanov, D., Selyunin, A., Serafini, A., Settanta, G., Settimo, M., Shahzad, M., Shi, G., Shi, J. Y., Shi, Y. J., Shutov, V., Sidorenkov, A., Simkovic, F., Sirignano, C., Siripak, J., Sisti, M., Slupecki, M., Smirnov, M., Smirnov, O., Sogo-Bezerra, T., Songwadhana, J., Soonthornthum, B., Sotnikov, A., Sramek, O., Sreethawong, W., Stahl, A., Stanco, L., Stankevich, K., Stefanik, D., Steiger, H., Steiner, H., Steinmann, J., Stender, M., Strati, V., Studenikin, A., Sun, G. X., Sun, L. T., Sun, J. L., Sun, S. F., Sun, X. L., Sun, Y. J., Sun, Y. Z., Suwonjandee, N., Szelezniak, M., Tang, J., Tang, Q., Tang, X., Tietzsch, A., Tkachev, I., Tmej, T., Treskov, K., Troni, G., Trzaska, W., Tse, W. -H., Tull, C. E., Tuve, C., van Waasen, S., Boom, J. Vanden, Vassilopoulos, N., Vedin, V., Verde, G., Vialkov, M., Viaud, B., Viren, B., Volpe, C., Vorobel, V., Votano, L., Walker, P., Wang, C., Wang, C. H., Wang, E., Wang, G. L., Wang, J., Wang, K. Y., Wang, L., Wang, M. F., Wang, M., Wang, N. Y., Wang, R. G., Wang, S. G., Wang, W., Wang, W. S., Wang, X., Wang, X. Y., Wang, Y., Wang, Y. F., Wang, Y. G., Wang, Y. M., Wang, Y. Q., Wang, Z., Wang, Z. M., Wang, Z. Y., Watcharangkool, A., Wei, H. Y., Wei, L. H., Wei, W., Wei, Y. D., Wen, L. J., Whisnant, K., White, C. G., Wiebusch, C., Wong, S. C. F., Wong, H. L. H., Wonsak, B., Worcester, E., Wu, C. H., Wu, D. R., Wu, F. L., Wu, Q., Wu, W. J., Wu, Z., Wurm, M., Wurtz, J., Wysotzki, C., Xi, Y. F., Xia, D. M., Xie, Y. G., Xie, Z. Q., Xing, Z. Z., Xu, D. L., Xu, F. R., Xu, H. K., Xu, J. L., Xu, J., Xu, M. H., Xu, T., Xu, Y., Xue, T., Yan, B. J., Yan, X. B., Yan, Y. P., Yang, A. B., Yang, C. G., Yang, H., Yang, J., Yang, L., Yang, X. Y., Yang, Y. F., Yang, Y. Z., Yao, H. F., Yasin, Z., Ye, J. X., Ye, M., Yegin, U., Yeh, M., Yermia, F., Yi, P. H., You, Z. Y., Young, B. L., Yu, B. X., Yu, C. X., Yu, C. Y., Yu, H. Z., Yu, M., Yu, X. H., Yu, Z. Y., Yuan, C. Z., Yuan, Y., Yuan, Z. X., Yuan, Z. Y., Yue, B. B., Zafar, N., Zambanini, A., Zeng, P., Zeng, S., Zeng, T. X., Zeng, Y. D., Zhan, L., Zhang, C., Zhang, F. Y., Zhang, G. Q., Zhang, H. H., Zhang, H. Q., Zhang, J., Zhang, J. B., Zhang, J. W., Zhang, P., Zhang, Q. M., Zhang, T., Zhang, X. M., Zhang, X. T., Zhang, Y., Zhang, Y. H., Zhang, Y. M., Zhang, Y. P., Zhang, Y. X., Zhang, Y. Y., Zhang, Z. J., Zhang, Z. P., Zhang, Z. Y., Zhao, F. Y., Zhao, J., Zhao, R., Zhao, S. J., Zhao, T. C., Zheng, D. Q., Zheng, H., Zheng, M. S., Zheng, Y. H., Zhong, W. R., Zhou, J., Zhou, L., Zhou, N., Zhou, S., Zhou, X., Zhu, J., Zhu, K. J., Zhuang, H. L., Zong, L., and Zou, J. H.
- Subjects
Physics - Instrumentation and Detectors ,High Energy Physics - Experiment - Abstract
To maximize the light yield of the liquid scintillator (LS) for the Jiangmen Underground Neutrino Observatory (JUNO), a 20 t LS sample was produced in a pilot plant at Daya Bay. The optical properties of the new LS in various compositions were studied by replacing the gadolinium-loaded LS in one antineutrino detector. The concentrations of the fluor, PPO, and the wavelength shifter, bis-MSB, were increased in 12 steps from 0.5 g/L and <0.01 mg/L to 4 g/L and 13 mg/L, respectively. The numbers of total detected photoelectrons suggest that, with the optically purified solvent, the bis-MSB concentration does not need to be more than 4 mg/L. To bridge the one order of magnitude in the detector size difference between Daya Bay and JUNO, the Daya Bay data were used to tune the parameters of a newly developed optical model. Then, the model and tuned parameters were used in the JUNO simulation. This enabled to determine the optimal composition for the JUNO LS: purified solvent LAB with 2.5 g/L PPO, and 1 to 4 mg/L bis-MSB., Comment: 13 pages, 8 figures
- Published
- 2020
18. Opioid-Sparing Effects of Flurbiprofen Axetil as an Adjuvant to Ropivacaine in Pre-Emptive Scalp Infiltration for Post-Craniotomy Pain: Study Protocol for a Multicenter, Randomized Controlled Trial
- Author
-
Zhang W, Li C, Zhao C, Ji N, and Luo F
- Subjects
flurbiprofen axetil ,opioid-sparing ,craniotomy ,pre-emptive analgesia ,scalp infiltration ,postoperative pain ,Medicine (General) ,R5-920 - Abstract
Wei Zhang,1,* Chunzhao Li,2,* Chunmei Zhao,3 Nan Ji,2 Fang Luo3 1Department of Day Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China; 2Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China; 3Department of Day Surgery and Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fang Luo, Department of Day Surgery and Pain Management, Beijing Tiantan Hospital, Capital Medical University, No. 119 West Road, South 4th Ring Road, Fengtai District, Beijing, 100070, People’s Republic of China, Tel +86 10 59976664, Fax +86 10 67050177, Email 13611326978@163.com Nan Ji, Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 West Road, South 4th Ring Road, Fengtai District, Beijing, 100070, People’s Republic of China, Email jinan@mail.ccmu.edu.cnBackground: Pain after craniotomy remains a poorly controlled problem that is mainly caused by the inflammatory reaction at the incision site. Nowadays, systemic opioids use, as first-line analgesics, is often limited because of adverse effects. Flurbiprofen axetil (FA) is a non-steroidal anti-inflammatory drug merged into emulsified lipid microspheres, which represent a strong affinity to inflammatory lesions. Local administration of flurbiprofen into a surgical wound has induced enhanced analgesic efficacy and few systemic or local adverse effects after oral surgery. However, the impact of local FA, as a non-opioid pharmacologic alternative, remains elusive on postoperative pain in craniotomy. In this study, we presume that pre-emptive infiltration of scalp with FA as an adjuvant to ropivacaine can lead to less sufentanil consumption postoperatively in patient controlled intravenous analgesia (PCIA) compared with ropivacaine alone.Methods/Design: We design a multicenter, randomized controlled study that will enroll 216 subjects who are planned to receive supratentorial craniotomy. Patients will receive pre-emptive infiltration of scalp either with 50 mg FA and 0.5% ropivacaine, or with 0.5% ropivacaine alone. Primary outcome is total consumption of sufentanil with PCIA device at 48 h postoperatively.Discussion: This is the first study attempting to explore the analgesic and safety profile of local FA as an adjuvant to ropivacaine for incisional pain in patients undergoing craniotomy. It will provide additional insights into the opioid-sparing analgesia pathways by local administration of NSAIDs for neurosurgery.Keywords: flurbiprofen axetil, pre-emptive analgesia, scalp infiltration, opioid-sparing, craniotomy, postoperative pain
- Published
- 2023
19. Transporter Associated with Antigen Processing 1 Gene Polymorphisms Increase the Susceptibility to Tuberculosis
- Author
-
Lu T, Wang M, Liu N, Zhang S, Shi L, Bao L, Luo F, Liu S, and Yao Y
- Subjects
tuberculosis ,association ,tap gene ,polymorphism ,novel allele ,Therapeutics. Pharmacology ,RM1-950 - Abstract
Tianchang Lu,1,* Minyi Wang,1,2,* Nannan Liu,1 Shuqiong Zhang,3 Lei Shi,1 Ling Bao,3 Feng Luo,3 Li Shi,1 Shuyuan Liu,1 Yufeng Yao4 1Department of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, 650118, People’s Republic of China; 2School of Life Science, Yunnan University, Kunming, 650500, People’s Republic of China; 3Department of Clinical Laboratory, The Third People’s Hospital of Kunming, Kunming, 650041, People’s Republic of China; 4Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease, Kunming, 650118, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shuyuan Liu, Department of Immunogenetics, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, 650118, People’s Republic of China, Tel +86 871 68334483, Email shuyuanliuoo@gmail.com Yufeng Yao, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Disease, Kunming, 650118, People’s Republic of China, Tel +86 871 68335632, Email leoyyf@gmail.comPurpose: Tuberculosis (TB) is known to result from a complex interaction between the host immune response and Mycobacterium infection. The transporter associated with antigen processing (TAP) plays an important role in the processing and presentation pathways for the Mycobacterium tuberculosis (M. tb) antigen. To investigate the possible association of the TAP1 and TAP2 genes with TB.Patients and Methods: A total of 449 TB patients and 435 control subjects were included in this study, and single nucleotide polymorphisms (SNPs) in the TAP gene, as well as TAP1 and TAP2 alleles, were genotyped.Results: TAP gene association analysis of TB diseases showed that rs41551515-T in the TAP1 gene was significantly associated with susceptibility to TB (P=7.96E-04, OR=4.124, 95% CI: 1.683– 10.102), especially pulmonary TB (PTB, P=6.84E-04, OR=4.350, 95% CI: 1.727– 10.945), and the combination of rs1057141-T-rs1135216-C in the TAP1 gene significantly increased the risk of TB susceptibility (P=5.51E-05, OR=10.899, 95% CI: 2.555– 46.493). Five novel TAP1 alleles were detected in Yunnan Han people, and the allele frequency of TAP1*unknown_3 (rs41555220-rs41549617-rs1057141-rs1135216-rs1057149-rs41551515: C-A-T-C-C-T) was notably increased in all TB patients, including in the PTB and EPTB subgroups, and was significantly associated with the risk of susceptibility to TB. However, no association between the TAP2 gene and TB was found in this study.Conclusion: Host genetic variants of rs41551515-T and the combination rs1057141-T-rs1135216-C, as well as TAP1*unknown_3 may play a critical role in susceptibility to TB disease.Keywords: tuberculosis, association, TAP gene, polymorphism, novel allele
- Published
- 2023
20. Effectiveness and Safety of Radiofrequency Thermocoagulation Treatment Guided by Computed Tomography for Infraorbital Neuralgia Following Failed Conservative Treatment: A Retrospective Study
- Author
-
Sun Z, Liu L, Liu H, and Luo F
- Subjects
infraorbital neuralgia ,radiofrequency thermocoagulation ,effectiveness ,safety ,retrospective study ,Medicine (General) ,R5-920 - Abstract
Zhe Sun,1,* Lu Liu,1,* Hongbing Liu,2 Fang Luo1,2 1Department of Day Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China; 2Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fang Luo, Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, No. 119 West Road, South 4th Ring Road, Fengtai District, Beijing, 100070, People’s Republic of China, Tel +86 010 59976664, Fax +86 010 67050177, Email luofangwt@yahoo.comPurpose: To evaluate the effectiveness and safety of CT-guided radiofrequency thermocoagulation (RFT) for the treatment of infraorbital neuralgia following the failure of conservative management.Patients and Methods: This was a single center, retrospective study which included 196 patients between the ages of 37 to 90 years, who suffered from infraorbital neuralgia, and had undergone CT-guided RFT treatment. The medical records of these patients were retrieved between January 7, 2015 and February 5, 2020, and the patients were followed up for 2 years. Follow-up outcomes included Numerical Rating Scale (NRS) scores, dosage of carbamazepine, time to take effect, status of recurrence and side effects. The effective rate was defined as the percentage of patients with postoperative NRS score reduction of > 50%.Results: The effective rates were 92.9%, 100%, 100%, 100%, 93.4% and 85.7% on the same day, week 1, month 1, month 6, year 1 and year 2 after RFT, respectively. After RFT, the postoperative NRS scores and dosage of carbamazepine were significantly reduced than those preoperatively (P < 0.05). The median time to take effect was zero day. Twenty-eight patients with recurrence underwent RFT again and achieved complete pain relief. All patients experienced numbness in the infraorbital nerve innervation area and the numbness scores gradually decreased over time.Conclusion: CT-guided RFT treatment may be an effective and safe technique for pain relief in patients with infraorbital neuralgia following failed results from conservative treatment.Keywords: infraorbital neuralgia, radiofrequency thermocoagulation, effectiveness, safety, retrospective study
- Published
- 2023
21. Comparison on PMT Waveform Reconstructions with JUNO Prototype
- Author
-
Zhang, H. Q., Wang, Z. M., Zhang, Y. P., Huang, Y. B., Luo, F. J., Zhang, P., Zhang, C. C., Xu, M. H., Liu, J. C., Heng, Y. K., Yang, C. G., Jiang, X. S., Li, F., Ye, M., and Chen, H. S.
- Subjects
Physics - Instrumentation and Detectors ,High Energy Physics - Experiment - Abstract
JUNO is proposed to determine the neutrino mass hierarchy and rich in many other neutrino topics. A prototype is designed and set up for better understanding sub-systems of future detector. The preliminary results show that its threshold reaches ~0.3MeV with trigger rate ~290 Hz on the ground with cosmic muon rate ~35 Hz. Aiming for a better detector understanding from PMT signal, three reconstruction algorithms are compared for PMT waveforms with different overshoot ratios, including charge integration, waveform fitting, and deconvolution. It is concluded that the three methods have similar performance on uncertainty and systematic bias while deconvolution algorithm is best to handle larger overshoot and the simplest charge integration could be considered with controlled overshoot for future fast preliminary reconstruction.
- Published
- 2019
- Full Text
- View/download PDF
22. Outcomes and Predictors of Response of Duloxetine for the Treatment of Persistent Idiopathic Dentoalveolar Pain: A Retrospective Multicenter Observational Study
- Author
-
Jia Z, Yu J, Zhao C, Ren H, and Luo F
- Subjects
persistent idiopathic dentoalveolar pain ,efficacy ,safety ,predictor of response ,duloxetine ,Medicine (General) ,R5-920 - Abstract
Zipu Jia,1 Jinyong Yu,2 Chunmei Zhao,2 Hao Ren,2 Fang Luo2 1Department of Day Surgery Center; Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Pain Management; Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Fang Luo, Department of Anesthesiology and Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, People’s Republic of China, Tel +86 13611326978, Email luofangwt@yahoo.comBackground: Duloxetine has been reported to significantly relieve the pain of persistent idiopathic dentoalveolar pain (PIDP); however, the number of studies available is scarce and no study has identified the predictors of response of duloxetine for the treatment of PIDP.Objective: To report the efficacy, safety, and identification of positive predictors of duloxetine for PIDP patients through a retrospective multicenter observational study.Methods: We retrospectively reviewed the clinical database of PIDP patients who were prescribed duloxetine at 3 hospitals between January 2018 and November 2021. Demographic and pain-related baseline data, efficacy of patients after 3 months of medication by visual analog scale (VAS) scores for pain and adverse events were extracted and analyzed. The predictors of pain-relieving effect of duloxetine were identified by logistic regression analysis.Results: A total of 135 patients were included in this study. Side effects occurred immediately after taking duloxetine in 24 (17.8%) patients, and the treatment with duloxetine was discontinued on 13 of them because they could not tolerate the side effects. Other 11 (8.1%) patients gradually tolerated the side effects within 2 weeks. Ninety-four out of 122 (77.0%) patients obtained pain relief with VAS significantly decreased (p < 0.01) and the other 28 (23.0%) patients stopped taking the drug because of weak efficacy. Binary logistic regression analysis showed that short disease duration (OR = 1.017, 95% CI = 1.004– 1.030, P = 0.012) was an independent predictor of the positive response of duloxetine.Conclusion: This study confirmed that duloxetine can significantly improve chronic pain of PIDP patients, and the safety was tolerable. Patients with shorter disease duration had more benefit from duloxetine.Limitations: This is a retrospective observational study. Long-term efficacy and safety of duloxetine in the treatment of PIDP patients were not evaluated.Keywords: persistent idiopathic dentoalveolar pain, efficacy, safety, predictor of response, duloxetine
- Published
- 2022
23. A rational design of microwire/CNT hybrid fiber for tunable microwire metacomposites
- Author
-
Estevez, D., Luo, F. X. Qin Y., Zheng, X., Wang, H., and Peng, H-X
- Subjects
Physics - Applied Physics - Abstract
Metacomposites are a type of engineering composite materials with metamaterial properties. We propose a design of hybrid filler consisting of ferromagnetic microwire and carbon nanotube to enable a tunable microwire metacomposite. There shows a sophisticated dependency of plasma frequency and bandwidth of double negative region on the carbon nanotube coating. Factors such as coating thickness, uniformity, morphology and number of microwires conspire to the formulation of the double negative characteristics. The intricate role of CNT on modulating negative {\epsilon} and {\mu} is elucidated by the plasma frequency formula and split-close paths model based on the layer-like structure of CNT coating., Comment: 16 pages, 5 figures
- Published
- 2017
24. Bone marrow mesenchymal stem cells promote the progression of prostate cancer through the SDF-1/CXCR4 axis in vivo and vitro
- Author
-
Luo, F., Su, Y., Zhang, Z., and Li, J.
- Published
- 2022
- Full Text
- View/download PDF
25. Likelihood Analysis of the Minimal AMSB Model
- Author
-
Bagnaschi, E., Borsato, M., Sakurai, K., Buchmueller, O., Cavanaugh, R., Chobanova, V., Citron, M., Costa, J. C., De Roeck, A., Dolan, M. J., Ellis, J. R., Flächer, H., Heinemeyer, S., Isidori, G., Lucio, M., Luo, F., Santos, D. Martínez, Olive, K. A., Richards, A., and Weiglein, G.
- Subjects
High Energy Physics - Phenomenology ,Astrophysics - High Energy Astrophysical Phenomena ,High Energy Physics - Experiment - Abstract
We perform a likelihood analysis of the minimal Anomaly-Mediated Supersymmetry Breaking (mAMSB) model using constraints from cosmology and accelerator experiments. We find that a wino-like or a Higgsino-like neutralino LSP, $m_{\tilde \chi^0_{1}}$, may provide the cold dark matter (DM) with similar likelihood. The upper limit on the DM density from Planck and other experiments enforces $m_{\tilde \chi^0_{1}} \lesssim 3~TeV$ after the inclusion of Sommerfeld enhancement in its annihilations. If most of the cold DM density is provided by the $\tilde \chi_0^1$, the measured value of the Higgs mass favours a limited range of $\tan \beta \sim 5$ (or for $\mu > 0$, $\tan \beta \sim 45$) but the scalar mass $m_0$ is poorly constrained. In the wino-LSP case, $m_{3/2}$ is constrained to about $900~TeV$ and ${m_{\tilde \chi^0_{1}}}$ to $2.9\pm0.1~TeV$, whereas in the Higgsino-LSP case $m_{3/2}$ has just a lower limit $\gtrsim 650TeV$ ($\gtrsim 480TeV$) and $m_{\tilde \chi^0_{1}}$ is constrained to $1.12 ~(1.13) \pm0.02~TeV$ in the $\mu>0$ ($\mu<0$) scenario. In neither case can the anomalous magnetic moment of the muon, ${(g-2)_\mu}$, be improved significantly relative to its Standard Model (SM) value, nor do flavour measurements constrain the model significantly, and there are poor prospects for discovering supersymmetric particles at the LHC, {though there} are some prospects for direct DM detection. On the other hand, if the ${m_{\tilde \chi^0_{1}}}$ contributes only a fraction of the cold DM density, {future LHC $E_T$-based searches for gluinos, squarks and heavier chargino and neutralino states as well as disappearing track searches in the wino-like LSP region will be relevant}, and interference effects enable ${\rm BR}(B_{s, d} \to \mu^+\mu^-)$ to agree with the data better than in the SM in the case of wino-like DM with $\mu > 0$.
- Published
- 2016
- Full Text
- View/download PDF
26. Performance-based evaluation of courtyard design in China's cold-winter hot-summer climate regions
- Author
-
Xu, X, Luo, F, Wang, W, Hong, T, and Fu, X
- Subjects
courtyard design ,ecological effect ,layout ,aspect ratio ,ecological buffer area ,Built Environment and Design - Abstract
A courtyard is a traditional and popular construction feature found in China's urban buildings. This case study evaluates the performance of the traditional courtyard design of the Jiangnan Museum, located in Jiangsu Province. In the evaluation, the spatial layout of courtyards is adjusted, the aspect ratio is changed, and an ecological buffer space is created. To model and evaluate the performance of the courtyard design, this study applied the Computational fluid dynamics (CFD) software, Parabolic Hyperbolic Or Elliptic Numerical Integration Code Series (PHOENICS), for wind environment simulation, and the EnergyPlus-based software, DesignBuilder, for energy simulation. Results show that a good combination of courtyard layout and aspect ratio can improve the use of natural ventilation by increasing free cooling during hot summers and reducing cold wind in winters. The results also show that ecological buffer areas of a courtyard can reduce cooling loads in summer by approximately 19.6% and heating loads in winter by approximately 22.3%. The study provides insights into the optimal design of a courtyard to maximize its benefit in regulating the microclimate during both winter and summer.
- Published
- 2018
27. Post-flooding with Associative Polymer/Alkali/Surfactant Ternary System After Polymer-Enhanced Oil Recovery
- Author
-
Han, P. H., Cao, R. B., Liu, H. S., Yan, W., Yang, L., Luo, F., Zhou, H., Wu, Wei, Series Editor, and Lin, Jia'en, editor
- Published
- 2020
- Full Text
- View/download PDF
28. PMT overshoot study for JUNO prototype detector
- Author
-
Luo, F. J., Heng, Y. K., Wang, Z. M., Wang, P. L., Qin, Z. H., Xu, M. H., Liao, D. H., Zhang, H. Q., Lei, X. C., Qian, S., Liu, S. L., Chen, Y. B., and Wang, Y. F.
- Subjects
Physics - Instrumentation and Detectors ,High Energy Physics - Experiment - Abstract
The quality of PMT signal is one of the key items for a large and high precision neutrino experiment, like Daya Bay, JUNO, while most of the experiments are affected by the PMT signal overshoot from its positive HV-single cable scheme. For JUNO prototype detector, we have a detailed study on the PMT overshoot and successfully reduced the ratio of overshoot amplitude to signal to ~1% from previous typical ~10%, with no affection to PMT other parameters. Furthermore, we calculated that the overshoot is a result of discharging of capacitors in the HV-signal splitter and the PMT voltage divider. The study result is extremely important for JUNO and other similar experiments., Comment: 6 pages, 11 figures
- Published
- 2016
- Full Text
- View/download PDF
29. Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma
- Author
-
Li L, Wang J, Li Z, Qiu S, Cao J, Zhao Y, Huang Z, He J, Luo F, and Yang K
- Subjects
papillary thyroid carcinoma ,lncrna hotair ,glactin-3 ,combination detection ,benign thyroid tumor ,roc curve analysis ,diagnostic efficiency ,tpo-ab ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Li Li,1,* Jianjun Wang,1,* Zhongquan Li,2 Shuang Qiu,1 Junyu Cao,1 Yuan Zhao,1 Zhenfan Huang,1 Jie He,1 Feipeng Luo,3 Kunxian Yang1 1Department of Breast and Thyroid Surgery, The First People’s Hospital of Yunnan Province (Kunhua Hospital Affiliated to Kunming University of Science and Technology), Kunming, Yunnan, 650032, People’s Republic of China; 2Department of Anesthesiology, Yunnan General Hospital of Armed Police, Kunming, Yunnan, 650032, People’s Republic of China; 3Department of Cardiothoracic Surgery, The Second People’s Hospital of Baoshan City, Kunming, Yunnan, 650032, People’s Republic of China*These authors contributed equally to this workCorrespondence: Kunxian YangDepartment of Breast and Thyroid Surgery, The First People’s Hospital of Yunnan Province (Kunhua Hospital Affiliated to Kunming University of Science and Technology), No. 157, Jinbi Road, Xishan District, Kunming, Yunnan, 650032, People’s Republic of ChinaTel +86-0871-63627184Email kunxy0125@163.comPurpose: Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. LncRNA HOTAIR (HOx Transcript AntIsense RNA) and Galectin-3 are involved in PTC. This study explored the clinical effect of lncRNA HOTAIR/Galectin-3 on PTC patients.Methods: Subjects were assigned into PTC (160 cases) and benign thyroid tumor groups (150 cases). Fasting peripheral venous blood was collected. LncRNA HOTAIR/Galectin-3 expressions in serum were detected. Subjects were assigned into HOTAIR/Glactin-3 high/low expression groups and their correlation with age, gender, BMI, tumor size, pathological stage, TSH, TPO-Ab, and TG-Ab in PTC was analyzed. Receiver operating characteristic (ROC) curve was conducted on diagnostic efficacy of HOTAIR or/and Galectin-3. The difference of area under the curve (AUC) was compared and analyzed.Results: HOTAIR and Glactin-3 were higher in PTC group and correlated with tumor pathological stage. Higher HOTAIR/Glactin-3 expression indicated a more advanced TNM stage. LncRNA HOTAIR was positively correlated with TPO-Ab and TG-Ab. AUC of HOTAIR for PTC diagnosis was 0.895, with 96.00% specificity and 80.63% sensitivity. AUC of Glactin-3 for PTC diagnosis was 0.817, with 66.67% specificity and 78.75% sensitivity. AUC of HOTAIR combining with Glactin-3 for PTC diagnosis was 0.969 with 96.00% specificity and 87.50% sensitivity. AUC of lncRNA HOTAIR was higher than that of Glactin-3, while AUC of the combination was higher than that of lncRNA HOTAIR or Glactin-3.Conclusion: LncRNA HOTAIR and Glactin-3 were highly expressed in PTC. The combination detection of lncRNA HOTAIR/Glactin-3 had higher diagnostic efficiency on the differential diagnosis of benign thyroid tumor and PTC.Keywords: papillary thyroid carcinoma, LncRNA HOTAIR, Glactin-3, combination detection, benign thyroid tumor, ROC curve analysis, diagnostic efficiency, TPO-Ab, PTC
- Published
- 2021
30. Resolving the heterogeneous tumour microenvironment in cardiac myxoma through single-cell and spatial transcriptomics.
- Author
-
Liu, X, Shen, H, Yu, J, Luo, F, Li, T, Li, Q, Yuan, X, Sun, Y, Zhou, Z, Liu, X, Shen, H, Yu, J, Luo, F, Li, T, Li, Q, Yuan, X, Sun, Y, and Zhou, Z
- Abstract
BACKGROUND: Cardiac myxoma (CM) is the most common (58%-80%) type of primary cardiac tumours. Currently, there is a need to develop medical therapies, especially for patients not physically suitable for surgeries. However, the mechanisms that shape the tumour microenvironment (TME) in CM remain largely unknown, which impedes the development of targeted therapies. Here, we aimed to dissect the TME in CM at single-cell and spatial resolution. METHODS: We performed single-cell transcriptomic sequencing and Visium CytAssist spatial transcriptomic (ST) assays on tumour samples from patients with CM. A comprehensive analysis was performed, including unsupervised clustering, RNA velocity, clonal substructure inference of tumour cells and cell-cell communication. RESULTS: Unsupervised clustering of 34 759 cells identified 12 clusters, which were assigned to endothelial cells (ECs), mesenchymal stroma cells (MSCs), and tumour-infiltrating immune cells. Myxoma tumour cells were found to encompass two closely related phenotypic states, namely, EC-like tumour cells (ETCs) and MSC-like tumour cells (MTCs). According to RNA velocity, our findings suggest that ETCs may be directly differentiated from MTCs. The immune microenvironment of CM was found to contain multiple factors that promote immune suppression and evasion, underscoring the potential of using immunotherapies as a treatment option. Hyperactive signals sent primarily by tumour cells were identified, such as MDK, HGF, chemerin, and GDF15 signalling. Finally, the ST assay uncovered spatial features of the subclusters, proximal cell-cell communication, and clonal evolution of myxoma tumour cells. CONCLUSIONS: Our study presents the first comprehensive characterisation of the TME in CM at both single-cell and spatial resolution. Our study provides novel insight into the differentiation of myxoma tumour cells and advance our understanding of the TME in CM. Given the rarity of cardiac tumours, our study provides invaluable d
- Published
- 2024
31. Real-time monitoring for the next core-collapse supernova in JUNO
- Author
-
Abusleme, A, Adam, T, Ahmad, S, Ahmed, R, Aiello, S, Akram, M, Aleem, A, An, F, An, Q, Andronico, G, Anfimov, N, Antonelli, V, Antoshkina, T, Asavapibhop, B, de André, J, Auguste, D, Bai, W, Balashov, N, Baldini, W, Barresi, A, Basilico, D, Baussan, E, Bellato, M, Beretta, M, Bergnoli, A, Bick, D, Bieger, L, Biktemerova, S, Birkenfeld, T, Morton-Blake, I, Blum, D, Blyth, S, Bolshakova, A, Bongrand, M, Bordereau, C, Breton, D, Brigatti, A, Brugnera, R, Bruno, R, Budano, A, Busto, J, Cabrera, A, Caccianiga, B, Cai, H, Cai, X, Cai, Y, Cai, Z, Callier, S, Cammi, A, Campeny, A, Cao, C, Cao, G, Cao, J, Caruso, R, Cerna, C, Cerrone, V, Chan, C, Chang, J, Chang, Y, Chatrabhuti, A, Chen, C, Chen, G, Chen, P, Chen, S, Chen, Y, Chen, Z, Cheng, J, Cheng, Y, Chepurnov, A, Chetverikov, A, Chiesa, D, Chimenti, P, Chin, Y, Chu, Z, Chukanov, A, Claverie, G, Clementi, C, Clerbaux, B, Molla, M, Lorenzo, S, Coppi, A, Corti, D, Csakli, S, Corso, F, Dalager, O, Datta, J, Taille, C, Deng, Z, Ding, X, Ding, Y, Dirgantara, B, Dittrich, C, Dmitrievsky, S, Dohnal, T, Dolzhikov, D, Donchenko, G, Dong, J, Doroshkevich, E, Dou, W, Dracos, M, Druillole, F, Du, R, Du, S, Dugas, K, Dusini, S, Duyang, H, Eck, J, Enqvist, T, Fabbri, A, Fahrendholz, U, Fan, L, Fang, J, Fang, W, Fargetta, M, Fedoseev, D, Fei, Z, Feng, L, Feng, Q, Ferraro, F, Fournier, A, Gan, H, Gao, F, Garfagnini, A, Gavrikov, A, Giammarchi, M, Giudice, N, Gonchar, M, Gong, G, Gong, H, Gornushkin, Y, Göttel, A, Grassi, M, Gromov, M, Gromov, V, Gu, M, Gu, X, Gu, Y, Guan, M, Guan, Y, Guardone, N, Guo, C, Guo, W, Guo, X, Hagner, C, Han, R, Han, Y, He, M, He, W, Heinz, T, Hellmuth, P, Heng, Y, Herrera, R, Hor, Y, Hou, S, Hsiung, Y, Hu, B, Hu, H, Hu, J, Hu, S, Hu, T, Hu, Y, Hu, Z, Huang, G, Huang, H, Huang, J, Huang, K, Huang, W, Huang, X, Huang, Y, Hui, J, Huo, L, Huo, W, Huss, C, Hussain, S, Imbert, L, Ioannisian, A, Isocrate, R, Jafar, A, Jelmini, B, Jeria, I, Ji, X, Jia, H, Jia, J, Jian, S, Jiang, C, Jiang, D, Jiang, W, Jiang, X, Jing, X, Jollet, C, Kampmann, P, Kang, L, Karaparambil, R, Kazarian, N, Khan, A, Khatun, A, Khosonthongkee, K, Korablev, D, Kouzakov, K, Krasnoperov, A, Kuleshov, S, Kutovskiy, N, Labit, L, Lachenmaier, T, Landini, C, Leblanc, S, Lebrin, V, Lefevre, F, Lei, R, Leitner, R, Leung, J, Li, D, Li, F, Li, G, Li, H, Li, J, Li, M, Li, N, Li, Q, Li, R, Li, S, Li, T, Li, W, Li, X, Li, Y, Li, Z, Liang, H, Liao, J, Limphirat, A, Lin, G, Lin, S, Lin, T, Ling, J, Ling, X, Lippi, I, Liu, C, Liu, F, Liu, H, Liu, J, Liu, M, Liu, Q, Liu, R, Liu, S, Liu, X, Liu, Y, Liu, Z, Lokhov, A, Lombardi, P, Lombardo, C, Loo, K, Lu, C, Lu, H, Lu, J, Lu, P, Lu, S, Lu, X, Lubsandorzhiev, B, Lubsandorzhiev, S, Ludhova, L, Lukanov, A, Luo, D, Luo, F, Luo, G, Luo, J, Luo, S, Luo, W, Luo, X, Lyashuk, V, Ma, B, Ma, Q, Ma, S, Ma, X, Maalmi, J, Magoni, M, Mai, J, Malyshkin, Y, Mandujano, R, Mantovani, F, Mao, X, Mao, Y, Mari, S, Marini, F, Martini, A, Mayer, M, Mayilyan, D, Mednieks, I, Meng, Y, Meraviglia, A, Meregaglia, A, Meroni, E, Meyhöfer, D, Miramonti, L, Mohan, N, Montuschi, M, Müller, A, Nastasi, M, Naumov, D, Naumova, E, Navas-Nicolas, D, Nemchenok, I, Thi, M, Nikolaev, A, Ning, F, Ning, Z, Nunokawa, H, Oberauer, L, Ochoa-Ricoux, J, Olshevskiy, A, Orestano, D, Ortica, F, Othegraven, R, Paoloni, A, Parmeggiano, S, Pei, Y, Pelicci, L, Peng, A, Peng, H, Peng, Y, Peng, Z, Perrot, F, Petitjean, P, Petrucci, F, Pilarczyk, O, Rico, L, Popov, A, Poussot, P, Previtali, E, Qi, F, Qi, M, Qi, X, Qian, S, Qian, X, Qian, Z, Qiao, H, Qin, Z, Qiu, S, Qu, M, Qu, Z, Ranucci, G, Rasheed, R, Re, A, Rebii, A, Redchuk, M, Ren, B, Ren, J, Ricci, B, Rientong, K, Rifai, M, Roche, M, Rodphai, N, Romani, A, Roskovec, B, Ruan, X, Rybnikov, A, Sadovsky, A, Saggese, P, Sandanayake, D, Sangka, A, Sava, G, Sawangwit, U, Schever, M, Schwab, C, Schweizer, K, Selyunin, A, Serafini, A, Settimo, M, Sharov, V, Shaydurova, A, Shi, J, Shi, Y, Shutov, V, Sidorenkov, A, Šimkovic, F, Singhal, A, Sirignano, C, Siripak, J, Sisti, M, Smirnov, M, Smirnov, O, Sogo-Bezerra, T, Sokolov, S, Songwadhana, J, Soonthornthum, B, Sotnikov, A, Šrámek, O, Sreethawong, W, Stahl, A, Stanco, L, Stankevich, K, Steiger, H, Steinmann, J, Sterr, T, Stock, M, Strati, V, Studenikin, A, Su, A, Su, J, Sun, S, Sun, X, Sun, Y, Sun, Z, Suwonjandee, N, Szelezniak, M, Takenaka, A, Tang, J, Tang, Q, Tang, X, Hariharan, V, Theisen, E, Tietzsch, A, Tkachev, I, Tmej, T, Torri, M, Tortorici, F, Treskov, K, Triossi, A, Triozzi, R, Trzaska, W, Tung, Y, Tuve, C, Ushakov, N, Vedin, V, Venettacci, C, Verde, G, Vialkov, M, Viaud, B, Vollbrecht, C, von Sturm, K, Vorobel, V, Voronin, D, Votano, L, Walker, P, Wang, C, Wang, E, Wang, G, Wang, J, Wang, L, Wang, M, Wang, R, Wang, S, Wang, W, Wang, X, Wang, Y, Wang, Z, Watcharangkool, A, Wei, W, Wei, Y, Wen, K, Wen, L, Weng, J, Wiebusch, C, Wirth, R, Wonsak, B, Wu, D, Wu, Q, Wu, Y, Wu, Z, Wurm, M, Wurtz, J, Wysotzki, C, Xi, Y, Xia, D, Xiao, F, Xiao, X, Xie, X, Xie, Y, Xie, Z, Xin, Z, Xing, Z, Xu, B, Xu, C, Xu, D, Xu, F, Xu, H, Xu, J, Xu, M, Xu, X, Xu, Y, Yan, B, Yan, Q, Yan, T, Yan, X, Yan, Y, Yang, C, Yang, J, Yang, L, Yang, X, Yang, Y, Yao, H, Ye, J, Ye, M, Ye, Z, Yermia, F, You, Z, Yu, B, Yu, C, Yu, G, Yu, H, Yu, M, Yu, X, Yu, Z, Yuan, C, Yuan, Y, Yuan, Z, Yue, B, Zafar, N, Zavadskyi, V, Zeng, F, Zeng, S, Zeng, T, Zeng, Y, Zhan, L, Zhang, A, Zhang, B, Zhang, F, Zhang, H, Zhang, J, Zhang, L, Zhang, M, Zhang, P, Zhang, Q, Zhang, S, Zhang, T, Zhang, X, Zhang, Y, Zhang, Z, Zhao, J, Zhao, R, Zhao, S, Zheng, D, Zheng, H, Zheng, Y, Zhong, W, Zhou, J, Zhou, L, Zhou, N, Zhou, S, Zhou, T, Zhou, X, Zhu, J, Zhu, K, Zhu, Z, Zhuang, B, Zhuang, H, Zong, L, Zou, J, Züfle, J, Null, N, Abusleme, Angel, Adam, Thomas, Ahmad, Shakeel, Ahmed, Rizwan, Aiello, Sebastiano, Akram, Muhammad, Aleem, Abid, An, Fengpeng, An, Qi, Andronico, Giuseppe, Anfimov, Nikolay, Antonelli, Vito, Antoshkina, Tatiana, Asavapibhop, Burin, de André, João Pedro Athayde Marcondes, Auguste, Didier, Bai, Weidong, Balashov, Nikita, Baldini, Wander, Barresi, Andrea, Basilico, Davide, Baussan, Eric, Bellato, Marco, Beretta, Marco, Bergnoli, Antonio, Bick, Daniel, Bieger, Lukas, Biktemerova, Svetlana, Birkenfeld, Thilo, Morton-Blake, Iwan, Blum, David, Blyth, Simon, Bolshakova, Anastasia, Bongrand, Mathieu, Bordereau, Clément, Breton, Dominique, Brigatti, Augusto, Brugnera, Riccardo, Bruno, Riccardo, Budano, Antonio, Busto, Jose, Cabrera, Anatael, Caccianiga, Barbara, Cai, Hao, Cai, Xiao, Cai, Yanke, Cai, Zhiyan, Callier, Stéphane, Cammi, Antonio, Campeny, Agustin, Cao, Chuanya, Cao, Guofu, Cao, Jun, Caruso, Rossella, Cerna, Cédric, Cerrone, Vanessa, Chan, Chi, Chang, Jinfan, Chang, Yun, Chatrabhuti, Auttakit, Chen, Chao, Chen, Guoming, Chen, Pingping, Chen, Shaomin, Chen, Yixue, Chen, Yu, Chen, Zhangming, Chen, Zhiyuan, Chen, Zikang, Cheng, Jie, Cheng, Yaping, Cheng, Yu Chin, Chepurnov, Alexander, Chetverikov, Alexey, Chiesa, Davide, Chimenti, Pietro, Chin, Yen-Ting, Chu, Ziliang, Chukanov, Artem, Claverie, Gérard, Clementi, Catia, Clerbaux, Barbara, Molla, Marta Colomer, Lorenzo, Selma Conforti Di, Coppi, Alberto, Corti, Daniele, Csakli, Simon, Corso, Flavio Dal, Dalager, Olivia, Datta, Jaydeep, Taille, Christophe De La, Deng, Zhi, Deng, Ziyan, Ding, Xiaoyu, Ding, Xuefeng, Ding, Yayun, Dirgantara, Bayu, Dittrich, Carsten, Dmitrievsky, Sergey, Dohnal, Tadeas, Dolzhikov, Dmitry, Donchenko, Georgy, Dong, Jianmeng, Doroshkevich, Evgeny, Dou, Wei, Dracos, Marcos, Druillole, Frédéric, Du, Ran, Du, Shuxian, Dugas, Katherine, Dusini, Stefano, Duyang, Hongyue, Eck, Jessica, Enqvist, Timo, Fabbri, Andrea, Fahrendholz, Ulrike, Fan, Lei, Fang, Jian, Fang, Wenxing, Fargetta, Marco, Fedoseev, Dmitry, Fei, Zhengyong, Feng, Li-Cheng, Feng, Qichun, Ferraro, Federico, Fournier, Amélie, Gan, Haonan, Gao, Feng, Garfagnini, Alberto, Gavrikov, Arsenii, Giammarchi, Marco, Giudice, Nunzio, Gonchar, Maxim, Gong, Guanghua, Gong, Hui, Gornushkin, Yuri, Göttel, Alexandre, Grassi, Marco, Gromov, Maxim, Gromov, Vasily, Gu, Minghao, Gu, Xiaofei, Gu, Yu, Guan, Mengyun, Guan, Yuduo, Guardone, Nunzio, Guo, Cong, Guo, Wanlei, Guo, Xinheng, Hagner, Caren, Han, Ran, Han, Yang, He, Miao, He, Wei, Heinz, Tobias, Hellmuth, Patrick, Heng, Yuekun, Herrera, Rafael, Hor, YuenKeung, Hou, Shaojing, Hsiung, Yee, Hu, Bei-Zhen, Hu, Hang, Hu, Jianrun, Hu, Jun, Hu, Shouyang, Hu, Tao, Hu, Yuxiang, Hu, Zhuojun, Huang, Guihong, Huang, Hanxiong, Huang, Jinhao, Huang, Junting, Huang, Kaixuan, Huang, Wenhao, Huang, Xin, Huang, Xingtao, Huang, Yongbo, Hui, Jiaqi, Huo, Lei, Huo, Wenju, Huss, Cédric, Hussain, Safeer, Imbert, Leonard, Ioannisian, Ara, Isocrate, Roberto, Jafar, Arshak, Jelmini, Beatrice, Jeria, Ignacio, Ji, Xiaolu, Jia, Huihui, Jia, Junji, Jian, Siyu, Jiang, Cailian, Jiang, Di, Jiang, Wei, Jiang, Xiaoshan, Jing, Xiaoping, Jollet, Cécile, Kampmann, Philipp, Kang, Li, Karaparambil, Rebin, Kazarian, Narine, Khan, Ali, Khatun, Amina, Khosonthongkee, Khanchai, Korablev, Denis, Kouzakov, Konstantin, Krasnoperov, Alexey, Kuleshov, Sergey, Kutovskiy, Nikolay, Labit, Loïc, Lachenmaier, Tobias, Landini, Cecilia, Leblanc, Sébastien, Lebrin, Victor, Lefevre, Frederic, Lei, Ruiting, Leitner, Rupert, Leung, Jason, Li, Demin, Li, Fei, Li, Fule, Li, Gaosong, Li, Huiling, Li, Jiajun, Li, Mengzhao, Li, Min, Li, Nan, Li, Qingjiang, Li, Ruhui, Li, Rui, Li, Shanfeng, Li, Tao, Li, Teng, Li, Weidong, Li, Weiguo, Li, Xiaomei, Li, Xiaonan, Li, Xinglong, Li, Yi, Li, Yichen, Li, Yufeng, Li, Zhaohan, Li, Zhibing, Li, Ziyuan, Li, Zonghai, Liang, Hao, Liao, Jiajun, Limphirat, Ayut, Lin, Guey-Lin, Lin, Shengxin, Lin, Tao, Ling, Jiajie, Ling, Xin, Lippi, Ivano, Liu, Caimei, Liu, Fang, Liu, Fengcheng, Liu, Haidong, Liu, Haotian, Liu, Hongbang, Liu, Hongjuan, Liu, Hongtao, Liu, Hui, Liu, Jianglai, Liu, Jiaxi, Liu, Jinchang, Liu, Min, Liu, Qian, Liu, Qin, Liu, Runxuan, Liu, Shenghui, Liu, Shubin, Liu, Shulin, Liu, Xiaowei, Liu, Xiwen, Liu, Xuewei, Liu, Yankai, Liu, Zhen, Lokhov, Alexey, Lombardi, Paolo, Lombardo, Claudio, Loo, Kai, Lu, Chuan, Lu, Haoqi, Lu, Jingbin, Lu, Junguang, Lu, Peizhi, Lu, Shuxiang, Lu, Xianguo, Lubsandorzhiev, Bayarto, Lubsandorzhiev, Sultim, Ludhova, Livia, Lukanov, Arslan, Luo, Daibin, Luo, Fengjiao, Luo, Guang, Luo, Jianyi, Luo, Shu, Luo, Wuming, Luo, Xiaojie, Lyashuk, Vladimir, Ma, Bangzheng, Ma, Bing, Ma, Qiumei, Ma, Si, Ma, Xiaoyan, Ma, Xubo, Maalmi, Jihane, Magoni, Marco, Mai, Jingyu, Malyshkin, Yury, Mandujano, Roberto Carlos, Mantovani, Fabio, Mao, Xin, Mao, Yajun, Mari, Stefano M., Marini, Filippo, Martini, Agnese, Mayer, Matthias, Mayilyan, Davit, Mednieks, Ints, Meng, Yue, Meraviglia, Anita, Meregaglia, Anselmo, Meroni, Emanuela, Meyhöfer, David, Miramonti, Lino, Mohan, Nikhil, Montuschi, Michele, Müller, Axel, Nastasi, Massimiliano, Naumov, Dmitry V., Naumova, Elena, Navas-Nicolas, Diana, Nemchenok, Igor, Thi, Minh Thuan Nguyen, Nikolaev, Alexey, Ning, Feipeng, Ning, Zhe, Nunokawa, Hiroshi, Oberauer, Lothar, Ochoa-Ricoux, Juan Pedro, Olshevskiy, Alexander, Orestano, Domizia, Ortica, Fausto, Othegraven, Rainer, Paoloni, Alessandro, Parmeggiano, Sergio, Pei, Yatian, Pelicci, Luca, Peng, Anguo, Peng, Haiping, Peng, Yu, Peng, Zhaoyuan, Perrot, Frédéric, Petitjean, Pierre-Alexandre, Petrucci, Fabrizio, Pilarczyk, Oliver, Rico, Luis Felipe Piñeres, Popov, Artyom, Poussot, Pascal, Previtali, Ezio, Qi, Fazhi, Qi, Ming, Qi, Xiaohui, Qian, Sen, Qian, Xiaohui, Qian, Zhen, Qiao, Hao, Qin, Zhonghua, Qiu, Shoukang, Qu, Manhao, Qu, Zhenning, Ranucci, Gioacchino, Rasheed, Reem, Re, Alessandra, Rebii, Abdel, Redchuk, Mariia, Ren, Bin, Ren, Jie, Ricci, Barbara, Rientong, Komkrit, Rifai, Mariam, Roche, Mathieu, Rodphai, Narongkiat, Romani, Aldo, Roskovec, Bedřich, Ruan, Xichao, Rybnikov, Arseniy, Sadovsky, Andrey, Saggese, Paolo, Sandanayake, Deshan, Sangka, Anut, Sava, Giuseppe, Sawangwit, Utane, Schever, Michaela, Schwab, Cédric, Schweizer, Konstantin, Selyunin, Alexandr, Serafini, Andrea, Settimo, Mariangela, Sharov, Vladislav, Shaydurova, Arina, Shi, Jingyan, Shi, Yanan, Shutov, Vitaly, Sidorenkov, Andrey, Šimkovic, Fedor, Singhal, Apeksha, Sirignano, Chiara, Siripak, Jaruchit, Sisti, Monica, Smirnov, Mikhail, Smirnov, Oleg, Sogo-Bezerra, Thiago, Sokolov, Sergey, Songwadhana, Julanan, Soonthornthum, Boonrucksar, Sotnikov, Albert, Šrámek, Ondřej, Sreethawong, Warintorn, Stahl, Achim, Stanco, Luca, Stankevich, Konstantin, Steiger, Hans, Steinmann, Jochen, Sterr, Tobias, Stock, Matthias Raphael, Strati, Virginia, Studenikin, Alexander, Su, Aoqi, Su, Jun, Sun, Shifeng, Sun, Xilei, Sun, Yongjie, Sun, Yongzhao, Sun, Zhengyang, Suwonjandee, Narumon, Szelezniak, Michal, Takenaka, Akira, Tang, Jian, Tang, Qiang, Tang, Quan, Tang, Xiao, Hariharan, Vidhya Thara, Theisen, Eric, Tietzsch, Alexander, Tkachev, Igor, Tmej, Tomas, Torri, Marco Danilo Claudio, Tortorici, Francesco, Treskov, Konstantin, Triossi, Andrea, Triozzi, Riccardo, Trzaska, Wladyslaw, Tung, Yu-Chen, Tuve, Cristina, Ushakov, Nikita, Vedin, Vadim, Venettacci, Carlo, Verde, Giuseppe, Vialkov, Maxim, Viaud, Benoit, Vollbrecht, Cornelius Moritz, von Sturm, Katharina, Vorobel, Vit, Voronin, Dmitriy, Votano, Lucia, Walker, Pablo, Wang, Caishen, Wang, Chung-Hsiang, Wang, En, Wang, Guoli, Wang, Jian, Wang, Jun, Wang, Li, Wang, Lu, Wang, Meng, Wang, Ruiguang, Wang, Siguang, Wang, Wei, Wang, Wenshuai, Wang, Xi, Wang, Xiangyue, Wang, Yangfu, Wang, Yaoguang, Wang, Yi, Wang, Yifang, Wang, Yuanqing, Wang, Yuyi, Wang, Zhe, Wang, Zheng, Wang, Zhimin, Watcharangkool, Apimook, Wei, Wei, Wei, Wenlu, Wei, Yadong, Wei, Yuehuan, Wen, Kaile, Wen, Liangjian, Weng, Jun, Wiebusch, Christopher, Wirth, Rosmarie, Wonsak, Bjoern, Wu, Diru, Wu, Qun, Wu, Yiyang, Wu, Zhi, Wurm, Michael, Wurtz, Jacques, Wysotzki, Christian, Xi, Yufei, Xia, Dongmei, Xiao, Fei, Xiao, Xiang, Xie, Xiaochuan, Xie, Yuguang, Xie, Zhangquan, Xin, Zhao, Xing, Zhizhong, Xu, Benda, Xu, Cheng, Xu, Donglian, Xu, Fanrong, Xu, Hangkun, Xu, Jilei, Xu, Jing, Xu, Meihang, Xu, Xunjie, Xu, Yin, Xu, Yu, Yan, Baojun, Yan, Qiyu, Yan, Taylor, Yan, Xiongbo, Yan, Yupeng, Yang, Changgen, Yang, Chengfeng, Yang, Jie, Yang, Lei, Yang, Xiaoyu, Yang, Yifan, Yao, Haifeng, Ye, Jiaxuan, Ye, Mei, Ye, Ziping, Yermia, Frédéric, You, Zhengyun, Yu, Boxiang, Yu, Chiye, Yu, Chunxu, Yu, Guojun, Yu, Hongzhao, Yu, Miao, Yu, Xianghui, Yu, Zeyuan, Yu, Zezhong, Yuan, Cenxi, Yuan, Chengzhuo, Yuan, Ying, Yuan, Zhenxiong, Yue, Baobiao, Zafar, Noman, Zavadskyi, Vitalii, Zeng, Fanrui, Zeng, Shan, Zeng, Tingxuan, Zeng, Yuda, Zhan, Liang, Zhang, Aiqiang, Zhang, Bin, Zhang, Binting, Zhang, Feiyang, Zhang, Haosen, Zhang, Honghao, Zhang, Jialiang, Zhang, Jiawen, Zhang, Jie, Zhang, Jingbo, Zhang, Jinnan, ZHANG, Lei, Zhang, Mohan, Zhang, Peng, Zhang, Ping, Zhang, Qingmin, Zhang, Shiqi, Zhang, Shu, Zhang, Shuihan, Zhang, Siyuan, Zhang, Tao, Zhang, Xiaomei, Zhang, Xin, Zhang, Xuantong, Zhang, Yinhong, Zhang, Yiyu, Zhang, Yongpeng, Zhang, Yu, Zhang, Yuanyuan, Zhang, Yumei, Zhang, Zhenyu, Zhang, Zhijian, Zhao, Jie, Zhao, Rong, Zhao, Runze, Zhao, Shujun, Zheng, Dongqin, Zheng, Hua, Zheng, Yangheng, Zhong, Weirong, Zhou, Jing, Zhou, Li, Zhou, Nan, Zhou, Shun, Zhou, Tong, Zhou, Xiang, Zhu, Jingsen, Zhu, Kangfu, Zhu, Kejun, Zhu, Zhihang, Zhuang, Bo, Zhuang, Honglin, Zong, Liang, Zou, Jiaheng, Züfle, Jan, null, null, Abusleme, A, Adam, T, Ahmad, S, Ahmed, R, Aiello, S, Akram, M, Aleem, A, An, F, An, Q, Andronico, G, Anfimov, N, Antonelli, V, Antoshkina, T, Asavapibhop, B, de André, J, Auguste, D, Bai, W, Balashov, N, Baldini, W, Barresi, A, Basilico, D, Baussan, E, Bellato, M, Beretta, M, Bergnoli, A, Bick, D, Bieger, L, Biktemerova, S, Birkenfeld, T, Morton-Blake, I, Blum, D, Blyth, S, Bolshakova, A, Bongrand, M, Bordereau, C, Breton, D, Brigatti, A, Brugnera, R, Bruno, R, Budano, A, Busto, J, Cabrera, A, Caccianiga, B, Cai, H, Cai, X, Cai, Y, Cai, Z, Callier, S, Cammi, A, Campeny, A, Cao, C, Cao, G, Cao, J, Caruso, R, Cerna, C, Cerrone, V, Chan, C, Chang, J, Chang, Y, Chatrabhuti, A, Chen, C, Chen, G, Chen, P, Chen, S, Chen, Y, Chen, Z, Cheng, J, Cheng, Y, Chepurnov, A, Chetverikov, A, Chiesa, D, Chimenti, P, Chin, Y, Chu, Z, Chukanov, A, Claverie, G, Clementi, C, Clerbaux, B, Molla, M, Lorenzo, S, Coppi, A, Corti, D, Csakli, S, Corso, F, Dalager, O, Datta, J, Taille, C, Deng, Z, Ding, X, Ding, Y, Dirgantara, B, Dittrich, C, Dmitrievsky, S, Dohnal, T, Dolzhikov, D, Donchenko, G, Dong, J, Doroshkevich, E, Dou, W, Dracos, M, Druillole, F, Du, R, Du, S, Dugas, K, Dusini, S, Duyang, H, Eck, J, Enqvist, T, Fabbri, A, Fahrendholz, U, Fan, L, Fang, J, Fang, W, Fargetta, M, Fedoseev, D, Fei, Z, Feng, L, Feng, Q, Ferraro, F, Fournier, A, Gan, H, Gao, F, Garfagnini, A, Gavrikov, A, Giammarchi, M, Giudice, N, Gonchar, M, Gong, G, Gong, H, Gornushkin, Y, Göttel, A, Grassi, M, Gromov, M, Gromov, V, Gu, M, Gu, X, Gu, Y, Guan, M, Guan, Y, Guardone, N, Guo, C, Guo, W, Guo, X, Hagner, C, Han, R, Han, Y, He, M, He, W, Heinz, T, Hellmuth, P, Heng, Y, Herrera, R, Hor, Y, Hou, S, Hsiung, Y, Hu, B, Hu, H, Hu, J, Hu, S, Hu, T, Hu, Y, Hu, Z, Huang, G, Huang, H, Huang, J, Huang, K, Huang, W, Huang, X, Huang, Y, Hui, J, Huo, L, Huo, W, Huss, C, Hussain, S, Imbert, L, Ioannisian, A, Isocrate, R, Jafar, A, Jelmini, B, Jeria, I, Ji, X, Jia, H, Jia, J, Jian, S, Jiang, C, Jiang, D, Jiang, W, Jiang, X, Jing, X, Jollet, C, Kampmann, P, Kang, L, Karaparambil, R, Kazarian, N, Khan, A, Khatun, A, Khosonthongkee, K, Korablev, D, Kouzakov, K, Krasnoperov, A, Kuleshov, S, Kutovskiy, N, Labit, L, Lachenmaier, T, Landini, C, Leblanc, S, Lebrin, V, Lefevre, F, Lei, R, Leitner, R, Leung, J, Li, D, Li, F, Li, G, Li, H, Li, J, Li, M, Li, N, Li, Q, Li, R, Li, S, Li, T, Li, W, Li, X, Li, Y, Li, Z, Liang, H, Liao, J, Limphirat, A, Lin, G, Lin, S, Lin, T, Ling, J, Ling, X, Lippi, I, Liu, C, Liu, F, Liu, H, Liu, J, Liu, M, Liu, Q, Liu, R, Liu, S, Liu, X, Liu, Y, Liu, Z, Lokhov, A, Lombardi, P, Lombardo, C, Loo, K, Lu, C, Lu, H, Lu, J, Lu, P, Lu, S, Lu, X, Lubsandorzhiev, B, Lubsandorzhiev, S, Ludhova, L, Lukanov, A, Luo, D, Luo, F, Luo, G, Luo, J, Luo, S, Luo, W, Luo, X, Lyashuk, V, Ma, B, Ma, Q, Ma, S, Ma, X, Maalmi, J, Magoni, M, Mai, J, Malyshkin, Y, Mandujano, R, Mantovani, F, Mao, X, Mao, Y, Mari, S, Marini, F, Martini, A, Mayer, M, Mayilyan, D, Mednieks, I, Meng, Y, Meraviglia, A, Meregaglia, A, Meroni, E, Meyhöfer, D, Miramonti, L, Mohan, N, Montuschi, M, Müller, A, Nastasi, M, Naumov, D, Naumova, E, Navas-Nicolas, D, Nemchenok, I, Thi, M, Nikolaev, A, Ning, F, Ning, Z, Nunokawa, H, Oberauer, L, Ochoa-Ricoux, J, Olshevskiy, A, Orestano, D, Ortica, F, Othegraven, R, Paoloni, A, Parmeggiano, S, Pei, Y, Pelicci, L, Peng, A, Peng, H, Peng, Y, Peng, Z, Perrot, F, Petitjean, P, Petrucci, F, Pilarczyk, O, Rico, L, Popov, A, Poussot, P, Previtali, E, Qi, F, Qi, M, Qi, X, Qian, S, Qian, X, Qian, Z, Qiao, H, Qin, Z, Qiu, S, Qu, M, Qu, Z, Ranucci, G, Rasheed, R, Re, A, Rebii, A, Redchuk, M, Ren, B, Ren, J, Ricci, B, Rientong, K, Rifai, M, Roche, M, Rodphai, N, Romani, A, Roskovec, B, Ruan, X, Rybnikov, A, Sadovsky, A, Saggese, P, Sandanayake, D, Sangka, A, Sava, G, Sawangwit, U, Schever, M, Schwab, C, Schweizer, K, Selyunin, A, Serafini, A, Settimo, M, Sharov, V, Shaydurova, A, Shi, J, Shi, Y, Shutov, V, Sidorenkov, A, Šimkovic, F, Singhal, A, Sirignano, C, Siripak, J, Sisti, M, Smirnov, M, Smirnov, O, Sogo-Bezerra, T, Sokolov, S, Songwadhana, J, Soonthornthum, B, Sotnikov, A, Šrámek, O, Sreethawong, W, Stahl, A, Stanco, L, Stankevich, K, Steiger, H, Steinmann, J, Sterr, T, Stock, M, Strati, V, Studenikin, A, Su, A, Su, J, Sun, S, Sun, X, Sun, Y, Sun, Z, Suwonjandee, N, Szelezniak, M, Takenaka, A, Tang, J, Tang, Q, Tang, X, Hariharan, V, Theisen, E, Tietzsch, A, Tkachev, I, Tmej, T, Torri, M, Tortorici, F, Treskov, K, Triossi, A, Triozzi, R, Trzaska, W, Tung, Y, Tuve, C, Ushakov, N, Vedin, V, Venettacci, C, Verde, G, Vialkov, M, Viaud, B, Vollbrecht, C, von Sturm, K, Vorobel, V, Voronin, D, Votano, L, Walker, P, Wang, C, Wang, E, Wang, G, Wang, J, Wang, L, Wang, M, Wang, R, Wang, S, Wang, W, Wang, X, Wang, Y, Wang, Z, Watcharangkool, A, Wei, W, Wei, Y, Wen, K, Wen, L, Weng, J, Wiebusch, C, Wirth, R, Wonsak, B, Wu, D, Wu, Q, Wu, Y, Wu, Z, Wurm, M, Wurtz, J, Wysotzki, C, Xi, Y, Xia, D, Xiao, F, Xiao, X, Xie, X, Xie, Y, Xie, Z, Xin, Z, Xing, Z, Xu, B, Xu, C, Xu, D, Xu, F, Xu, H, Xu, J, Xu, M, Xu, X, Xu, Y, Yan, B, Yan, Q, Yan, T, Yan, X, Yan, Y, Yang, C, Yang, J, Yang, L, Yang, X, Yang, Y, Yao, H, Ye, J, Ye, M, Ye, Z, Yermia, F, You, Z, Yu, B, Yu, C, Yu, G, Yu, H, Yu, M, Yu, X, Yu, Z, Yuan, C, Yuan, Y, Yuan, Z, Yue, B, Zafar, N, Zavadskyi, V, Zeng, F, Zeng, S, Zeng, T, Zeng, Y, Zhan, L, Zhang, A, Zhang, B, Zhang, F, Zhang, H, Zhang, J, Zhang, L, Zhang, M, Zhang, P, Zhang, Q, Zhang, S, Zhang, T, Zhang, X, Zhang, Y, Zhang, Z, Zhao, J, Zhao, R, Zhao, S, Zheng, D, Zheng, H, Zheng, Y, Zhong, W, Zhou, J, Zhou, L, Zhou, N, Zhou, S, Zhou, T, Zhou, X, Zhu, J, Zhu, K, Zhu, Z, Zhuang, B, Zhuang, H, Zong, L, Zou, J, Züfle, J, Null, N, Abusleme, Angel, Adam, Thomas, Ahmad, Shakeel, Ahmed, Rizwan, Aiello, Sebastiano, Akram, Muhammad, Aleem, Abid, An, Fengpeng, An, Qi, Andronico, Giuseppe, Anfimov, Nikolay, Antonelli, Vito, Antoshkina, Tatiana, Asavapibhop, Burin, de André, João Pedro Athayde Marcondes, Auguste, Didier, Bai, Weidong, Balashov, Nikita, Baldini, Wander, Barresi, Andrea, Basilico, Davide, Baussan, Eric, Bellato, Marco, Beretta, Marco, Bergnoli, Antonio, Bick, Daniel, Bieger, Lukas, Biktemerova, Svetlana, Birkenfeld, Thilo, Morton-Blake, Iwan, Blum, David, Blyth, Simon, Bolshakova, Anastasia, Bongrand, Mathieu, Bordereau, Clément, Breton, Dominique, Brigatti, Augusto, Brugnera, Riccardo, Bruno, Riccardo, Budano, Antonio, Busto, Jose, Cabrera, Anatael, Caccianiga, Barbara, Cai, Hao, Cai, Xiao, Cai, Yanke, Cai, Zhiyan, Callier, Stéphane, Cammi, Antonio, Campeny, Agustin, Cao, Chuanya, Cao, Guofu, Cao, Jun, Caruso, Rossella, Cerna, Cédric, Cerrone, Vanessa, Chan, Chi, Chang, Jinfan, Chang, Yun, Chatrabhuti, Auttakit, Chen, Chao, Chen, Guoming, Chen, Pingping, Chen, Shaomin, Chen, Yixue, Chen, Yu, Chen, Zhangming, Chen, Zhiyuan, Chen, Zikang, Cheng, Jie, Cheng, Yaping, Cheng, Yu Chin, Chepurnov, Alexander, Chetverikov, Alexey, Chiesa, Davide, Chimenti, Pietro, Chin, Yen-Ting, Chu, Ziliang, Chukanov, Artem, Claverie, Gérard, Clementi, Catia, Clerbaux, Barbara, Molla, Marta Colomer, Lorenzo, Selma Conforti Di, Coppi, Alberto, Corti, Daniele, Csakli, Simon, Corso, Flavio Dal, Dalager, Olivia, Datta, Jaydeep, Taille, Christophe De La, Deng, Zhi, Deng, Ziyan, Ding, Xiaoyu, Ding, Xuefeng, Ding, Yayun, Dirgantara, Bayu, Dittrich, Carsten, Dmitrievsky, Sergey, Dohnal, Tadeas, Dolzhikov, Dmitry, Donchenko, Georgy, Dong, Jianmeng, Doroshkevich, Evgeny, Dou, Wei, Dracos, Marcos, Druillole, Frédéric, Du, Ran, Du, Shuxian, Dugas, Katherine, Dusini, Stefano, Duyang, Hongyue, Eck, Jessica, Enqvist, Timo, Fabbri, Andrea, Fahrendholz, Ulrike, Fan, Lei, Fang, Jian, Fang, Wenxing, Fargetta, Marco, Fedoseev, Dmitry, Fei, Zhengyong, Feng, Li-Cheng, Feng, Qichun, Ferraro, Federico, Fournier, Amélie, Gan, Haonan, Gao, Feng, Garfagnini, Alberto, Gavrikov, Arsenii, Giammarchi, Marco, Giudice, Nunzio, Gonchar, Maxim, Gong, Guanghua, Gong, Hui, Gornushkin, Yuri, Göttel, Alexandre, Grassi, Marco, Gromov, Maxim, Gromov, Vasily, Gu, Minghao, Gu, Xiaofei, Gu, Yu, Guan, Mengyun, Guan, Yuduo, Guardone, Nunzio, Guo, Cong, Guo, Wanlei, Guo, Xinheng, Hagner, Caren, Han, Ran, Han, Yang, He, Miao, He, Wei, Heinz, Tobias, Hellmuth, Patrick, Heng, Yuekun, Herrera, Rafael, Hor, YuenKeung, Hou, Shaojing, Hsiung, Yee, Hu, Bei-Zhen, Hu, Hang, Hu, Jianrun, Hu, Jun, Hu, Shouyang, Hu, Tao, Hu, Yuxiang, Hu, Zhuojun, Huang, Guihong, Huang, Hanxiong, Huang, Jinhao, Huang, Junting, Huang, Kaixuan, Huang, Wenhao, Huang, Xin, Huang, Xingtao, Huang, Yongbo, Hui, Jiaqi, Huo, Lei, Huo, Wenju, Huss, Cédric, Hussain, Safeer, Imbert, Leonard, Ioannisian, Ara, Isocrate, Roberto, Jafar, Arshak, Jelmini, Beatrice, Jeria, Ignacio, Ji, Xiaolu, Jia, Huihui, Jia, Junji, Jian, Siyu, Jiang, Cailian, Jiang, Di, Jiang, Wei, Jiang, Xiaoshan, Jing, Xiaoping, Jollet, Cécile, Kampmann, Philipp, Kang, Li, Karaparambil, Rebin, Kazarian, Narine, Khan, Ali, Khatun, Amina, Khosonthongkee, Khanchai, Korablev, Denis, Kouzakov, Konstantin, Krasnoperov, Alexey, Kuleshov, Sergey, Kutovskiy, Nikolay, Labit, Loïc, Lachenmaier, Tobias, Landini, Cecilia, Leblanc, Sébastien, Lebrin, Victor, Lefevre, Frederic, Lei, Ruiting, Leitner, Rupert, Leung, Jason, Li, Demin, Li, Fei, Li, Fule, Li, Gaosong, Li, Huiling, Li, Jiajun, Li, Mengzhao, Li, Min, Li, Nan, Li, Qingjiang, Li, Ruhui, Li, Rui, Li, Shanfeng, Li, Tao, Li, Teng, Li, Weidong, Li, Weiguo, Li, Xiaomei, Li, Xiaonan, Li, Xinglong, Li, Yi, Li, Yichen, Li, Yufeng, Li, Zhaohan, Li, Zhibing, Li, Ziyuan, Li, Zonghai, Liang, Hao, Liao, Jiajun, Limphirat, Ayut, Lin, Guey-Lin, Lin, Shengxin, Lin, Tao, Ling, Jiajie, Ling, Xin, Lippi, Ivano, Liu, Caimei, Liu, Fang, Liu, Fengcheng, Liu, Haidong, Liu, Haotian, Liu, Hongbang, Liu, Hongjuan, Liu, Hongtao, Liu, Hui, Liu, Jianglai, Liu, Jiaxi, Liu, Jinchang, Liu, Min, Liu, Qian, Liu, Qin, Liu, Runxuan, Liu, Shenghui, Liu, Shubin, Liu, Shulin, Liu, Xiaowei, Liu, Xiwen, Liu, Xuewei, Liu, Yankai, Liu, Zhen, Lokhov, Alexey, Lombardi, Paolo, Lombardo, Claudio, Loo, Kai, Lu, Chuan, Lu, Haoqi, Lu, Jingbin, Lu, Junguang, Lu, Peizhi, Lu, Shuxiang, Lu, Xianguo, Lubsandorzhiev, Bayarto, Lubsandorzhiev, Sultim, Ludhova, Livia, Lukanov, Arslan, Luo, Daibin, Luo, Fengjiao, Luo, Guang, Luo, Jianyi, Luo, Shu, Luo, Wuming, Luo, Xiaojie, Lyashuk, Vladimir, Ma, Bangzheng, Ma, Bing, Ma, Qiumei, Ma, Si, Ma, Xiaoyan, Ma, Xubo, Maalmi, Jihane, Magoni, Marco, Mai, Jingyu, Malyshkin, Yury, Mandujano, Roberto Carlos, Mantovani, Fabio, Mao, Xin, Mao, Yajun, Mari, Stefano M., Marini, Filippo, Martini, Agnese, Mayer, Matthias, Mayilyan, Davit, Mednieks, Ints, Meng, Yue, Meraviglia, Anita, Meregaglia, Anselmo, Meroni, Emanuela, Meyhöfer, David, Miramonti, Lino, Mohan, Nikhil, Montuschi, Michele, Müller, Axel, Nastasi, Massimiliano, Naumov, Dmitry V., Naumova, Elena, Navas-Nicolas, Diana, Nemchenok, Igor, Thi, Minh Thuan Nguyen, Nikolaev, Alexey, Ning, Feipeng, Ning, Zhe, Nunokawa, Hiroshi, Oberauer, Lothar, Ochoa-Ricoux, Juan Pedro, Olshevskiy, Alexander, Orestano, Domizia, Ortica, Fausto, Othegraven, Rainer, Paoloni, Alessandro, Parmeggiano, Sergio, Pei, Yatian, Pelicci, Luca, Peng, Anguo, Peng, Haiping, Peng, Yu, Peng, Zhaoyuan, Perrot, Frédéric, Petitjean, Pierre-Alexandre, Petrucci, Fabrizio, Pilarczyk, Oliver, Rico, Luis Felipe Piñeres, Popov, Artyom, Poussot, Pascal, Previtali, Ezio, Qi, Fazhi, Qi, Ming, Qi, Xiaohui, Qian, Sen, Qian, Xiaohui, Qian, Zhen, Qiao, Hao, Qin, Zhonghua, Qiu, Shoukang, Qu, Manhao, Qu, Zhenning, Ranucci, Gioacchino, Rasheed, Reem, Re, Alessandra, Rebii, Abdel, Redchuk, Mariia, Ren, Bin, Ren, Jie, Ricci, Barbara, Rientong, Komkrit, Rifai, Mariam, Roche, Mathieu, Rodphai, Narongkiat, Romani, Aldo, Roskovec, Bedřich, Ruan, Xichao, Rybnikov, Arseniy, Sadovsky, Andrey, Saggese, Paolo, Sandanayake, Deshan, Sangka, Anut, Sava, Giuseppe, Sawangwit, Utane, Schever, Michaela, Schwab, Cédric, Schweizer, Konstantin, Selyunin, Alexandr, Serafini, Andrea, Settimo, Mariangela, Sharov, Vladislav, Shaydurova, Arina, Shi, Jingyan, Shi, Yanan, Shutov, Vitaly, Sidorenkov, Andrey, Šimkovic, Fedor, Singhal, Apeksha, Sirignano, Chiara, Siripak, Jaruchit, Sisti, Monica, Smirnov, Mikhail, Smirnov, Oleg, Sogo-Bezerra, Thiago, Sokolov, Sergey, Songwadhana, Julanan, Soonthornthum, Boonrucksar, Sotnikov, Albert, Šrámek, Ondřej, Sreethawong, Warintorn, Stahl, Achim, Stanco, Luca, Stankevich, Konstantin, Steiger, Hans, Steinmann, Jochen, Sterr, Tobias, Stock, Matthias Raphael, Strati, Virginia, Studenikin, Alexander, Su, Aoqi, Su, Jun, Sun, Shifeng, Sun, Xilei, Sun, Yongjie, Sun, Yongzhao, Sun, Zhengyang, Suwonjandee, Narumon, Szelezniak, Michal, Takenaka, Akira, Tang, Jian, Tang, Qiang, Tang, Quan, Tang, Xiao, Hariharan, Vidhya Thara, Theisen, Eric, Tietzsch, Alexander, Tkachev, Igor, Tmej, Tomas, Torri, Marco Danilo Claudio, Tortorici, Francesco, Treskov, Konstantin, Triossi, Andrea, Triozzi, Riccardo, Trzaska, Wladyslaw, Tung, Yu-Chen, Tuve, Cristina, Ushakov, Nikita, Vedin, Vadim, Venettacci, Carlo, Verde, Giuseppe, Vialkov, Maxim, Viaud, Benoit, Vollbrecht, Cornelius Moritz, von Sturm, Katharina, Vorobel, Vit, Voronin, Dmitriy, Votano, Lucia, Walker, Pablo, Wang, Caishen, Wang, Chung-Hsiang, Wang, En, Wang, Guoli, Wang, Jian, Wang, Jun, Wang, Li, Wang, Lu, Wang, Meng, Wang, Ruiguang, Wang, Siguang, Wang, Wei, Wang, Wenshuai, Wang, Xi, Wang, Xiangyue, Wang, Yangfu, Wang, Yaoguang, Wang, Yi, Wang, Yifang, Wang, Yuanqing, Wang, Yuyi, Wang, Zhe, Wang, Zheng, Wang, Zhimin, Watcharangkool, Apimook, Wei, Wei, Wei, Wenlu, Wei, Yadong, Wei, Yuehuan, Wen, Kaile, Wen, Liangjian, Weng, Jun, Wiebusch, Christopher, Wirth, Rosmarie, Wonsak, Bjoern, Wu, Diru, Wu, Qun, Wu, Yiyang, Wu, Zhi, Wurm, Michael, Wurtz, Jacques, Wysotzki, Christian, Xi, Yufei, Xia, Dongmei, Xiao, Fei, Xiao, Xiang, Xie, Xiaochuan, Xie, Yuguang, Xie, Zhangquan, Xin, Zhao, Xing, Zhizhong, Xu, Benda, Xu, Cheng, Xu, Donglian, Xu, Fanrong, Xu, Hangkun, Xu, Jilei, Xu, Jing, Xu, Meihang, Xu, Xunjie, Xu, Yin, Xu, Yu, Yan, Baojun, Yan, Qiyu, Yan, Taylor, Yan, Xiongbo, Yan, Yupeng, Yang, Changgen, Yang, Chengfeng, Yang, Jie, Yang, Lei, Yang, Xiaoyu, Yang, Yifan, Yao, Haifeng, Ye, Jiaxuan, Ye, Mei, Ye, Ziping, Yermia, Frédéric, You, Zhengyun, Yu, Boxiang, Yu, Chiye, Yu, Chunxu, Yu, Guojun, Yu, Hongzhao, Yu, Miao, Yu, Xianghui, Yu, Zeyuan, Yu, Zezhong, Yuan, Cenxi, Yuan, Chengzhuo, Yuan, Ying, Yuan, Zhenxiong, Yue, Baobiao, Zafar, Noman, Zavadskyi, Vitalii, Zeng, Fanrui, Zeng, Shan, Zeng, Tingxuan, Zeng, Yuda, Zhan, Liang, Zhang, Aiqiang, Zhang, Bin, Zhang, Binting, Zhang, Feiyang, Zhang, Haosen, Zhang, Honghao, Zhang, Jialiang, Zhang, Jiawen, Zhang, Jie, Zhang, Jingbo, Zhang, Jinnan, ZHANG, Lei, Zhang, Mohan, Zhang, Peng, Zhang, Ping, Zhang, Qingmin, Zhang, Shiqi, Zhang, Shu, Zhang, Shuihan, Zhang, Siyuan, Zhang, Tao, Zhang, Xiaomei, Zhang, Xin, Zhang, Xuantong, Zhang, Yinhong, Zhang, Yiyu, Zhang, Yongpeng, Zhang, Yu, Zhang, Yuanyuan, Zhang, Yumei, Zhang, Zhenyu, Zhang, Zhijian, Zhao, Jie, Zhao, Rong, Zhao, Runze, Zhao, Shujun, Zheng, Dongqin, Zheng, Hua, Zheng, Yangheng, Zhong, Weirong, Zhou, Jing, Zhou, Li, Zhou, Nan, Zhou, Shun, Zhou, Tong, Zhou, Xiang, Zhu, Jingsen, Zhu, Kangfu, Zhu, Kejun, Zhu, Zhihang, Zhuang, Bo, Zhuang, Honglin, Zong, Liang, Zou, Jiaheng, Züfle, Jan, and null, null
- Abstract
The core-collapse supernova (CCSN) is considered one of the most energetic astrophysical events in the universe. The early and prompt detection of neutrinos before (pre-SN) and during the supernova (SN) burst presents a unique opportunity for multi-messenger observations of CCSN events. In this study, we describe the monitoring concept and present the sensitivity of the system to pre-SN and SN neutrinos at the Jiangmen Underground Neutrino Observatory (JUNO), a 20 kton liquid scintillator detector currently under construction in South China. The real-time monitoring system is designed to ensure both prompt alert speed and comprehensive coverage of progenitor stars. It incorporates prompt monitors on the electronic board as well as online monitors at the data acquisition stage. Assuming a false alert rate of 1 per year, this monitoring system exhibits sensitivity to pre-SN neutrinos up to a distance of approximately 1.6 (0.9) kiloparsecs and SN neutrinos up to about 370 (360) kiloparsecs for a progenitor mass of 30 solar masses, considering both normal and inverted mass ordering scenarios. The pointing ability of the CCSN is evaluated by analyzing the accumulated event anisotropy of inverse beta decay interactions from pre-SN or SN neutrinos. This, along with the early alert, can play a crucial role in facilitating follow-up multi-messenger observations of the next galactic or nearby extragalactic CCSN.
- Published
- 2024
32. Towards High-Quality Photorealistic Image Style Transfer
- Author
-
Ding, H, Zhang, H, Fu, G, Jiang, C, Luo, F, Xiao, C, Xu, M, Ding, H, Zhang, H, Fu, G, Jiang, C, Luo, F, Xiao, C, and Xu, M
- Published
- 2024
33. JUNO Conceptual Design Report
- Author
-
Adam, T., An, F., An, G., An, Q., Anfimov, N., Antonelli, V., Baccolo, G., Baldoncini, M., Baussan, E., Bellato, M., Bezrukov, L., Bick, D., Blyth, S., Boarin, S., Brigatti, A., Brugière, T., Brugnera, R., Avanzini, M. Buizza, Busto, J., Cabrera, A., Cai, H., Cai, X., Cammi, A., Cao, D., Cao, G., Cao, J., Chang, J., Chang, Y., Chen, M., Chen, P., Chen, Q., Chen, S., Chen, X., Chen, Y., Cheng, Y., Chiesa, D., Chukanov, A., Clemenza, M., Clerbaux, B., D'Angelo, D., de Kerret, H., Deng, Z., Ding, X., Ding, Y., Djurcic, Z., Dmitrievsky, S., Dolgareva, M., Dornic, D., Doroshkevich, E., Dracos, M., Drapier, O., Dusini, S., Díaz, M. A., Enqvist, T., Fan, D., Fang, C., Fang, J., Fang, X., Favart, L., Fedoseev, D., Fiorentini, G., Ford, R., Formozov, A., Gaigher, R., Gan, H., Garfagnini, A., Gaudiot, G., Genster, C., Giammarchi, M., Giuliani, F., Gonchar, M., Gong, G., Gong, H., Gonin, M., Gornushkin, Y., Grassi, M., Grewing, C., Gromov, V., Gu, M., Guan, M., Guarino, V., Guo, W., Guo, X., Guo, Y., Göger-Neff, M., Hackspacher, P., Hagner, C., Han, R., Han, Z., Hao, J., He, M., Hellgartner, D., Heng, Y., Hong, D., Hou, S., Hsiung, Y., Hu, B., Hu, J., Hu, S., Hu, T., Hu, W., Huang, H., Huang, X., Huo, L., Huo, W., Ioannisian, A., Ioannisyan, D., Jeitler, M., Jen, K., Jetter, S., Ji, X., Jian, S., Jiang, D., Jiang, X., Jollet, C., Kaiser, M., Kan, B., Kang, L., Karagounis, M., Kazarian, N., Kettell, S., Korablev, D., Krasnoperov, A., Krokhaleva, S., Krumshteyn, Z., Kruth, A., Kuusiniemi, P., Lachenmaier, T., Lei, L., Lei, R., Lei, X., Leitner, R., Lenz, F., Li, C., Li, F., Li, J., Li, N., Li, S., Li, T., Li, W., Li, X., Li, Y., Li, Z., Liang, H., Liang, J., Licciardi, M., Lin, G., Lin, S., Lin, T., Lin, Y., Lippi, I., Liu, G., Liu, H., Liu, J., Liu, Q., Liu, S., Liu, Y., Lombardi, P., Long, Y., Lorenz, S., Lu, C., Lu, F., Lu, H., Lu, J., Lubsandorzhiev, B., Lubsandorzhiev, S., Ludhova, L., Luo, F., Luo, S., Lv, Z., Lyashuk, V., Ma, Q., Ma, S., Ma, X., Malyshkin, Y., Mantovani, F., Mao, Y., Mari, S., Mayilyan, D., McDonough, W., Meng, G., Meregaglia, A., Meroni, E., Mezzetto, M., Min, J., Miramonti, L., Montuschi, M., Morozov, N., Mueller, T., Muralidharan, P., Nastasi, M., Naumov, D., Naumova, E., Nemchenok, I., Ning, Z., Nunokawa, H., Oberauer, L., Ochoa-Ricoux, J. P., Olshevskiy, A., Ortica, F., Pan, H., Paoloni, A., Parkalian, N., Parmeggiano, S., Pec, V., Pelliccia, N., Peng, H., Poussot, P., Pozzi, S., Previtali, E., Prummer, S., Qi, F., Qi, M., Qian, S., Qian, X., Qiao, H., Qin, Z., Ranucci, G., Re, A., Ren, B., Ren, J., Rezinko, T., Ricci, B., Robens, M., Romani, A., Roskovec, B., Ruan, X., Rybnikov, A., Sadovsky, A., Saggese, P., Salamanna, G., Sawatzki, J., Schuler, J., Selyunin, A., Shi, G., Shi, J., Shi, Y., Sinev, V., Sirignano, C., Sisti, M., Smirnov, O., Soiron, M., Stahl, A., Stanco, L., Steinmann, J., Strati, V., Sun, G., Sun, X., Sun, Y., Taichenachev, D., Tang, J., Tietzsch, A., Tkachev, I., Trzaska, W. H., Tung, Y., van Waasen, S., Volpe, C., Vorobel, V., Votano, L., Wang, C., Wang, G., Wang, H., Wang, M., Wang, R., Wang, S., Wang, W., Wang, Y., Wang, Z., Wei, W., Wei, Y., Weifels, M., Wen, L., Wen, Y., Wiebusch, C., Wipperfurth, S., Wong, S. C., Wonsak, B., Wu, C., Wu, Q., Wu, Z., Wurm, M., Wurtz, J., Xi, Y., Xia, D., Xia, J., Xiao, M., Xie, Y., Xu, J., Xu, L., Xu, Y., Yan, B., Yan, X., Yang, C., Yang, H., Yang, L., Yang, M., Yang, Y., Yanovich, E., Yao, Y., Ye, M., Ye, X., Yegin, U., Yermia, F., You, Z., Yu, B., Yu, C., Yu, G., Yu, Z., Yuan, Y., Yuan, Z., Zanetti, M., Zeng, P., Zeng, S., Zeng, T., Zhan, L., Zhang, C., Zhang, F., Zhang, G., Zhang, H., Zhang, J., Zhang, K., Zhang, P., Zhang, Q., Zhang, T., Zhang, X., Zhang, Y., Zhang, Z., Zhao, J., Zhao, M., Zhao, T., Zhao, Y., Zheng, H., Zheng, M., Zheng, X., Zheng, Y., Zhong, W., Zhou, G., Zhou, J., Zhou, L., Zhou, N., Zhou, R., Zhou, S., Zhou, W., Zhou, X., Zhou, Y., Zhu, H., Zhu, K., Zhuang, H., Zong, L., and Zou, J.
- Subjects
Physics - Instrumentation and Detectors ,High Energy Physics - Experiment - Abstract
The Jiangmen Underground Neutrino Observatory (JUNO) is proposed to determine the neutrino mass hierarchy using an underground liquid scintillator detector. It is located 53 km away from both Yangjiang and Taishan Nuclear Power Plants in Guangdong, China. The experimental hall, spanning more than 50 meters, is under a granite mountain of over 700 m overburden. Within six years of running, the detection of reactor antineutrinos can resolve the neutrino mass hierarchy at a confidence level of 3-4$\sigma$, and determine neutrino oscillation parameters $\sin^2\theta_{12}$, $\Delta m^2_{21}$, and $|\Delta m^2_{ee}|$ to an accuracy of better than 1%. The JUNO detector can be also used to study terrestrial and extra-terrestrial neutrinos and new physics beyond the Standard Model. The central detector contains 20,000 tons liquid scintillator with an acrylic sphere of 35 m in diameter. $\sim$17,000 508-mm diameter PMTs with high quantum efficiency provide $\sim$75% optical coverage. The current choice of the liquid scintillator is: linear alkyl benzene (LAB) as the solvent, plus PPO as the scintillation fluor and a wavelength-shifter (Bis-MSB). The number of detected photoelectrons per MeV is larger than 1,100 and the energy resolution is expected to be 3% at 1 MeV. The calibration system is designed to deploy multiple sources to cover the entire energy range of reactor antineutrinos, and to achieve a full-volume position coverage inside the detector. The veto system is used for muon detection, muon induced background study and reduction. It consists of a Water Cherenkov detector and a Top Tracker system. The readout system, the detector control system and the offline system insure efficient and stable data acquisition and processing., Comment: 328 pages, 211 figures
- Published
- 2015
34. Pre-Emptive Incision-Site Infiltration with Ropivacaine Plus Dexamethasone for Postoperative Pain After Supratentorial Craniotomy: A Prospective Randomized Controlled Trial
- Author
-
Zhao C, Wang S, Pan Y, Ji N, and Luo F
- Subjects
postoperative pain ,craniotomy ,dexamethasone ,incision-site infiltration ,randomized controlled trial ,Medicine (General) ,R5-920 - Abstract
Chunmei Zhao,1 Shaoheng Wang,1 Yuesong Pan,2,3 Nan Ji,4 Fang Luo1 1Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China; 2Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of China; 3China National Clinical Research Center for Neurological Diseases, Beijing, 100070, People’s Republic of China; 4Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100070, People’s Republic of ChinaCorrespondence: Fang LuoDepartment of Pain Management, Beijing Tiantan Hospital, Capital Medical University, No. 119 West Road, South 4th Ring Road, Fengtai District, Beijing, 100070, People’s Republic of ChinaTel +86 010 59976664Fax +86 010 67050177Email luofangwt@yahoo.comNan JiDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, No. 119 West Road, South 4th Ring Road, Fengtai District, Beijing, 100070, People’s Republic of ChinaTel +86 010 59976516Email jinan@bjtth.orgBackground: Incision-site infiltration with local anesthetics prevents pain on incision site, but pain relief is limited to the first few postoperative hours. Dexamethasone as an adjuvant to local infiltration successfully achieves better postoperative pain relief; however, this has not been studied in craniotomy patients yet.Study Design and Methods: This is a prospective, single-center, blinded, randomized, controlled trial included patients aged between 18 and 64 years, ASA physical status of I–II, scheduled for elective supratentorial tumor craniotomy under general anesthesia. We screened patients for enrollment from April 4, 2019 through August 15, 2019. The final study visit of the last patient was conducted on February 13, 2020. We randomly assigned eligible participants (1:1) to either the dexamethasone group who received incision-site infiltration of 0.5% ropivacaine plus 0.033% dexamethasone (N=70) or the control group who received 0.5% ropivacaine alone (N=70). Primary outcome was the cumulative sufentanil consumption (μg) within 48 hours postoperatively. Primary analysis was performed based on the modified intention-to-treat (MITT) principle.Results: Baseline characteristics were similar between the groups (p> 0.05). Sufentanil consumption during the first 48 hours postoperatively was 29.0 (10.7) μg in the dexamethasone group and 38.3 (13.7) μg in the control group (mean difference − 9.3, 95% CI − 13.4 to − 5.1; p< 0.001). There was no serious adverse effect directly associated with incision-site infiltration or local dexamethasone use.Conclusion: The addition of dexamethasone to pre-emptive incision-site infiltration with the local anesthetic can reduce about 27% of opioids consumption and the postoperative pain scores within 72 hours after craniotomy.Trial Registration: ClinicalTrials.Gov (NCT03618264).Keywords: postoperative pain, craniotomy, dexamethasone, incision-site infiltration, randomized controlled trial
- Published
- 2021
35. Effect of nanocrystallization of magnetic amorphous ribbon on thermoelectric and magnetic properties
- Author
-
Yang, Z., He, X., Ning, Z., Zhang, K.B., Luo, F., Li, C.C., Ma, S.F., Wei, P., Zhao, W.Y., Sun, Z.G., and He, J.
- Published
- 2020
- Full Text
- View/download PDF
36. Human genome meeting 2016
- Author
-
Srivastava, AK, Wang, Y, Huang, R, Skinner, C, Thompson, T, Pollard, L, Wood, T, Luo, F, Stevenson, R, Polimanti, R, Gelernter, J, Lin, X, Lim, IY, Wu, Y, Teh, AL, Chen, L, Aris, IM, Soh, SE, Tint, MT, MacIsaac, JL, Yap, F, Kwek, K, Saw, SM, Kobor, MS, Meaney, MJ, Godfrey, KM, Chong, YS, Holbrook, JD, Lee, YS, Gluckman, PD, Karnani, N, GUSTO study group, Kapoor, A, Lee, D, Chakravarti, A, Maercker, C, Graf, F, Boutros, M, Stamoulis, G, Santoni, F, Makrythanasis, P, Letourneau, A, Guipponi, M, Panousis, N, Garieri, M, Ribaux, P, Falconnet, E, Borel, C, Antonarakis, SE, Kumar, S, Curran, J, Blangero, J, Chatterjee, S, Akiyama, J, Auer, D, Berrios, C, Pennacchio, L, Donti, TR, Cappuccio, G, Miller, M, Atwal, P, Kennedy, A, Cardon, A, Bacino, C, Emrick, L, Hertecant, J, Baumer, F, Porter, B, Bainbridge, M, Bonnen, P, Graham, B, Sutton, R, Sun, Q, Elsea, S, Hu, Z, Wang, P, Zhu, Y, Zhao, J, Xiong, M, Bennett, David A, Hidalgo-Miranda, A, Romero-Cordoba, S, Rodriguez-Cuevas, S, Rebollar-Vega, R, Tagliabue, E, Iorio, M, D’Ippolito, E, Baroni, S, Kaczkowski, B, Tanaka, Y, Kawaji, H, Sandelin, A, Andersson, R, Itoh, M, Lassmann, T, The FANTOM5 Consortium, Hayashizaki, Y, and Carninci, P
- Subjects
Cancer ,Biotechnology ,Rare Diseases ,Human Genome ,Clinical Research ,Prevention ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Genetics & Heredity - Abstract
O1 The metabolomics approach to autism: identification of biomarkers for early detection of autism spectrum disorder A. K. Srivastava, Y. Wang, R. Huang, C. Skinner, T. Thompson, L. Pollard, T. Wood, F. Luo, R. Stevenson O2 Phenome-wide association study for smoking- and drinking-associated genes in 26,394 American women with African, Asian, European, and Hispanic descents R. Polimanti, J. Gelernter O3 Effects of prenatal environment, genotype and DNA methylation on birth weight and subsequent postnatal outcomes: findings from GUSTO, an Asian birth cohort X. Lin, I. Y. Lim, Y. Wu, A. L. Teh, L. Chen, I. M. Aris, S. E. Soh, M. T. Tint, J. L. MacIsaac, F. Yap, K. Kwek, S. M. Saw, M. S. Kobor, M. J. Meaney, K. M. Godfrey, Y. S. Chong, J. D. Holbrook, Y. S. Lee, P. D. Gluckman, N. Karnani, GUSTO study group O4 High-throughput identification of specific qt interval modulating enhancers at the SCN5A locus A. Kapoor, D. Lee, A. Chakravarti O5 Identification of extracellular matrix components inducing cancer cell migration in the supernatant of cultivated mesenchymal stem cells C. Maercker, F. Graf, M. Boutros O6 Single cell allele specific expression (ASE) IN T21 and common trisomies: a novel approach to understand DOWN syndrome and other aneuploidies G. Stamoulis, F. Santoni, P. Makrythanasis, A. Letourneau, M. Guipponi, N. Panousis, M. Garieri, P. Ribaux, E. Falconnet, C. Borel, S. E. Antonarakis O7 Role of microRNA in LCL to IPSC reprogramming S. Kumar, J. Curran, J. Blangero O8 Multiple enhancer variants disrupt gene regulatory network in Hirschsprung disease S. Chatterjee, A. Kapoor, J. Akiyama, D. Auer, C. Berrios, L. Pennacchio, A. Chakravarti O9 Metabolomic profiling for the diagnosis of neurometabolic disorders T. R. Donti, G. Cappuccio, M. Miller, P. Atwal, A. Kennedy, A. Cardon, C. Bacino, L. Emrick, J. Hertecant, F. Baumer, B. Porter, M. Bainbridge, P. Bonnen, B. Graham, R. Sutton, Q. Sun, S. Elsea O10 A novel causal methylation network approach to Alzheimer’s disease Z. Hu, P. Wang, Y. Zhu, J. Zhao, M. Xiong, David A Bennett O11 A microRNA signature identifies subtypes of triple-negative breast cancer and reveals MIR-342-3P as regulator of a lactate metabolic pathway A. Hidalgo-Miranda, S. Romero-Cordoba, S. Rodriguez-Cuevas, R. Rebollar-Vega, E. Tagliabue, M. Iorio, E. D’Ippolito, S. Baroni O12 Transcriptome analysis identifies genes, enhancer RNAs and repetitive elements that are recurrently deregulated across multiple cancer types B. Kaczkowski, Y. Tanaka, H. Kawaji, A. Sandelin, R. Andersson, M. Itoh, T. Lassmann, the FANTOM5 consortium, Y. Hayashizaki, P. Carninci, A. R. R. Forrest O13 Elevated mutation and widespread loss of constraint at regulatory and architectural binding sites across 11 tumour types C. A. Semple O14 Exome sequencing provides evidence of pathogenicity for genes implicated in colorectal cancer E. A. Rosenthal, B. Shirts, L. Amendola, C. Gallego, M. Horike-Pyne, A. Burt, P. Robertson, P. Beyers, C. Nefcy, D. Veenstra, F. Hisama, R. Bennett, M. Dorschner, D. Nickerson, J. Smith, K. Patterson, D. Crosslin, R. Nassir, N. Zubair, T. Harrison, U. Peters, G. Jarvik, NHLBI GO Exome Sequencing Project O15 The tandem duplicator phenotype as a distinct genomic configuration in cancer F. Menghi, K. Inaki, X. Woo, P. Kumar, K. Grzeda, A. Malhotra, H. Kim, D. Ucar, P. Shreckengast, K. Karuturi, J. Keck, J. Chuang, E. T. Liu O16 Modeling genetic interactions associated with molecular subtypes of breast cancer B. Ji, A. Tyler, G. Ananda, G. Carter O17 Recurrent somatic mutation in the MYC associated factor X in brain tumors H. Nikbakht, M. Montagne, M. Zeinieh, A. Harutyunyan, M. Mcconechy, N. Jabado, P. Lavigne, J. Majewski O18 Predictive biomarkers to metastatic pancreatic cancer treatment J. B. Goldstein, M. Overman, G. Varadhachary, R. Shroff, R. Wolff, M. Javle, A. Futreal, D. Fogelman O19 DDIT4 gene expression as a prognostic marker in several malignant tumors L. Bravo, W. Fajardo, H. Gomez, C. Castaneda, C. Rolfo, J. A. Pinto O20 Spatial organization of the genome and genomic alterations in human cancers K. C. Akdemir, L. Chin, A. Futreal, ICGC PCAWG Structural Alterations Group O21 Landscape of targeted therapies in solid tumors S. Patterson, C. Statz, S. Mockus O22 Genomic analysis reveals novel drivers and progression pathways in skin basal cell carcinoma S. N. Nikolaev, X. I. Bonilla, L. Parmentier, B. King, F. Bezrukov, G. Kaya, V. Zoete, V. Seplyarskiy, H. Sharpe, T. McKee, A. Letourneau, P. Ribaux, K. Popadin, N. Basset-Seguin, R. Ben Chaabene, F. Santoni, M. Andrianova, M. Guipponi, M. Garieri, C. Verdan, K. Grosdemange, O. Sumara, M. Eilers, I. Aifantis, O. Michielin, F. de Sauvage, S. Antonarakis O23 Identification of differential biomarkers of hepatocellular carcinoma and cholangiocarcinoma via transcriptome microarray meta-analysis S. Likhitrattanapisal O24 Clinical validity and actionability of multigene tests for hereditary cancers in a large multi-center study S. Lincoln, A. Kurian, A. Desmond, S. Yang, Y. Kobayashi, J. Ford, L. Ellisen O25 Correlation with tumor ploidy status is essential for correct determination of genome-wide copy number changes by SNP array T. L. Peters, K. R. Alvarez, E. F. Hollingsworth, D. H. Lopez-Terrada O26 Nanochannel based next-generation mapping for interrogation of clinically relevant structural variation A. Hastie, Z. Dzakula, A. W. Pang, E. T. Lam, T. Anantharaman, M. Saghbini, H. Cao, BioNano Genomics O27 Mutation spectrum in a pulmonary arterial hypertension (PAH) cohort and identification of associated truncating mutations in TBX4 C. Gonzaga-Jauregui, L. Ma, A. King, E. Berman Rosenzweig, U. Krishnan, J. G. Reid, J. D. Overton, F. Dewey, W. K. Chung O28 NORTH CAROLINA macular dystrophy (MCDR1): mutations found affecting PRDM13 K. Small, A. DeLuca, F. Cremers, R. A. Lewis, V. Puech, B. Bakall, R. Silva-Garcia, K. Rohrschneider, M. Leys, F. S. Shaya, E. Stone O29 PhenoDB and genematcher, solving unsolved whole exome sequencing data N. L. Sobreira, F. Schiettecatte, H. Ling, E. Pugh, D. Witmer, K. Hetrick, P. Zhang, K. Doheny, D. Valle, A. Hamosh O30 Baylor-Johns Hopkins Center for Mendelian genomics: a four year review S. N. Jhangiani, Z. Coban Akdemir, M. N. Bainbridge, W. Charng, W. Wiszniewski, T. Gambin, E. Karaca, Y. Bayram, M. K. Eldomery, J. Posey, H. Doddapaneni, J. Hu, V. R. Sutton, D. M. Muzny, E. A. Boerwinkle, D. Valle, J. R. Lupski, R. A. Gibbs O31 Using read overlap assembly to accurately identify structural genetic differences in an ashkenazi jewish trio S. Shekar, W. Salerno, A. English, A. Mangubat, J. Bruestle O32 Legal interoperability: a sine qua non for international data sharing A. Thorogood, B. M. Knoppers, Global Alliance for Genomics and Health - Regulatory and Ethics Working Group O33 High throughput screening platform of competent sineups: that can enhance translation activities of therapeutic target H. Takahashi, K. R. Nitta, A. Kozhuharova, A. M. Suzuki, H. Sharma, D. Cotella, C. Santoro, S. Zucchelli, S. Gustincich, P. Carninci O34 The undiagnosed diseases network international (UDNI): clinical and laboratory research to meet patient needs J. J. Mulvihill, G. Baynam, W. Gahl, S. C. Groft, K. Kosaki, P. Lasko, B. Melegh, D. Taruscio O36 Performance of computational algorithms in pathogenicity predictions for activating variants in oncogenes versus loss of function mutations in tumor suppressor genes R. Ghosh, S. Plon O37 Identification and electronic health record incorporation of clinically actionable pharmacogenomic variants using prospective targeted sequencing S. Scherer, X. Qin, R. Sanghvi, K. Walker, T. Chiang, D. Muzny, L. Wang, J. Black, E. Boerwinkle, R. Weinshilboum, R. Gibbs O38 Melanoma reprogramming state correlates with response to CTLA-4 blockade in metastatic melanoma T. Karpinets, T. Calderone, K. Wani, X. Yu, C. Creasy, C. Haymaker, M. Forget, V. Nanda, J. Roszik, J. Wargo, L. Haydu, X. Song, A. Lazar, J. Gershenwald, M. Davies, C. Bernatchez, J. Zhang, A. Futreal, S. Woodman O39 Data-driven refinement of complex disease classification from integration of heterogeneous functional genomics data in GeneWeaver E. J. Chesler, T. Reynolds, J. A. Bubier, C. Phillips, M. A. Langston, E. J. Baker O40 A general statistic framework for genome-based disease risk prediction M. Xiong, L. Ma, N. Lin, C. Amos O41 Integrative large-scale causal network analysis of imaging and genomic data and its application in schizophrenia studies N. Lin, P. Wang, Y. Zhu, J. Zhao, V. Calhoun, M. Xiong O42 Big data and NGS data analysis: the cloud to the rescue O. Dobretsberger, M. Egger, F. Leimgruber O43 Cpipe: a convergent clinical exome pipeline specialised for targeted sequencing S. Sadedin, A. Oshlack, Melbourne Genomics Health Alliance O44 A Bayesian classification of biomedical images using feature extraction from deep neural networks implemented on lung cancer data V. A. A. Antonio, N. Ono, Clark Kendrick C. Go O45 MAV-SEQ: an interactive platform for the Management, Analysis, and Visualization of sequence data Z. Ahmed, M. Bolisetty, S. Zeeshan, E. Anguiano, D. Ucar O47 Allele specific enhancer in EPAS1 intronic regions may contribute to high altitude adaptation of Tibetans C. Zeng, J. Shao O48 Nanochannel based next-generation mapping for structural variation detection and comparison in trios and populations H. Cao, A. Hastie, A. W. Pang, E. T. Lam, T. Liang, K. Pham, M. Saghbini, Z. Dzakula O49 Archaic introgression in indigenous populations of Malaysia revealed by whole genome sequencing Y. Chee-Wei, L. Dongsheng, W. Lai-Ping, D. Lian, R. O. Twee Hee, Y. Yunus, F. Aghakhanian, S. S. Mokhtar, C. V. Lok-Yung, J. Bhak, M. Phipps, X. Shuhua, T. Yik-Ying, V. Kumar, H. Boon-Peng O50 Breast and ovarian cancer prevention: is it time for population-based mutation screening of high risk genes? I. Campbell, M.-A. Young, P. James, Lifepool O53 Comprehensive coverage from low DNA input using novel NGS library preparation methods for WGS and WGBS C. Schumacher, S. Sandhu, T. Harkins, V. Makarov O54 Methods for large scale construction of robust PCR-free libraries for sequencing on Illumina HiSeqX platform H. DoddapaneniR. Glenn, Z. Momin, B. Dilrukshi, H. Chao, Q. Meng, B. Gudenkauf, R. Kshitij, J. Jayaseelan, C. Nessner, S. Lee, K. Blankenberg, L. Lewis, J. Hu, Y. Han, H. Dinh, S. Jireh, K. Walker, E. Boerwinkle, D. Muzny, R. Gibbs O55 Rapid capture methods for clinical sequencing J. Hu, K. Walker, C. Buhay, X. Liu, Q. Wang, R. Sanghvi, H. Doddapaneni, Y. Ding, N. Veeraraghavan, Y. Yang, E. Boerwinkle, A. L. Beaudet, C. M. Eng, D. M. Muzny, R. A. Gibbs O56 A diploid personal human genome model for better genomes from diverse sequence data K. C. C. Worley, Y. Liu, D. S. T. Hughes, S. C. Murali, R. A. Harris, A. C. English, X. Qin, O. A. Hampton, P. Larsen, C. Beck, Y. Han, M. Wang, H. Doddapaneni, C. L. Kovar, W. J. Salerno, A. Yoder, S. Richards, J. Rogers, J. R. Lupski, D. M. Muzny, R. A. Gibbs O57 Development of PacBio long range capture for detection of pathogenic structural variants Q. Meng, M. Bainbridge, M. Wang, H. Doddapaneni, Y. Han, D. Muzny, R. Gibbs O58 Rhesus macaques exhibit more non-synonymous variation but greater impact of purifying selection than humans R. A. Harris, M. Raveenedran, C. Xue, M. Dahdouli, L. Cox, G. Fan, B. Ferguson, J. Hovarth, Z. Johnson, S. Kanthaswamy, M. Kubisch, M. Platt, D. Smith, E. Vallender, R. Wiseman, X. Liu, J. Below, D. Muzny, R. Gibbs, F. Yu, J. Rogers O59 Assessing RNA structure disruption induced by single-nucleotide variation J. Lin, Y. Zhang, Z. Ouyang P1 A meta-analysis of genome-wide association studies of mitochondrial dna copy number A. Moore, Z. Wang, J. Hofmann, M. Purdue, R. Stolzenberg-Solomon, S. Weinstein, D. Albanes, C.-S. Liu, W.-L. Cheng, T.-T. Lin, Q. Lan, N. Rothman, S. Berndt P2 Missense polymorphic genetic combinations underlying down syndrome susceptibility E. S. Chen P4 The evaluation of alteration of ELAM-1 expression in the endometriosis patients H. Bahrami, A. Khoshzaban, S. Heidari Keshal P5 Obesity and the incidence of apolipoprotein E polymorphisms in an assorted population from Saudi Arabia population K. K. R. Alharbi P6 Genome-associated personalized antithrombotical therapy for patients with high risk of thrombosis and bleeding M. Zhalbinova, A. Akilzhanova, S. Rakhimova, M. Bekbosynova, S. Myrzakhmetova P7 Frequency of Xmn1 polymorphism among sickle cell carrier cases in UAE population M. Matar P8 Differentiating inflammatory bowel diseases by using genomic data: dimension of the problem and network organization N. Mili, R. Molinari, Y. Ma, S. Guerrier P9 Vulnerability of genetic variants to the risk of autism among Saudi children N. Elhawary, M. Tayeb, N. Bogari, N. Qotb P10 Chromatin profiles from ex vivo purified dopaminergic neurons establish a promising model to support studies of neurological function and dysfunction S. A. McClymont, P. W. Hook, L. A. Goff, A. McCallion P11 Utilization of a sensitized chemical mutagenesis screen to identify genetic modifiers of retinal dysplasia in homozygous Nr2e3rd7 mice Y. Kong, J. R. Charette, W. L. Hicks, J. K. Naggert, L. Zhao, P. M. Nishina P12 Ion torrent next generation sequencing of recessive polycystic kidney disease in Saudi patients B. M. Edrees, M. Athar, F. A. Al-Allaf, M. M. Taher, W. Khan, A. Bouazzaoui, N. A. Harbi, R. Safar, H. Al-Edressi, A. Anazi, N. Altayeb, M. A. Ahmed, K. Alansary, Z. Abduljaleel P13 Digital expression profiling of Purkinje neurons and dendrites in different subcellular compartments A. Kratz, P. Beguin, S. Poulain, M. Kaneko, C. Takahiko, A. Matsunaga, S. Kato, A. M. Suzuki, N. Bertin, T. Lassmann, R. Vigot, P. Carninci, C. Plessy, T. Launey P14 The evolution of imperfection and imperfection of evolution: the functional and functionless fractions of the human genome D. Graur P16 Species-independent identification of known and novel recurrent genomic entities in multiple cancer patients J. Friis-Nielsen, J. M. Izarzugaza, S. Brunak P18 Discovery of active gene modules which are densely conserved across multiple cancer types reveal their prognostic power and mutually exclusive mutation patterns B. S. Soibam P19 Whole exome sequencing of dysplastic leukoplakia tissue indicates sequential accumulation of somatic mutations from oral precancer to cancer D. Das, N. Biswas, S. Das, S. Sarkar, A. Maitra, C. Panda, P. Majumder P21 Epigenetic mechanisms of carcinogensis by hereditary breast cancer genes J. J. Gruber, N. Jaeger, M. Snyder P22 RNA direct: a novel RNA enrichment strategy applied to transcripts associated with solid tumors K. Patel, S. Bowman, T. Davis, D. Kraushaar, A. Emerman, S. Russello, N. Henig, C. Hendrickson P23 RNA sequencing identifies gene mutations for neuroblastoma K. Zhang P24 Participation of SFRP1 in the modulation of TMPRSS2-ERG fusion gene in prostate cancer cell lines M. Rodriguez-Dorantes, C. D. Cruz-Hernandez, C. D. P. Garcia-Tobilla, S. Solorzano-Rosales P25 Targeted Methylation Sequencing of Prostate Cancer N. Jäger, J. Chen, R. Haile, M. Hitchins, J. D. Brooks, M. Snyder P26 Mutant TPMT alleles in children with acute lymphoblastic leukemia from México City and Yucatán, Mexico S. Jiménez-Morales, M. Ramírez, J. Nuñez, V. Bekker, Y. Leal, E. Jiménez, A. Medina, A. Hidalgo, J. Mejía P28 Genetic modifiers of Alström syndrome J. Naggert, G. B. Collin, K. DeMauro, R. Hanusek, P. M. Nishina P31 Association of genomic variants with the occurrence of angiotensin-converting-enzyme inhibitor (ACEI)-induced coughing among Filipinos E. M. Cutiongco De La Paz, R. Sy, J. Nevado, P. Reganit, L. Santos, J. D. Magno, F. E. Punzalan , D. Ona , E. Llanes, R. L. Santos-Cortes , R. Tiongco, J. Aherrera, L. Abrahan, P. Pagauitan-Alan; Philippine Cardiogenomics Study Group P32 The use of “humanized” mouse models to validate disease association of a de novo GARS variant and to test a novel gene therapy strategy for Charcot-Marie-Tooth disease type 2D K. H. Morelli, J. S. Domire, N. Pyne, S. Harper, R. Burgess P34 Molecular regulation of chondrogenic human induced pluripotent stem cells M. A. Gari, A. Dallol, H. Alsehli, A. Gari, M. Gari, A. Abuzenadah P35 Molecular profiling of hematologic malignancies: implementation of a variant assessment algorithm for next generation sequencing data analysis and clinical reporting M. Thomas, M. Sukhai, S. Garg, M. Misyura, T. Zhang, A. Schuh, T. Stockley, S. Kamel-Reid P36 Accessing genomic evidence for clinical variants at NCBI S. Sherry, C. Xiao, D. Slotta, K. Rodarmer, M. Feolo, M. Kimelman, G. Godynskiy, C. O’Sullivan, E. Yaschenko P37 NGS-SWIFT: a cloud-based variant analysis framework using control-accessed sequencing data from DBGAP/SRA C. Xiao, E. Yaschenko, S. Sherry P38 Computational assessment of drug induced hepatotoxicity through gene expression profiling C. Rangel-Escareño, H. Rueda-Zarate P40 Flowr: robust and efficient pipelines using a simple language-agnostic approach;ultraseq; fast modular pipeline for somatic variation calling using flowr S. Seth, S. Amin, X. Song, X. Mao, H. Sun, R. G. Verhaak, A. Futreal, J. Zhang P41 Applying “Big data” technologies to the rapid analysis of heterogenous large cohort data S. J. Whiite, T. Chiang, A. English, J. Farek, Z. Kahn, W. Salerno, N. Veeraraghavan, E. Boerwinkle, R. Gibbs P42 FANTOM5 web resource for the large-scale genome-wide transcription start site activity profiles of wide-range of mammalian cells T. Kasukawa, M. Lizio, J. Harshbarger, S. Hisashi, J. Severin, A. Imad, S. Sahin, T. C. Freeman, K. Baillie, A. Sandelin, P. Carninci, A. R. R. Forrest, H. Kawaji, The FANTOM Consortium P43 Rapid and scalable typing of structural variants for disease cohorts W. Salerno, A. English, S. N. Shekar, A. Mangubat, J. Bruestle, E. Boerwinkle, R. A. Gibbs P44 Polymorphism of glutathione S-transferases and sulphotransferases genes in an Arab population A. H. Salem, M. Ali, A. Ibrahim, M. Ibrahim P46 Genetic divergence of CYP3A5*3 pharmacogenomic marker for native and admixed Mexican populations J. C. Fernandez-Lopez, V. Bonifaz-Peña, C. Rangel-Escareño, A. Hidalgo-Miranda, A. V. Contreras P47 Whole exome sequence meta-analysis of 13 white blood cell, red blood cell, and platelet traits L. Polfus, CHARGE and NHLBI Exome Sequence Project Working Groups P48 Association of adipoq gene with type 2 diabetes and related phenotypes in african american men and women: The jackson heart study S. Davis, R. Xu, S. Gebeab, P Riestra, A Gaye, R. Khan, J. Wilson, A. Bidulescu P49 Common variants in casr gene are associated with serum calcium levels in koreans S. H. Jung, N. Vinayagamoorthy, S. H. Yim, Y. J. Chung P50 Inference of multiple-wave population admixture by modeling decay of linkage disequilibrium with multiple exponential functions Y. Zhou, S. Xu P51 A Bayesian framework for generalized linear mixed models in genome-wide association studies X. Wang, V. Philip, G. Carter P52 Targeted sequencing approach for the identification of the genetic causes of hereditary hearing impairment A. A. Abuzenadah, M. Gari, R. Turki, A. Dallol P53 Identification of enhancer sequences by ATAC-seq open chromatin profiling A. Uyar, A. Kaygun, S. Zaman, E. Marquez, J. George, D. Ucar P54 Direct enrichment for the rapid preparation of targeted NGS libraries C. L. Hendrickson, A. Emerman, D. Kraushaar, S. Bowman, N. Henig, T. Davis, S. Russello, K. Patel P56 Performance of the Agilent D5000 and High Sensitivity D5000 ScreenTape assays for the Agilent 4200 Tapestation System R. Nitsche, L. Prieto-Lafuente P57 ClinVar: a multi-source archive for variant interpretation M. Landrum, J. Lee, W. Rubinstein, D. Maglott P59 Association of functional variants and protein physical interactions of human MUTY homolog linked with familial adenomatous polyposis and colorectal cancer syndrome Z. Abduljaleel, W. Khan, F. A. Al-Allaf, M. Athar , M. M. Taher, N. Shahzad P60 Modification of the microbiom constitution in the gut using chicken IgY antibodies resulted in a reduction of acute graft-versus-host disease after experimental bone marrow transplantation A. Bouazzaoui, E. Huber, A. Dan, F. A. Al-Allaf, W. Herr, G. Sprotte, J. Köstler, A. Hiergeist, A. Gessner, R. Andreesen, E. Holler P61 Compound heterozygous mutation in the LDLR gene in Saudi patients suffering severe hypercholesterolemia F. Al-Allaf, A. Alashwal, Z. Abduljaleel, M. Taher, A. Bouazzaoui, H. Abalkhail, A. Al-Allaf, R. Bamardadh, M. Athar
- Published
- 2016
37. Measurement of Leakage Neutron Spectra for Tungsten with D-T Neutrons and Validation of Evaluated Nuclear Data
- Author
-
Zhanga, S., Chen, Z., Nie, Y., Wada, R., Ruan, X., Han, R., Liu, X., Lin, W., Liu, J., Shi, F., Ren, P., Tian, G., Luo, F., Ren, J., and Bao, J.
- Subjects
Physics - Instrumentation and Detectors ,Nuclear Experiment - Abstract
Integral neutronics experiments have been investigated at Institute of Modern Physics, Chinese Academy of Sciences (IMP, CAS) in order to validate evaluated nuclear data related to the design of Chinese Initiative Accelerator Driven Systems (CIADS). In present paper, the accuracy of evaluated nuclear data for Tungsten has been examined by comparing measured leakage neutron spectra with calculated ones. Leakage neutron spectra from the irradiation of D-T neutrons on Tungsten slab sample were experimentally measured at 60$^{\circ}$ and 120$^{\circ}$ by using a time-of-flight method. Theoretical calculations are carried out by Monte Carlo neutron transport code MCNP-4C with evaluated nuclear data of the ADS-2.0, ENDF/B-VII.0, ENDF/B-VII.1, JENDL-4.0 and CENDL-3.1 libraries. From the comparisons, it is found that the calculations with ADS-2.0 and ENDF/B-VII.1 give good agreements with the experiments in the whole energy regions at 60$^{\circ}$, while a large discrepancy is observed at 120$^{\circ}$ in the elastic scattering peak, caused by a slight difference in the oscillation pattern of the elastic angular distribution at angles larger than 20$^{\circ}$. However, the calculated spectra using data from ENDF/B-VII.0, JENDL-4.0 and CENDL-3.1 libraries showed larger discrepancies with the measured ones, especially around 8.5-13.5 MeV. Further studies are presented for these disagreements., Comment: 10pages, 7figures
- Published
- 2014
38. Fast neutron scattering on Gallium target at 14.8 MeV
- Author
-
Han, R., Wada, R., Chen, Z., Nie, Y., Liu, X., Zhang, S., Ren, P., Jia, B., Tian, G., Luo, F., Lin, W., Liu, J., Shi, F., Huang, M., Ruan, X., Ren, J., Zhou, Z., Huang, H., Bao, J., Zhang, K., and Hu, B.
- Subjects
Nuclear Experiment - Abstract
Benchmarking of evaluated nuclear data libraries was performed for $\sim 14.8$ MeV neutrons on Gallium targets. The experiments were performed at China Institute of Atomic Energy(CIAE). Solid samples of natural Gallium (3.2 cm and 6.4 cm thick) were bombarded by $\sim 14.8$ MeV neutrons and leakage neutron energy spectra were measured at 60$^{\circ}$ and 120$^{\circ}$. The measured spectra are rather well reproduced by MCNP-4C simulations with the CENDL-3.1, ENDF/B-VII and JENDL-4.0 evaluated nuclear data libraries, except for the inelastic contributions around $E_{n} = 10-13$ MeV. All three libraries significantly underestimate the inelastic contributions. The inelastic contributions are further studied, using the Talys simulation code and the experimental spectra are reproduced reasonably well in the whole energy range by the Talys calculation, including the inelastic contributions., Comment: 12 pages, 7 figures
- Published
- 2014
- Full Text
- View/download PDF
39. ON THE QUALITY CONTROL OF MONITORING RESULTS OF URBAN SPECIAL GEOGRAPHY AND NATIONAL CONDITIONS
- Author
-
Chen, C., primary, Wang, X., additional, Zhao, H., additional, Luo, F., additional, and Li, H., additional
- Published
- 2023
- Full Text
- View/download PDF
40. Generalized seniority with realistic interactions in open-shell nuclei
- Author
-
Caprio, M. A., Luo, F. Q., Cai, K., Constantinou, Ch., and Hellemans, V.
- Subjects
Nuclear Theory - Abstract
Generalized seniority provides a truncation scheme for the nuclear shell model, based on pairing correlations, which offers the possibility of dramatically reducing the dimensionality of the nuclear shell-model problem. Systematic comparisons against results obtained in the full shell-model space are required to assess the viability of this scheme. Here, we extend recent generalized seniority calculations for semimagic nuclei, the Ca isotopes, to open-shell nuclei, with both valence protons and valence neutrons. The even-mass Ti and Cr isotopes are treated in a full major shell and with realistic interactions, in the generalized seniority scheme with one broken proton pair and one broken neutron pair. Results for level energies, orbital occupations, and electromagnetic observables are compared with those obtained in the full shell-model space. We demonstrate that, even for the Ti isotopes, significant benefit would be obtained in going beyond the approximation of one broken pair of each type, while the Cr isotopes require further broken pairs to provide even qualitative accuracy., Comment: 19 pages, 9 figures; published in J. Phys. G
- Published
- 2014
- Full Text
- View/download PDF
41. The Long-Term Outcome of CT-Guided Pulsed Radiofrequency in the Treatment of Idiopathic Glossopharyngeal Neuralgia: A Retrospective Multi-Center Case Series
- Author
-
Jia Y, Shrestha N, Wang X, Wang T, and Luo F
- Subjects
pulsed radiofrequency ,idiopathic glossopharyngeal neuralgia ,long-term outcome ,efficacy ,safety ,retrospective study ,Medicine (General) ,R5-920 - Abstract
Yitong Jia,1,* Niti Shrestha,2,* Xiaodi Wang,2,* Tao Wang,3 Fang Luo2 1Department of Anesthesiology, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 3Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fang LuoDepartment of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of ChinaEmail 13611326978@163.comBackground: Safer and minimal invasive treatment options with minor side effects are in great demand in the treatment of glossopharyngeal neuralgia (GPN). Pulsed radiofrequency (PRF) is a micro-destructive procedure that could be applied repeatedly without irreversible damage to target tissue. However, few studies have reported the long-term clinical outcomes of PRF in the management of idiopathic GPN patients.Methods: We retrospectively investigated the efficacy and safety of computed tomography (CT)-guided PRF in the treatment of 30 patients with idiopathic GPN in a multi-center clinical study. Numeric rating scale (NRS) score was used to evaluate pain intensity before and after PRF treatment. The effective rate was defined as the percentage of patients with NRS reduction of more than 50%. Baseline characteristics, surgical records, initial pain relief, time to take effect, long-term outcomes, patient satisfaction using a five-level Likert Scale, the incidence of recurrence as well as subsequent treatment choices, intraoperative and postoperative complications were retrieved from electronic medical records.Results: A total of 30 idiopathic GPN patients who received PRF under CT-guidance were included in our study and the initial effective rate was 93.3%. The cumulative proportion of patients with satisfactory pain relief survival was 93.3% at 12 months, 89.6% at 24 months, 85.3% at 36 months, 79.6% at 48 months, 73.0% at 60 months and 72 months, and 54.8% at 84 months, 108 months as well as 120 months. No serious morbidity or mortality were observed in any of the cases. The median patient satisfaction in Likert scale rating was 4.0 (IQR, 3.0– 5.0).Conclusion: According to our results, PRF is an effective and safe therapy for patients with idiopathic GPN. This minimally invasive, micro-destructive, neuro-modulatory technique could be a potential intervention of choice for the treatment of GPN patients who respond poorly to pharmacological treatment.Keywords: pulsed radiofrequency, idiopathic glossopharyngeal neuralgia, long-term outcome, efficacy, safety, retrospective study
- Published
- 2020
42. JUNO sensitivity to the annihilation of MeV dark matter in the galactic halo
- Author
-
Abusleme, A, Adam, T, Ahmad, S, Ahmed, R, Aiello, S, Akram, M, Aleem, A, Alexandros, T, An, F, An, Q, Andronico, G, Anfimov, N, Antonelli, V, Antoshkina, T, Asavapibhop, B, de Andre, J, Auguste, D, Bai, W, Balashov, N, Baldini, W, Barresi, A, Basilico, D, Baussan, E, Bellato, M, Bergnoli, A, Birkenfeld, T, Blin, S, Blum, D, Blyth, S, Bolshakova, A, Bongrand, M, Bordereau, C, Breton, D, Brigatti, A, Brugnera, R, Bruno, R, Budano, A, Busto, J, Cabrera, A, Caccianiga, B, Cai, H, Cai, X, Cai, Y, Cai, Z, Callegari, R, Cammi, A, Campeny, A, Cao, C, Cao, G, Cao, J, Caruso, R, Cerna, C, Chan, C, Chang, J, Chang, Y, Chen, G, Chen, P, Chen, S, Chen, X, Chen, Y, Chen, Z, Cheng, J, Cheng, Y, Chetverikov, A, Chiesa, D, Chimenti, P, Chu, Z, Chukanov, A, Claverie, G, Clementi, C, Clerbaux, B, Di Lorenzo, S, Corti, D, Corso, F, Dalager, O, De La Taille, C, Deng, Z, Depnering, W, Diaz, M, Ding, X, Ding, Y, Dirgantara, B, Dmitrievsky, S, Dohnal, T, Dolzhikov, D, Donchenko, G, Dong, J, Doroshkevich, E, Dou, W, Dracos, M, Druillole, F, Du, R, Du, S, Dusini, S, Dvorak, M, Eck, J, Enqvist, T, Fabbri, A, Fahrendholz, U, Fan, D, Fan, L, Fang, J, Fang, W, Fargetta, M, Fedoseev, D, Fei, Z, Feng, L, Feng, Q, Ferraro, F, Ford, R, Fournier, A, Gan, H, Gao, F, Garfagnini, A, Gavrikov, A, Giammarchi, M, Giudice, N, Gonchar, M, Gong, G, Gong, H, Gornushkin, Y, Gottel, A, Grassi, M, Gromov, V, Gu, M, Gu, X, Gu, Y, Guan, M, Guan, Y, Guardone, N, Guo, C, Guo, J, Guo, W, Guo, X, Guo, Y, Hagner, C, Han, R, Han, Y, He, M, He, W, Heinz, T, Hellmuth, P, Heng, Y, Herrera, R, Hor, Y, Hou, S, Hsiung, Y, Hu, B, Hu, H, Hu, J, Hu, S, Hu, T, Hu, Y, Hu, Z, Huang, G, Huang, H, Huang, K, Huang, W, Huang, X, Huang, Y, Hui, J, Huo, L, Huo, W, Huss, C, Hussain, S, Ioannisian, A, Isocrate, R, Jelmini, B, Jeria, I, Ji, X, Jia, H, Jia, J, Jian, S, Jiang, D, Jiang, W, Jiang, X, Jing, X, Jollet, C, Joutsenvaara, J, Kalousis, L, Kampmann, P, Kang, L, Karaparambil, R, Kazarian, N, Khatun, A, Khosonthongkee, K, Korablev, D, Kouzakov, K, Krasnoperov, A, Kutovskiy, N, Kuusiniemi, P, Lachenmaier, T, Landini, C, Leblanc, S, Lebrin, V, Lefevre, F, Lei, R, Leitner, R, Leung, J, Li, D, Li, F, Li, G, Li, H, Li, M, Li, N, Li, Q, Li, R, Li, S, Li, T, Li, W, Li, X, Li, Y, Li, Z, Liang, H, Liao, J, Limphirat, A, Lin, G, Lin, S, Lin, T, Ling, J, Lippi, I, Liu, F, Liu, H, Liu, J, Liu, M, Liu, Q, Liu, R, Liu, S, Liu, X, Liu, Y, Lokhov, A, Lombardi, P, Lombardo, C, Loo, K, Lu, C, Lu, H, Lu, J, Lu, P, Lu, S, Lubsandorzhiev, B, Lubsandorzhiev, S, Ludhova, L, Lukanov, A, Luo, D, Luo, F, Luo, G, Luo, S, Luo, W, Luo, X, Lyashuk, V, Ma, B, Ma, Q, Ma, S, Ma, X, Maalmi, J, Magoni, M, Mai, J, Malyshkin, Y, Mandujano, R, Mantovani, F, Mao, X, Mao, Y, Mari, S, Marini, F, Martellini, C, Martin-Chassard, G, Martini, A, Mayer, M, Mayilyan, D, Mednieks, I, Meinusch, A, Meng, Y, Meregaglia, A, Meroni, E, Meyhofer, D, Mezzetto, M, Miller, J, Miramonti, L, Molla, M, Montini, P, Montuschi, M, Muller, A, Nastasi, M, Naumov, D, Naumova, E, Navas-Nicolas, D, Nemchenok, I, Thi, M, Ning, F, Ning, Z, Nunokawa, H, Oberauer, L, Ochoa-Ricoux, J, Olshevskiy, A, Orestano, D, Ortica, F, Othegraven, R, Paoloni, A, Parmeggiano, S, Pei, Y, Pelicci, L, Pelliccia, N, Peng, A, Peng, H, Peng, Y, Peng, Z, Perrot, F, Petitjean, P, Petrucci, F, Pilarczyk, O, Rico, L, Popov, A, Poussot, P, Previtali, E, Qi, F, Qi, M, Qian, S, Qian, X, Qian, Z, Qiao, H, Qin, Z, Qiu, S, Ranucci, G, Raper, N, Rasheed, R, Re, A, Rebber, H, Rebii, A, Redchuk, M, Ren, B, Ren, J, Ricci, B, Rifai, M, Roche, M, Rodphai, N, Romani, A, Roskovec, B, Ruan, X, Rybnikov, A, Sadovsky, A, Saggese, P, Sanfilippo, S, Sangka, A, Sawangwit, U, Sawatzki, J, Schever, M, Schwab, C, Schweizer, K, Selyunin, A, Serafini, A, Settanta, G, Settimo, M, Shao, Z, Sharov, V, Shaydurova, A, Shi, J, Shi, Y, Shutov, V, Sidorenkov, A, Simkovic, F, Sirignano, C, Siripak, J, Sisti, M, Slupecki, M, Smirnov, M, Smirnov, O, Sogo-Bezerra, T, Sokolov, S, Songwadhana, J, Soonthornthum, B, Sotnikov, A, Sramek, O, Sreethawong, W, Stahl, A, Stanco, L, Stankevich, K, Stefanik, D, Steiger, H, Steinmann, J, Sterr, T, Stock, M, Strati, V, Studenikin, A, Su, J, Sun, S, Sun, X, Sun, Y, Sun, Z, Suwonjandee, N, Szelezniak, M, Tang, J, Tang, Q, Tang, X, Hariharan, V, Theisen, E, Tietzsch, A, Tkachev, I, Tmej, T, Torri, M, Treskov, K, Triossi, A, Troni, G, Trzaska, W, Tuve, C, Ushakov, N, Vedin, V, Verde, G, Vialkov, M, Viaud, B, Vollbrecht, C, Volpe, C, Sturm, K, Vorobel, V, Voronin, D, Votano, L, Walker, P, Wang, C, Wang, E, Wang, G, Wang, J, Wang, L, Wang, M, Wang, R, Wang, S, Wang, W, Wang, X, Wang, Y, Weng, Y, Wang, Z, Watcharangkool, A, Wei, W, Wei, Y, Wen, K, Wen, L, Weng, J, Wiebusch, C, Wong, S, Wonsak, B, Wu, D, Wu, Q, Wu, Z, Wurm, M, Wurtz, J, Wysotzki, C, Xi, Y, Xia, D, Xiao, X, Xie, X, Xie, Y, Xie, Z, Xin, Z, Xing, Z, Xu, B, Xu, C, Xu, D, Xu, F, Xu, H, Xu, J, Xu, M, Xu, Y, Yan, B, Yan, Q, Yan, T, Yan, W, Yan, X, Yan, Y, Yang, C, Yang, H, Yang, J, Yang, L, Yang, X, Yang, Y, Yeng, Y, Yao, H, Ye, J, Ye, M, Ye, Z, Yermia, F, You, Z, Yu, B, Yu, C, Yu, H, Yu, M, Yu, X, Yu, Z, Yuan, C, Yuan, Y, Yuan, Z, Yue, B, Zafar, N, Zavadskyi, V, Zeng, S, Zeng, T, Zeng, Y, Zhan, L, Zhang, A, Zhang, B, Zhang, F, Zhang, G, Zhang, H, Zhang, J, Zhang, M, Zhang, P, Zhang, Q, Zhang, S, Zhang, T, Zhang, X, Zhang, Y, Zhang, Z, Zhao, F, Zhao, J, Zhao, R, Zhao, S, Zheng, D, Zheng, H, Zheng, Y, Zhong, W, Zhou, J, Zhou, L, Zhou, N, Zhou, S, Zhou, T, Zhou, X, Zhu, J, Zhu, K, Zhu, Z, Zhuang, B, Zhuang, H, Zong, L, Zou, J, Zwickel, S, Abusleme A., Adam T., Ahmad S., Ahmed R., Aiello S., Akram M., Aleem A., Alexandros T., An F., An Q., Andronico G., Anfimov N., Antonelli V., Antoshkina T., Asavapibhop B., de Andre J. P. A. M., Auguste D., Bai W., Balashov N., Baldini W., Barresi A., Basilico D., Baussan E., Bellato M., Bergnoli A., Birkenfeld T., Blin S., Blum D., Blyth S., Bolshakova A., Bongrand M., Bordereau C., Breton D., Brigatti A., Brugnera R., Bruno R., Budano A., Busto J., Cabrera A., Caccianiga B., Cai H., Cai X., Cai Y., Cai Z., Callegari R., Cammi A., Campeny A., Cao C., Cao G., Cao J., Caruso R., Cerna C., Chan C., Chang J., Chang Y., Chen G., Chen P., Chen P. -A., Chen S., Chen X., Chen Y., Chen Z., Cheng J., Cheng Y., Cheng Y. C., Chetverikov A., Chiesa D., Chimenti P., Chu Z., Chukanov A., Claverie G., Clementi C., Clerbaux B., Di Lorenzo S. C., Corti D., Corso F. D., Dalager O., De La Taille C., Deng Z., Depnering W., Diaz M., Ding X., Ding Y., Dirgantara B., Dmitrievsky S., Dohnal T., Dolzhikov D., Donchenko G., Dong J., Doroshkevich E., Dou W., Dracos M., Druillole F., Du R., Du S., Dusini S., Dvorak M., Eck J., Enqvist T., Fabbri A., Fahrendholz U., Fan D., Fan L., Fang J., Fang W., Fargetta M., Fedoseev D., Fei Z., Feng L. -C., Feng Q., Ferraro F., Ford R., Fournier A., Gan H., Gao F., Garfagnini A., Gavrikov A., Giammarchi M., Giudice N., Gonchar M., Gong G., Gong H., Gornushkin Y., Gottel A., Grassi M., Gromov V., Gu M., Gu X., Gu Y., Guan M., Guan Y., Guardone N., Guo C., Guo J., Guo W., Guo X., Guo Y., Hagner C., Han R., Han Y., He M., He W., Heinz T., Hellmuth P., Heng Y., Herrera R., Hor Y., Hou S., Hsiung Y., Hu B. -Z., Hu H., Hu J., Hu S., Hu T., Hu Y., Hu Z., Huang G., Huang H., Huang K., Huang W., Huang X., Huang Y., Hui J., Huo L., Huo W., Huss C., Hussain S., Ioannisian A., Isocrate R., Jelmini B., Jeria I., Ji X., Jia H., Jia J., Jian S., Jiang D., Jiang W., Jiang X., Jing X., Jollet C., Joutsenvaara J., Kalousis L., Kampmann P., Kang L., Karaparambil R., Kazarian N., Khatun A., Khosonthongkee K., Korablev D., Kouzakov K., Krasnoperov A., Kutovskiy N., Kuusiniemi P., Lachenmaier T., Landini C., Leblanc S., Lebrin V., Lefevre F., Lei R., Leitner R., Leung J., Li D., Li F., Li G., Li H., Li M., Li N., Li Q., Li R., Li S., Li T., Li W., Li X., Li Y., Li Z., Liang H., Liao J., Limphirat A., Lin G. -L., Lin S., Lin T., Ling J., Lippi I., Liu F., Liu H., Liu J., Liu M., Liu Q., Liu R., Liu S., Liu X., Liu Y., Lokhov A., Lombardi P., Lombardo C., Loo K., Lu C., Lu H., Lu J., Lu P., Lu S., Lubsandorzhiev B., Lubsandorzhiev S., Ludhova L., Lukanov A., Luo D., Luo F., Luo G., Luo S., Luo W., Luo X., Lyashuk V., Ma B., Ma Q., Ma S., Ma X., Maalmi J., Magoni M., Mai J., Malyshkin Y., Mandujano R. C., Mantovani F., Mao X., Mao Y., Mari S. M., Marini F., Martellini C., Martin-Chassard G., Martini A., Mayer M., Mayilyan D., Mednieks I., Meinusch A., Meng Y., Meregaglia A., Meroni E., Meyhofer D., Mezzetto M., Miller J., Miramonti L., Molla M. C., Montini P., Montuschi M., Muller A., Nastasi M., Naumov D. V., Naumova E., Navas-Nicolas D., Nemchenok I., Thi M. T. N., Ning F., Ning Z., Nunokawa H., Oberauer L., Ochoa-Ricoux J. P., Olshevskiy A., Orestano D., Ortica F., Othegraven R., Paoloni A., Parmeggiano S., Pei Y., Pelicci L., Pelliccia N., Peng A., Peng H., Peng Y., Peng Z., Perrot F., Petitjean P. -A., Petrucci F., Pilarczyk O., Rico L. F. P., Popov A., Poussot P., Previtali E., Qi F., Qi M., Qian S., Qian X., Qian Z., Qiao H., Qin Z., Qiu S., Ranucci G., Raper N., Rasheed R., Re A., Rebber H., Rebii A., Redchuk M., Ren B., Ren J., Ricci B., Rifai M., Roche M., Rodphai N., Romani A., Roskovec B., Ruan X., Rybnikov A., Sadovsky A., Saggese P., Sanfilippo S., Sangka A., Sawangwit U., Sawatzki J., Schever M., Schwab C., Schweizer K., Selyunin A., Serafini A., Settanta G., Settimo M., Shao Z., Sharov V., Shaydurova A., Shi J., Shi Y., Shutov V., Sidorenkov A., Simkovic F., Sirignano C., Siripak J., Sisti M., Slupecki M., Smirnov M., Smirnov O., Sogo-Bezerra T., Sokolov S., Songwadhana J., Soonthornthum B., Sotnikov A., Sramek O., Sreethawong W., Stahl A., Stanco L., Stankevich K., Stefanik D., Steiger H., Steinmann J., Sterr T., Stock M. R., Strati V., Studenikin A., Su J., Sun S., Sun X., Sun Y., Sun Z., Suwonjandee N., Szelezniak M., Tang J., Tang Q., Tang X., Hariharan V. T., Theisen E., Tietzsch A., Tkachev I., Tmej T., Torri M. D. C., Treskov K., Triossi A., Troni G., Trzaska W., Tuve C., Ushakov N., Vedin V., Verde G., Vialkov M., Viaud B., Vollbrecht C. M., Volpe C., Sturm K. V., Vorobel V., Voronin D., Votano L., Walker P., Wang C., Wang C. -H., Wang E., Wang G., Wang J., Wang L., Wang M., Wang R., Wang S., Wang W., Wang X., Wang Y., Weng Y., Wang Z., Watcharangkool A., Wei W., Wei Y., Wen K., Wen L., Weng J., Wiebusch C., Wong S. C. -F., Wonsak B., Wu D., Wu Q., Wu Z., Wurm M., Wurtz J., Wysotzki C., Xi Y., Xia D., Xiao X., Xie X., Xie Y., Xie Z., Xin Z., Xing Z., Xu B., Xu C., Xu D., Xu F., Xu H., Xu J., Xu M., Xu Y., Yan B., Yan Q., Yan T., Yan W., Yan X., Yan Y., Yang C., Yang H., Yang J., Yang L., Yang X., Yang Y., Yeng Y., Yao H., Ye J., Ye M., Ye Z., Yermia F., You Z., Yu B., Yu C., Yu H., Yu M., Yu X., Yu Z., Yuan C., Yuan Y., Yuan Z., Yue B., Zafar N., Zavadskyi V., Zeng S., Zeng T., Zeng Y., Zhan L., Zhang A., Zhang B., Zhang F., Zhang G., Zhang H., Zhang J., Zhang M., Zhang P., Zhang Q., Zhang S., Zhang T., Zhang X., Zhang Y., Zhang Z., Zhao F., Zhao J., Zhao R., Zhao S., Zheng D., Zheng H., Zheng Y., Zhong W., Zhou J., Zhou L., Zhou N., Zhou S., Zhou T., Zhou X., Zhu J., Zhu K., Zhu Z., Zhuang B., Zhuang H., Zong L., Zou J., Zwickel S., Abusleme, A, Adam, T, Ahmad, S, Ahmed, R, Aiello, S, Akram, M, Aleem, A, Alexandros, T, An, F, An, Q, Andronico, G, Anfimov, N, Antonelli, V, Antoshkina, T, Asavapibhop, B, de Andre, J, Auguste, D, Bai, W, Balashov, N, Baldini, W, Barresi, A, Basilico, D, Baussan, E, Bellato, M, Bergnoli, A, Birkenfeld, T, Blin, S, Blum, D, Blyth, S, Bolshakova, A, Bongrand, M, Bordereau, C, Breton, D, Brigatti, A, Brugnera, R, Bruno, R, Budano, A, Busto, J, Cabrera, A, Caccianiga, B, Cai, H, Cai, X, Cai, Y, Cai, Z, Callegari, R, Cammi, A, Campeny, A, Cao, C, Cao, G, Cao, J, Caruso, R, Cerna, C, Chan, C, Chang, J, Chang, Y, Chen, G, Chen, P, Chen, S, Chen, X, Chen, Y, Chen, Z, Cheng, J, Cheng, Y, Chetverikov, A, Chiesa, D, Chimenti, P, Chu, Z, Chukanov, A, Claverie, G, Clementi, C, Clerbaux, B, Di Lorenzo, S, Corti, D, Corso, F, Dalager, O, De La Taille, C, Deng, Z, Depnering, W, Diaz, M, Ding, X, Ding, Y, Dirgantara, B, Dmitrievsky, S, Dohnal, T, Dolzhikov, D, Donchenko, G, Dong, J, Doroshkevich, E, Dou, W, Dracos, M, Druillole, F, Du, R, Du, S, Dusini, S, Dvorak, M, Eck, J, Enqvist, T, Fabbri, A, Fahrendholz, U, Fan, D, Fan, L, Fang, J, Fang, W, Fargetta, M, Fedoseev, D, Fei, Z, Feng, L, Feng, Q, Ferraro, F, Ford, R, Fournier, A, Gan, H, Gao, F, Garfagnini, A, Gavrikov, A, Giammarchi, M, Giudice, N, Gonchar, M, Gong, G, Gong, H, Gornushkin, Y, Gottel, A, Grassi, M, Gromov, V, Gu, M, Gu, X, Gu, Y, Guan, M, Guan, Y, Guardone, N, Guo, C, Guo, J, Guo, W, Guo, X, Guo, Y, Hagner, C, Han, R, Han, Y, He, M, He, W, Heinz, T, Hellmuth, P, Heng, Y, Herrera, R, Hor, Y, Hou, S, Hsiung, Y, Hu, B, Hu, H, Hu, J, Hu, S, Hu, T, Hu, Y, Hu, Z, Huang, G, Huang, H, Huang, K, Huang, W, Huang, X, Huang, Y, Hui, J, Huo, L, Huo, W, Huss, C, Hussain, S, Ioannisian, A, Isocrate, R, Jelmini, B, Jeria, I, Ji, X, Jia, H, Jia, J, Jian, S, Jiang, D, Jiang, W, Jiang, X, Jing, X, Jollet, C, Joutsenvaara, J, Kalousis, L, Kampmann, P, Kang, L, Karaparambil, R, Kazarian, N, Khatun, A, Khosonthongkee, K, Korablev, D, Kouzakov, K, Krasnoperov, A, Kutovskiy, N, Kuusiniemi, P, Lachenmaier, T, Landini, C, Leblanc, S, Lebrin, V, Lefevre, F, Lei, R, Leitner, R, Leung, J, Li, D, Li, F, Li, G, Li, H, Li, M, Li, N, Li, Q, Li, R, Li, S, Li, T, Li, W, Li, X, Li, Y, Li, Z, Liang, H, Liao, J, Limphirat, A, Lin, G, Lin, S, Lin, T, Ling, J, Lippi, I, Liu, F, Liu, H, Liu, J, Liu, M, Liu, Q, Liu, R, Liu, S, Liu, X, Liu, Y, Lokhov, A, Lombardi, P, Lombardo, C, Loo, K, Lu, C, Lu, H, Lu, J, Lu, P, Lu, S, Lubsandorzhiev, B, Lubsandorzhiev, S, Ludhova, L, Lukanov, A, Luo, D, Luo, F, Luo, G, Luo, S, Luo, W, Luo, X, Lyashuk, V, Ma, B, Ma, Q, Ma, S, Ma, X, Maalmi, J, Magoni, M, Mai, J, Malyshkin, Y, Mandujano, R, Mantovani, F, Mao, X, Mao, Y, Mari, S, Marini, F, Martellini, C, Martin-Chassard, G, Martini, A, Mayer, M, Mayilyan, D, Mednieks, I, Meinusch, A, Meng, Y, Meregaglia, A, Meroni, E, Meyhofer, D, Mezzetto, M, Miller, J, Miramonti, L, Molla, M, Montini, P, Montuschi, M, Muller, A, Nastasi, M, Naumov, D, Naumova, E, Navas-Nicolas, D, Nemchenok, I, Thi, M, Ning, F, Ning, Z, Nunokawa, H, Oberauer, L, Ochoa-Ricoux, J, Olshevskiy, A, Orestano, D, Ortica, F, Othegraven, R, Paoloni, A, Parmeggiano, S, Pei, Y, Pelicci, L, Pelliccia, N, Peng, A, Peng, H, Peng, Y, Peng, Z, Perrot, F, Petitjean, P, Petrucci, F, Pilarczyk, O, Rico, L, Popov, A, Poussot, P, Previtali, E, Qi, F, Qi, M, Qian, S, Qian, X, Qian, Z, Qiao, H, Qin, Z, Qiu, S, Ranucci, G, Raper, N, Rasheed, R, Re, A, Rebber, H, Rebii, A, Redchuk, M, Ren, B, Ren, J, Ricci, B, Rifai, M, Roche, M, Rodphai, N, Romani, A, Roskovec, B, Ruan, X, Rybnikov, A, Sadovsky, A, Saggese, P, Sanfilippo, S, Sangka, A, Sawangwit, U, Sawatzki, J, Schever, M, Schwab, C, Schweizer, K, Selyunin, A, Serafini, A, Settanta, G, Settimo, M, Shao, Z, Sharov, V, Shaydurova, A, Shi, J, Shi, Y, Shutov, V, Sidorenkov, A, Simkovic, F, Sirignano, C, Siripak, J, Sisti, M, Slupecki, M, Smirnov, M, Smirnov, O, Sogo-Bezerra, T, Sokolov, S, Songwadhana, J, Soonthornthum, B, Sotnikov, A, Sramek, O, Sreethawong, W, Stahl, A, Stanco, L, Stankevich, K, Stefanik, D, Steiger, H, Steinmann, J, Sterr, T, Stock, M, Strati, V, Studenikin, A, Su, J, Sun, S, Sun, X, Sun, Y, Sun, Z, Suwonjandee, N, Szelezniak, M, Tang, J, Tang, Q, Tang, X, Hariharan, V, Theisen, E, Tietzsch, A, Tkachev, I, Tmej, T, Torri, M, Treskov, K, Triossi, A, Troni, G, Trzaska, W, Tuve, C, Ushakov, N, Vedin, V, Verde, G, Vialkov, M, Viaud, B, Vollbrecht, C, Volpe, C, Sturm, K, Vorobel, V, Voronin, D, Votano, L, Walker, P, Wang, C, Wang, E, Wang, G, Wang, J, Wang, L, Wang, M, Wang, R, Wang, S, Wang, W, Wang, X, Wang, Y, Weng, Y, Wang, Z, Watcharangkool, A, Wei, W, Wei, Y, Wen, K, Wen, L, Weng, J, Wiebusch, C, Wong, S, Wonsak, B, Wu, D, Wu, Q, Wu, Z, Wurm, M, Wurtz, J, Wysotzki, C, Xi, Y, Xia, D, Xiao, X, Xie, X, Xie, Y, Xie, Z, Xin, Z, Xing, Z, Xu, B, Xu, C, Xu, D, Xu, F, Xu, H, Xu, J, Xu, M, Xu, Y, Yan, B, Yan, Q, Yan, T, Yan, W, Yan, X, Yan, Y, Yang, C, Yang, H, Yang, J, Yang, L, Yang, X, Yang, Y, Yeng, Y, Yao, H, Ye, J, Ye, M, Ye, Z, Yermia, F, You, Z, Yu, B, Yu, C, Yu, H, Yu, M, Yu, X, Yu, Z, Yuan, C, Yuan, Y, Yuan, Z, Yue, B, Zafar, N, Zavadskyi, V, Zeng, S, Zeng, T, Zeng, Y, Zhan, L, Zhang, A, Zhang, B, Zhang, F, Zhang, G, Zhang, H, Zhang, J, Zhang, M, Zhang, P, Zhang, Q, Zhang, S, Zhang, T, Zhang, X, Zhang, Y, Zhang, Z, Zhao, F, Zhao, J, Zhao, R, Zhao, S, Zheng, D, Zheng, H, Zheng, Y, Zhong, W, Zhou, J, Zhou, L, Zhou, N, Zhou, S, Zhou, T, Zhou, X, Zhu, J, Zhu, K, Zhu, Z, Zhuang, B, Zhuang, H, Zong, L, Zou, J, Zwickel, S, Abusleme A., Adam T., Ahmad S., Ahmed R., Aiello S., Akram M., Aleem A., Alexandros T., An F., An Q., Andronico G., Anfimov N., Antonelli V., Antoshkina T., Asavapibhop B., de Andre J. P. A. M., Auguste D., Bai W., Balashov N., Baldini W., Barresi A., Basilico D., Baussan E., Bellato M., Bergnoli A., Birkenfeld T., Blin S., Blum D., Blyth S., Bolshakova A., Bongrand M., Bordereau C., Breton D., Brigatti A., Brugnera R., Bruno R., Budano A., Busto J., Cabrera A., Caccianiga B., Cai H., Cai X., Cai Y., Cai Z., Callegari R., Cammi A., Campeny A., Cao C., Cao G., Cao J., Caruso R., Cerna C., Chan C., Chang J., Chang Y., Chen G., Chen P., Chen P. -A., Chen S., Chen X., Chen Y., Chen Z., Cheng J., Cheng Y., Cheng Y. C., Chetverikov A., Chiesa D., Chimenti P., Chu Z., Chukanov A., Claverie G., Clementi C., Clerbaux B., Di Lorenzo S. C., Corti D., Corso F. D., Dalager O., De La Taille C., Deng Z., Depnering W., Diaz M., Ding X., Ding Y., Dirgantara B., Dmitrievsky S., Dohnal T., Dolzhikov D., Donchenko G., Dong J., Doroshkevich E., Dou W., Dracos M., Druillole F., Du R., Du S., Dusini S., Dvorak M., Eck J., Enqvist T., Fabbri A., Fahrendholz U., Fan D., Fan L., Fang J., Fang W., Fargetta M., Fedoseev D., Fei Z., Feng L. -C., Feng Q., Ferraro F., Ford R., Fournier A., Gan H., Gao F., Garfagnini A., Gavrikov A., Giammarchi M., Giudice N., Gonchar M., Gong G., Gong H., Gornushkin Y., Gottel A., Grassi M., Gromov V., Gu M., Gu X., Gu Y., Guan M., Guan Y., Guardone N., Guo C., Guo J., Guo W., Guo X., Guo Y., Hagner C., Han R., Han Y., He M., He W., Heinz T., Hellmuth P., Heng Y., Herrera R., Hor Y., Hou S., Hsiung Y., Hu B. -Z., Hu H., Hu J., Hu S., Hu T., Hu Y., Hu Z., Huang G., Huang H., Huang K., Huang W., Huang X., Huang Y., Hui J., Huo L., Huo W., Huss C., Hussain S., Ioannisian A., Isocrate R., Jelmini B., Jeria I., Ji X., Jia H., Jia J., Jian S., Jiang D., Jiang W., Jiang X., Jing X., Jollet C., Joutsenvaara J., Kalousis L., Kampmann P., Kang L., Karaparambil R., Kazarian N., Khatun A., Khosonthongkee K., Korablev D., Kouzakov K., Krasnoperov A., Kutovskiy N., Kuusiniemi P., Lachenmaier T., Landini C., Leblanc S., Lebrin V., Lefevre F., Lei R., Leitner R., Leung J., Li D., Li F., Li G., Li H., Li M., Li N., Li Q., Li R., Li S., Li T., Li W., Li X., Li Y., Li Z., Liang H., Liao J., Limphirat A., Lin G. -L., Lin S., Lin T., Ling J., Lippi I., Liu F., Liu H., Liu J., Liu M., Liu Q., Liu R., Liu S., Liu X., Liu Y., Lokhov A., Lombardi P., Lombardo C., Loo K., Lu C., Lu H., Lu J., Lu P., Lu S., Lubsandorzhiev B., Lubsandorzhiev S., Ludhova L., Lukanov A., Luo D., Luo F., Luo G., Luo S., Luo W., Luo X., Lyashuk V., Ma B., Ma Q., Ma S., Ma X., Maalmi J., Magoni M., Mai J., Malyshkin Y., Mandujano R. C., Mantovani F., Mao X., Mao Y., Mari S. M., Marini F., Martellini C., Martin-Chassard G., Martini A., Mayer M., Mayilyan D., Mednieks I., Meinusch A., Meng Y., Meregaglia A., Meroni E., Meyhofer D., Mezzetto M., Miller J., Miramonti L., Molla M. C., Montini P., Montuschi M., Muller A., Nastasi M., Naumov D. V., Naumova E., Navas-Nicolas D., Nemchenok I., Thi M. T. N., Ning F., Ning Z., Nunokawa H., Oberauer L., Ochoa-Ricoux J. P., Olshevskiy A., Orestano D., Ortica F., Othegraven R., Paoloni A., Parmeggiano S., Pei Y., Pelicci L., Pelliccia N., Peng A., Peng H., Peng Y., Peng Z., Perrot F., Petitjean P. -A., Petrucci F., Pilarczyk O., Rico L. F. P., Popov A., Poussot P., Previtali E., Qi F., Qi M., Qian S., Qian X., Qian Z., Qiao H., Qin Z., Qiu S., Ranucci G., Raper N., Rasheed R., Re A., Rebber H., Rebii A., Redchuk M., Ren B., Ren J., Ricci B., Rifai M., Roche M., Rodphai N., Romani A., Roskovec B., Ruan X., Rybnikov A., Sadovsky A., Saggese P., Sanfilippo S., Sangka A., Sawangwit U., Sawatzki J., Schever M., Schwab C., Schweizer K., Selyunin A., Serafini A., Settanta G., Settimo M., Shao Z., Sharov V., Shaydurova A., Shi J., Shi Y., Shutov V., Sidorenkov A., Simkovic F., Sirignano C., Siripak J., Sisti M., Slupecki M., Smirnov M., Smirnov O., Sogo-Bezerra T., Sokolov S., Songwadhana J., Soonthornthum B., Sotnikov A., Sramek O., Sreethawong W., Stahl A., Stanco L., Stankevich K., Stefanik D., Steiger H., Steinmann J., Sterr T., Stock M. R., Strati V., Studenikin A., Su J., Sun S., Sun X., Sun Y., Sun Z., Suwonjandee N., Szelezniak M., Tang J., Tang Q., Tang X., Hariharan V. T., Theisen E., Tietzsch A., Tkachev I., Tmej T., Torri M. D. C., Treskov K., Triossi A., Troni G., Trzaska W., Tuve C., Ushakov N., Vedin V., Verde G., Vialkov M., Viaud B., Vollbrecht C. M., Volpe C., Sturm K. V., Vorobel V., Voronin D., Votano L., Walker P., Wang C., Wang C. -H., Wang E., Wang G., Wang J., Wang L., Wang M., Wang R., Wang S., Wang W., Wang X., Wang Y., Weng Y., Wang Z., Watcharangkool A., Wei W., Wei Y., Wen K., Wen L., Weng J., Wiebusch C., Wong S. C. -F., Wonsak B., Wu D., Wu Q., Wu Z., Wurm M., Wurtz J., Wysotzki C., Xi Y., Xia D., Xiao X., Xie X., Xie Y., Xie Z., Xin Z., Xing Z., Xu B., Xu C., Xu D., Xu F., Xu H., Xu J., Xu M., Xu Y., Yan B., Yan Q., Yan T., Yan W., Yan X., Yan Y., Yang C., Yang H., Yang J., Yang L., Yang X., Yang Y., Yeng Y., Yao H., Ye J., Ye M., Ye Z., Yermia F., You Z., Yu B., Yu C., Yu H., Yu M., Yu X., Yu Z., Yuan C., Yuan Y., Yuan Z., Yue B., Zafar N., Zavadskyi V., Zeng S., Zeng T., Zeng Y., Zhan L., Zhang A., Zhang B., Zhang F., Zhang G., Zhang H., Zhang J., Zhang M., Zhang P., Zhang Q., Zhang S., Zhang T., Zhang X., Zhang Y., Zhang Z., Zhao F., Zhao J., Zhao R., Zhao S., Zheng D., Zheng H., Zheng Y., Zhong W., Zhou J., Zhou L., Zhou N., Zhou S., Zhou T., Zhou X., Zhu J., Zhu K., Zhu Z., Zhuang B., Zhuang H., Zong L., Zou J., and Zwickel S.
- Abstract
We discuss JUNO sensitivity to the annihilation of MeV dark matter in the galactic halo via detecting inverse beta decay reactions of electron anti-neutrinos resulting from the annihilation. We study possible backgrounds to the signature, including the reactor neutrinos, diffuse supernova neutrino background, charged- and neutral-current interactions of atmospheric neutrinos, backgrounds from muon-induced fast neutrons and cosmogenic isotopes. A fiducial volume cut, as well as the pulse shape discrimination and the muon veto are applied to suppress the above backgrounds. It is shown that JUNO sensitivity to the thermally averaged dark matter annihilation rate in 10 years of exposure would be significantly better than the present-day best limit set by Super-Kamiokande and would be comparable to that expected by Hyper-Kamiokande.
- Published
- 2023
43. JUNO sensitivity to 7Be, pep, and CNO solar neutrinos
- Author
-
Abusleme, A, Adam, T, Ahmad, S, Ahmed, R, Aiello, S, Akram, M, Aleem, A, Alexandros, T, An, F, An, Q, Andronico, G, Anfimov, N, Antonelli, V, Antoshkina, T, Asavapibhop, B, de Andre, J, Auguste, D, Bai, W, Balashov, N, Baldini, W, Barresi, A, Basilico, D, Baussan, E, Bellato, M, Beretta, M, Bergnoli, A, Bick, D, Bieger, L, Biktemerova, S, Birkenfeld, T, Blum, D, Blyth, S, Bolshakova, A, Bongrand, M, Bordereau, C, Breton, D, Brigatti, A, Brugnera, R, Bruno, R, Budano, A, Busto, J, Cabrera, A, Caccianiga, B, Cai, H, Cai, X, Cai, Y, Cai, Z, Callier, S, Cammi, A, Campeny, A, Cao, C, Cao, G, Cao, J, Caruso, R, Cerna, C, Cerrone, V, Chan, C, Chang, J, Chang, Y, Chen, C, Chen, G, Chen, P, Chen, S, Chen, Y, Chen, Z, Cheng, J, Cheng, Y, Chepurnov, A, Chetverikov, A, Chiesa, D, Chimenti, P, Chu, Z, Chukanov, A, Claverie, G, Clementi, C, Clerbaux, B, Molla, M, Di Lorenzo, S, Coppi, A, Corti, D, Csakli, S, Dal Corso, F, Dalager, O, Datta, J, De La Taille, C, Deng, Z, Depnering, W, Ding, X, Ding, Y, Dirgantara, B, Dittrich, C, Dmitrievsky, S, Dohnal, T, Dolzhikov, D, Donchenko, G, Dong, J, Doroshkevich, E, Dou, W, Dracos, M, Druillole, F, Du, R, Du, S, Dugas, K, Dusini, S, Duyang, H, Eck, J, Enqvist, T, Fabbri, A, Fahrendholz, U, Fan, L, Fang, J, Fang, W, Fargetta, M, Fedoseev, D, Fei, Z, Feng, L, Feng, Q, Ferraro, F, Fournier, A, Gan, H, Gao, F, Garfagnini, A, Gavrikov, A, Giammarchi, M, Giudice, N, Gonchar, M, Gong, G, Gong, H, Gornushkin, Y, Gottel, A, Grassi, M, Gromov, M, Gromov, V, Gu, M, Gu, X, Gu, Y, Guan, M, Guan, Y, Guardone, N, Guo, C, Guo, W, Guo, X, Hagner, C, Han, R, Han, Y, He, M, He, W, Heinz, T, Hellmuth, P, Heng, Y, Herrera, R, Hor, Y, Hou, S, Hsiung, Y, Hu, B, Hu, H, Hu, J, Hu, S, Hu, T, Hu, Y, Hu, Z, Huang, G, Huang, H, Huang, J, Huang, K, Huang, W, Huang, X, Huang, Y, Hui, J, Huo, L, Huo, W, Huss, C, Hussain, S, Imbert, L, Ioannisian, A, Isocrate, R, Jelmini, B, Jeria, I, Ji, X, Jia, H, Jia, J, Jian, S, Jiang, C, Jiang, D, Jiang, W, Jiang, X, Jing, X, Jollet, C, Kampmann, P, Kang, L, Karaparambil, R, Kazarian, N, Khan, A, Khatun, A, Khosonthongkee, K, Korablev, D, Kouzakov, K, Krasnoperov, A, Kuleshov, S, Kutovskiy, N, Lachenmaier, T, Landini, C, Leblanc, S, Lebrin, V, Lefevre, F, Lei, R, Leitner, R, Leung, J, Li, D, Li, F, Li, G, Li, H, Li, J, Li, M, Li, N, Li, Q, Li, R, Li, S, Li, T, Li, W, Li, X, Li, Y, Li, Z, Liang, H, Liao, J, Limphirat, A, Lin, G, Lin, S, Lin, T, Ling, J, Ling, X, Lippi, I, Liu, C, Liu, F, Liu, H, Liu, J, Liu, M, Liu, Q, Liu, R, Liu, S, Liu, X, Liu, Y, Liu, Z, Lokhov, A, Lombardi, P, Lombardo, C, Loo, K, Lu, C, Lu, H, Lu, J, Lu, P, Lu, S, Lubsandorzhiev, B, Lubsandorzhiev, S, Ludhova, L, Lukanov, A, Luo, D, Luo, F, Luo, G, Luo, J, Luo, S, Luo, W, Luo, X, Lyashuk, V, Ma, B, Ma, Q, Ma, S, Ma, X, Maalmi, J, Magoni, M, Mai, J, Malyshkin, Y, Mandujano, R, Mantovani, F, Mao, X, Mao, Y, Mari, S, Marini, F, Martini, A, Mayer, M, Mayilyan, D, Mednieks, I, Meng, Y, Meraviglia, A, Meregaglia, A, Meroni, E, Meyhofer, D, Miramonti, L, Mohan, N, Montini, P, Montuschi, M, Muller, A, Nastasi, M, Naumov, D, Naumova, E, Navas-Nicolas, D, Nemchenok, I, Thi, M, Nikolaev, A, Ning, F, Ning, Z, Nunokawa, H, Oberauer, L, Ochoa-Ricoux, J, Olshevskiy, A, Orestano, D, Ortica, F, Othegraven, R, Paoloni, A, Parmeggiano, S, Pei, Y, Pelicci, L, Peng, A, Peng, H, Peng, Y, Peng, Z, Perrot, F, Petitjean, P, Petrucci, F, Pilarczyk, O, Rico, L, Popov, A, Poussot, P, Previtali, E, Qi, F, Qi, M, Qi, X, Qian, S, Qian, X, Qian, Z, Qiao, H, Qin, Z, Qiu, S, Ranucci, G, Rasheed, R, Re, A, Rebii, A, Redchuk, M, Ren, B, Ren, J, Ricci, B, Rifai, M, Roche, M, Rodphai, N, Romani, A, Roskovec, B, Ruan, X, Rybnikov, A, Sadovsky, A, Saggese, P, Sandanayake, D, Sanfilippo, S, Sangka, A, Sawangwit, U, Schever, M, Schwab, C, Schweizer, K, Selyunin, A, Serafini, A, Settimo, M, Sharov, V, Shaydurova, A, Shi, J, Shi, Y, Shutov, V, Sidorenkov, A, Simkovic, F, Singhal, A, Sirignano, C, Siripak, J, Sisti, M, Smirnov, M, Smirnov, O, Sogo-Bezerra, T, Sokolov, S, Songwadhana, J, Soonthornthum, B, Sotnikov, A, Sramek, O, Sreethawong, W, Stahl, A, Stanco, L, Stankevich, K, Steiger, H, Steinmann, J, Sterr, T, Stock, M, Strati, V, Studenikin, A, Su, J, Sun, S, Sun, X, Sun, Y, Sun, Z, Suwonjandee, N, Szelezniak, M, Takenaka, A, Tang, J, Tang, Q, Tang, X, Hariharan, V, Theisen, E, Tietzsch, A, Tkachev, I, Tmej, T, Torri, M, Tortorici, F, Treskov, K, Triossi, A, Triozzi, R, Trzaska, W, Tung, Y, Tuve, C, Ushakov, N, Vedin, V, Verde, G, Vialkov, M, Viaud, B, Vollbrecht, C, von Sturm, K, Vorobel, V, Voronin, D, Votano, L, Walker, P, Wang, C, Wang, E, Wang, G, Wang, J, Wang, L, Wang, M, Wang, R, Wang, S, Wang, W, Wang, X, Wang, Y, Wang, Z, Watcharangkool, A, Wei, W, Wei, Y, Wen, K, Wen, L, Weng, J, Wiebusch, C, Wirth, R, Wonsak, B, Wu, D, Wu, Q, Wu, Y, Wu, Z, Wurm, M, Wurtz, J, Wysotzki, C, Xi, Y, Xia, D, Xiao, X, Xie, X, Xie, Y, Xie, Z, Xin, Z, Xing, Z, Xu, B, Xu, C, Xu, D, Xu, F, Xu, H, Xu, J, Xu, M, Xu, Y, Yan, B, Yan, Q, Yan, T, Yan, X, Yan, Y, Yang, C, Yang, J, Yang, L, Yang, X, Yang, Y, Yao, H, Ye, J, Ye, M, Ye, Z, Yermia, F, You, Z, Yu, B, Yu, C, Yu, G, Yu, H, Yu, M, Yu, X, Yu, Z, Yuan, C, Yuan, Y, Yuan, Z, Yue, B, Zafar, N, Zavadskyi, V, Zeng, S, Zeng, T, Zeng, Y, Zhan, L, Zhang, A, Zhang, B, Zhang, F, Zhang, H, Zhang, J, Zhang, M, Zhang, P, Zhang, Q, Zhang, S, Zhang, T, Zhang, X, Zhang, Y, Zhang, Z, Zhao, J, Zhao, R, Zhao, S, Zheng, D, Zheng, H, Zheng, Y, Zhong, W, Zhou, J, Zhou, L, Zhou, N, Zhou, S, Zhou, T, Zhou, X, Zhu, J, Zhu, K, Zhu, Z, Zhuang, B, Zhuang, H, Zong, L, Zou, J, Zufle, J, Zwickel, S, Abusleme A., Adam T., Ahmad S., Ahmed R., Aiello S., Akram M., Aleem A., Alexandros T., An F., An Q., Andronico G., Anfimov N., Antonelli V., Antoshkina T., Asavapibhop B., de Andre J. P. A. M., Auguste D., Bai W., Balashov N., Baldini W., Barresi A., Basilico D., Baussan E., Bellato M., Beretta M., Bergnoli A., Bick D., Bieger L., Biktemerova S., Birkenfeld T., Blum D., Blyth S., Bolshakova A., Bongrand M., Bordereau C., Breton D., Brigatti A., Brugnera R., Bruno R., Budano A., Busto J., Cabrera A., Caccianiga B., Cai H., Cai X., Cai Y., Cai Z., Callier S., Cammi A., Campeny A., Cao C., Cao G., Cao J., Caruso R., Cerna C., Cerrone V., Chan C., Chang J., Chang Y., Chen C., Chen G., Chen P., Chen S., Chen Y., Chen Z., Cheng J., Cheng Y., Cheng Y. C., Chepurnov A., Chetverikov A., Chiesa D., Chimenti P., Chu Z., Chukanov A., Claverie G., Clementi C., Clerbaux B., Molla M. C., Di Lorenzo S. C., Coppi A., Corti D., Csakli S., Dal Corso F., Dalager O., Datta J., De La Taille C., Deng Z., Depnering W., Ding X., Ding Y., Dirgantara B., Dittrich C., Dmitrievsky S., Dohnal T., Dolzhikov D., Donchenko G., Dong J., Doroshkevich E., Dou W., Dracos M., Druillole F., Du R., Du S., Dugas K., Dusini S., Duyang H., Eck J., Enqvist T., Fabbri A., Fahrendholz U., Fan L., Fang J., Fang W., Fargetta M., Fedoseev D., Fei Z., Feng L. -C., Feng Q., Ferraro F., Fournier A., Gan H., Gao F., Garfagnini A., Gavrikov A., Giammarchi M., Giudice N., Gonchar M., Gong G., Gong H., Gornushkin Y., Gottel A., Grassi M., Gromov M., Gromov V., Gu M., Gu X., Gu Y., Guan M., Guan Y., Guardone N., Guo C., Guo W., Guo X., Hagner C., Han R., Han Y., He M., He W., Heinz T., Hellmuth P., Heng Y., Herrera R., Hor Y., Hou S., Hsiung Y., Hu B. -Z., Hu H., Hu J., Hu S., Hu T., Hu Y., Hu Z., Huang G., Huang H., Huang J., Huang K., Huang W., Huang X., Huang Y., Hui J., Huo L., Huo W., Huss C., Hussain S., Imbert L., Ioannisian A., Isocrate R., Jelmini B., Jeria I., Ji X., Jia H., Jia J., Jian S., Jiang C., Jiang D., Jiang W., Jiang X., Jing X., Jollet C., Kampmann P., Kang L., Karaparambil R., Kazarian N., Khan A., Khatun A., Khosonthongkee K., Korablev D., Kouzakov K., Krasnoperov A., Kuleshov S., Kutovskiy N., Lachenmaier T., Landini C., Leblanc S., Lebrin V., Lefevre F., Lei R., Leitner R., Leung J., Li D., Li F., Li G., Li H., Li J., Li M., Li N., Li Q., Li R., Li S., Li T., Li W., Li X., Li Y., Li Z., Liang H., Liao J., Limphirat A., Lin G. -L., Lin S., Lin T., Ling J., Ling X., Lippi I., Liu C., Liu F., Liu H., Liu J., Liu M., Liu Q., Liu R., Liu S., Liu X., Liu Y., Liu Z., Lokhov A., Lombardi P., Lombardo C., Loo K., Lu C., Lu H., Lu J., Lu P., Lu S., Lubsandorzhiev B., Lubsandorzhiev S., Ludhova L., Lukanov A., Luo D., Luo F., Luo G., Luo J., Luo S., Luo W., Luo X., Lyashuk V., Ma B., Ma Q., Ma S., Ma X., Maalmi J., Magoni M., Mai J., Malyshkin Y., Mandujano R. C., Mantovani F., Mao X., Mao Y., Mari S. M., Marini F., Martini A., Mayer M., Mayilyan D., Mednieks I., Meng Y., Meraviglia A., Meregaglia A., Meroni E., Meyhofer D., Miramonti L., Mohan N., Montini P., Montuschi M., Muller A., Nastasi M., Naumov D. V., Naumova E., Navas-Nicolas D., Nemchenok I., Thi M. T. N., Nikolaev A., Ning F., Ning Z., Nunokawa H., Oberauer L., Ochoa-Ricoux J. P., Olshevskiy A., Orestano D., Ortica F., Othegraven R., Paoloni A., Parmeggiano S., Pei Y., Pelicci L., Peng A., Peng H., Peng Y., Peng Z., Perrot F., Petitjean P. -A., Petrucci F., Pilarczyk O., Rico L. F. P., Popov A., Poussot P., Previtali E., Qi F., Qi M., Qi X., Qian S., Qian X., Qian Z., Qiao H., Qin Z., Qiu S., Ranucci G., Rasheed R., Re A., Rebii A., Redchuk M., Ren B., Ren J., Ricci B., Rifai M., Roche M., Rodphai N., Romani A., Roskovec B., Ruan X., Rybnikov A., Sadovsky A., Saggese P., Sandanayake D., Sanfilippo S., Sangka A., Sawangwit U., Schever M., Schwab C., Schweizer K., Selyunin A., Serafini A., Settimo M., Sharov V., Shaydurova A., Shi J., Shi Y., Shutov V., Sidorenkov A., Simkovic F., Singhal A., Sirignano C., Siripak J., Sisti M., Smirnov M., Smirnov O., Sogo-Bezerra T., Sokolov S., Songwadhana J., Soonthornthum B., Sotnikov A., Sramek O., Sreethawong W., Stahl A., Stanco L., Stankevich K., Steiger H., Steinmann J., Sterr T., Stock M. R., Strati V., Studenikin A., Su J., Sun S., Sun X., Sun Y., Sun Z., Suwonjandee N., Szelezniak M., Takenaka A., Tang J., Tang Q., Tang X., Hariharan V. T., Theisen E., Tietzsch A., Tkachev I., Tmej T., Torri M. D. C., Tortorici F., Treskov K., Triossi A., Triozzi R., Trzaska W., Tung Y. -C., Tuve C., Ushakov N., Vedin V., Verde G., Vialkov M., Viaud B., Vollbrecht C. M., von Sturm K., Vorobel V., Voronin D., Votano L., Walker P., Wang C., Wang C. -H., Wang E., Wang G., Wang J., Wang L., Wang M., Wang R., Wang S., Wang W., Wang X., Wang Y., Wang Z., Watcharangkool A., Wei W., Wei Y., Wen K., Wen L., Weng J., Wiebusch C., Wirth R., Wonsak B., Wu D., Wu Q., Wu Y., Wu Z., Wurm M., Wurtz J., Wysotzki C., Xi Y., Xia D., Xiao X., Xie X., Xie Y., Xie Z., Xin Z., Xing Z., Xu B., Xu C., Xu D., Xu F., Xu H., Xu J., Xu M., Xu Y., Yan B., Yan Q., Yan T., Yan X., Yan Y., Yang C., Yang J., Yang L., Yang X., Yang Y., Yao H., Ye J., Ye M., Ye Z., Yermia F., You Z., Yu B., Yu C., Yu G., Yu H., Yu M., Yu X., Yu Z., Yuan C., Yuan Y., Yuan Z., Yue B., Zafar N., Zavadskyi V., Zeng S., Zeng T., Zeng Y., Zhan L., Zhang A., Zhang B., Zhang F., Zhang H., Zhang J., Zhang M., Zhang P., Zhang Q., Zhang S., Zhang T., Zhang X., Zhang Y., Zhang Z., Zhao J., Zhao R., Zhao S., Zheng D., Zheng H., Zheng Y., Zhong W., Zhou J., Zhou L., Zhou N., Zhou S., Zhou T., Zhou X., Zhu J., Zhu K., Zhu Z., Zhuang B., Zhuang H., Zong L., Zou J., Zufle J., Zwickel S., Abusleme, A, Adam, T, Ahmad, S, Ahmed, R, Aiello, S, Akram, M, Aleem, A, Alexandros, T, An, F, An, Q, Andronico, G, Anfimov, N, Antonelli, V, Antoshkina, T, Asavapibhop, B, de Andre, J, Auguste, D, Bai, W, Balashov, N, Baldini, W, Barresi, A, Basilico, D, Baussan, E, Bellato, M, Beretta, M, Bergnoli, A, Bick, D, Bieger, L, Biktemerova, S, Birkenfeld, T, Blum, D, Blyth, S, Bolshakova, A, Bongrand, M, Bordereau, C, Breton, D, Brigatti, A, Brugnera, R, Bruno, R, Budano, A, Busto, J, Cabrera, A, Caccianiga, B, Cai, H, Cai, X, Cai, Y, Cai, Z, Callier, S, Cammi, A, Campeny, A, Cao, C, Cao, G, Cao, J, Caruso, R, Cerna, C, Cerrone, V, Chan, C, Chang, J, Chang, Y, Chen, C, Chen, G, Chen, P, Chen, S, Chen, Y, Chen, Z, Cheng, J, Cheng, Y, Chepurnov, A, Chetverikov, A, Chiesa, D, Chimenti, P, Chu, Z, Chukanov, A, Claverie, G, Clementi, C, Clerbaux, B, Molla, M, Di Lorenzo, S, Coppi, A, Corti, D, Csakli, S, Dal Corso, F, Dalager, O, Datta, J, De La Taille, C, Deng, Z, Depnering, W, Ding, X, Ding, Y, Dirgantara, B, Dittrich, C, Dmitrievsky, S, Dohnal, T, Dolzhikov, D, Donchenko, G, Dong, J, Doroshkevich, E, Dou, W, Dracos, M, Druillole, F, Du, R, Du, S, Dugas, K, Dusini, S, Duyang, H, Eck, J, Enqvist, T, Fabbri, A, Fahrendholz, U, Fan, L, Fang, J, Fang, W, Fargetta, M, Fedoseev, D, Fei, Z, Feng, L, Feng, Q, Ferraro, F, Fournier, A, Gan, H, Gao, F, Garfagnini, A, Gavrikov, A, Giammarchi, M, Giudice, N, Gonchar, M, Gong, G, Gong, H, Gornushkin, Y, Gottel, A, Grassi, M, Gromov, M, Gromov, V, Gu, M, Gu, X, Gu, Y, Guan, M, Guan, Y, Guardone, N, Guo, C, Guo, W, Guo, X, Hagner, C, Han, R, Han, Y, He, M, He, W, Heinz, T, Hellmuth, P, Heng, Y, Herrera, R, Hor, Y, Hou, S, Hsiung, Y, Hu, B, Hu, H, Hu, J, Hu, S, Hu, T, Hu, Y, Hu, Z, Huang, G, Huang, H, Huang, J, Huang, K, Huang, W, Huang, X, Huang, Y, Hui, J, Huo, L, Huo, W, Huss, C, Hussain, S, Imbert, L, Ioannisian, A, Isocrate, R, Jelmini, B, Jeria, I, Ji, X, Jia, H, Jia, J, Jian, S, Jiang, C, Jiang, D, Jiang, W, Jiang, X, Jing, X, Jollet, C, Kampmann, P, Kang, L, Karaparambil, R, Kazarian, N, Khan, A, Khatun, A, Khosonthongkee, K, Korablev, D, Kouzakov, K, Krasnoperov, A, Kuleshov, S, Kutovskiy, N, Lachenmaier, T, Landini, C, Leblanc, S, Lebrin, V, Lefevre, F, Lei, R, Leitner, R, Leung, J, Li, D, Li, F, Li, G, Li, H, Li, J, Li, M, Li, N, Li, Q, Li, R, Li, S, Li, T, Li, W, Li, X, Li, Y, Li, Z, Liang, H, Liao, J, Limphirat, A, Lin, G, Lin, S, Lin, T, Ling, J, Ling, X, Lippi, I, Liu, C, Liu, F, Liu, H, Liu, J, Liu, M, Liu, Q, Liu, R, Liu, S, Liu, X, Liu, Y, Liu, Z, Lokhov, A, Lombardi, P, Lombardo, C, Loo, K, Lu, C, Lu, H, Lu, J, Lu, P, Lu, S, Lubsandorzhiev, B, Lubsandorzhiev, S, Ludhova, L, Lukanov, A, Luo, D, Luo, F, Luo, G, Luo, J, Luo, S, Luo, W, Luo, X, Lyashuk, V, Ma, B, Ma, Q, Ma, S, Ma, X, Maalmi, J, Magoni, M, Mai, J, Malyshkin, Y, Mandujano, R, Mantovani, F, Mao, X, Mao, Y, Mari, S, Marini, F, Martini, A, Mayer, M, Mayilyan, D, Mednieks, I, Meng, Y, Meraviglia, A, Meregaglia, A, Meroni, E, Meyhofer, D, Miramonti, L, Mohan, N, Montini, P, Montuschi, M, Muller, A, Nastasi, M, Naumov, D, Naumova, E, Navas-Nicolas, D, Nemchenok, I, Thi, M, Nikolaev, A, Ning, F, Ning, Z, Nunokawa, H, Oberauer, L, Ochoa-Ricoux, J, Olshevskiy, A, Orestano, D, Ortica, F, Othegraven, R, Paoloni, A, Parmeggiano, S, Pei, Y, Pelicci, L, Peng, A, Peng, H, Peng, Y, Peng, Z, Perrot, F, Petitjean, P, Petrucci, F, Pilarczyk, O, Rico, L, Popov, A, Poussot, P, Previtali, E, Qi, F, Qi, M, Qi, X, Qian, S, Qian, X, Qian, Z, Qiao, H, Qin, Z, Qiu, S, Ranucci, G, Rasheed, R, Re, A, Rebii, A, Redchuk, M, Ren, B, Ren, J, Ricci, B, Rifai, M, Roche, M, Rodphai, N, Romani, A, Roskovec, B, Ruan, X, Rybnikov, A, Sadovsky, A, Saggese, P, Sandanayake, D, Sanfilippo, S, Sangka, A, Sawangwit, U, Schever, M, Schwab, C, Schweizer, K, Selyunin, A, Serafini, A, Settimo, M, Sharov, V, Shaydurova, A, Shi, J, Shi, Y, Shutov, V, Sidorenkov, A, Simkovic, F, Singhal, A, Sirignano, C, Siripak, J, Sisti, M, Smirnov, M, Smirnov, O, Sogo-Bezerra, T, Sokolov, S, Songwadhana, J, Soonthornthum, B, Sotnikov, A, Sramek, O, Sreethawong, W, Stahl, A, Stanco, L, Stankevich, K, Steiger, H, Steinmann, J, Sterr, T, Stock, M, Strati, V, Studenikin, A, Su, J, Sun, S, Sun, X, Sun, Y, Sun, Z, Suwonjandee, N, Szelezniak, M, Takenaka, A, Tang, J, Tang, Q, Tang, X, Hariharan, V, Theisen, E, Tietzsch, A, Tkachev, I, Tmej, T, Torri, M, Tortorici, F, Treskov, K, Triossi, A, Triozzi, R, Trzaska, W, Tung, Y, Tuve, C, Ushakov, N, Vedin, V, Verde, G, Vialkov, M, Viaud, B, Vollbrecht, C, von Sturm, K, Vorobel, V, Voronin, D, Votano, L, Walker, P, Wang, C, Wang, E, Wang, G, Wang, J, Wang, L, Wang, M, Wang, R, Wang, S, Wang, W, Wang, X, Wang, Y, Wang, Z, Watcharangkool, A, Wei, W, Wei, Y, Wen, K, Wen, L, Weng, J, Wiebusch, C, Wirth, R, Wonsak, B, Wu, D, Wu, Q, Wu, Y, Wu, Z, Wurm, M, Wurtz, J, Wysotzki, C, Xi, Y, Xia, D, Xiao, X, Xie, X, Xie, Y, Xie, Z, Xin, Z, Xing, Z, Xu, B, Xu, C, Xu, D, Xu, F, Xu, H, Xu, J, Xu, M, Xu, Y, Yan, B, Yan, Q, Yan, T, Yan, X, Yan, Y, Yang, C, Yang, J, Yang, L, Yang, X, Yang, Y, Yao, H, Ye, J, Ye, M, Ye, Z, Yermia, F, You, Z, Yu, B, Yu, C, Yu, G, Yu, H, Yu, M, Yu, X, Yu, Z, Yuan, C, Yuan, Y, Yuan, Z, Yue, B, Zafar, N, Zavadskyi, V, Zeng, S, Zeng, T, Zeng, Y, Zhan, L, Zhang, A, Zhang, B, Zhang, F, Zhang, H, Zhang, J, Zhang, M, Zhang, P, Zhang, Q, Zhang, S, Zhang, T, Zhang, X, Zhang, Y, Zhang, Z, Zhao, J, Zhao, R, Zhao, S, Zheng, D, Zheng, H, Zheng, Y, Zhong, W, Zhou, J, Zhou, L, Zhou, N, Zhou, S, Zhou, T, Zhou, X, Zhu, J, Zhu, K, Zhu, Z, Zhuang, B, Zhuang, H, Zong, L, Zou, J, Zufle, J, Zwickel, S, Abusleme A., Adam T., Ahmad S., Ahmed R., Aiello S., Akram M., Aleem A., Alexandros T., An F., An Q., Andronico G., Anfimov N., Antonelli V., Antoshkina T., Asavapibhop B., de Andre J. P. A. M., Auguste D., Bai W., Balashov N., Baldini W., Barresi A., Basilico D., Baussan E., Bellato M., Beretta M., Bergnoli A., Bick D., Bieger L., Biktemerova S., Birkenfeld T., Blum D., Blyth S., Bolshakova A., Bongrand M., Bordereau C., Breton D., Brigatti A., Brugnera R., Bruno R., Budano A., Busto J., Cabrera A., Caccianiga B., Cai H., Cai X., Cai Y., Cai Z., Callier S., Cammi A., Campeny A., Cao C., Cao G., Cao J., Caruso R., Cerna C., Cerrone V., Chan C., Chang J., Chang Y., Chen C., Chen G., Chen P., Chen S., Chen Y., Chen Z., Cheng J., Cheng Y., Cheng Y. C., Chepurnov A., Chetverikov A., Chiesa D., Chimenti P., Chu Z., Chukanov A., Claverie G., Clementi C., Clerbaux B., Molla M. C., Di Lorenzo S. C., Coppi A., Corti D., Csakli S., Dal Corso F., Dalager O., Datta J., De La Taille C., Deng Z., Depnering W., Ding X., Ding Y., Dirgantara B., Dittrich C., Dmitrievsky S., Dohnal T., Dolzhikov D., Donchenko G., Dong J., Doroshkevich E., Dou W., Dracos M., Druillole F., Du R., Du S., Dugas K., Dusini S., Duyang H., Eck J., Enqvist T., Fabbri A., Fahrendholz U., Fan L., Fang J., Fang W., Fargetta M., Fedoseev D., Fei Z., Feng L. -C., Feng Q., Ferraro F., Fournier A., Gan H., Gao F., Garfagnini A., Gavrikov A., Giammarchi M., Giudice N., Gonchar M., Gong G., Gong H., Gornushkin Y., Gottel A., Grassi M., Gromov M., Gromov V., Gu M., Gu X., Gu Y., Guan M., Guan Y., Guardone N., Guo C., Guo W., Guo X., Hagner C., Han R., Han Y., He M., He W., Heinz T., Hellmuth P., Heng Y., Herrera R., Hor Y., Hou S., Hsiung Y., Hu B. -Z., Hu H., Hu J., Hu S., Hu T., Hu Y., Hu Z., Huang G., Huang H., Huang J., Huang K., Huang W., Huang X., Huang Y., Hui J., Huo L., Huo W., Huss C., Hussain S., Imbert L., Ioannisian A., Isocrate R., Jelmini B., Jeria I., Ji X., Jia H., Jia J., Jian S., Jiang C., Jiang D., Jiang W., Jiang X., Jing X., Jollet C., Kampmann P., Kang L., Karaparambil R., Kazarian N., Khan A., Khatun A., Khosonthongkee K., Korablev D., Kouzakov K., Krasnoperov A., Kuleshov S., Kutovskiy N., Lachenmaier T., Landini C., Leblanc S., Lebrin V., Lefevre F., Lei R., Leitner R., Leung J., Li D., Li F., Li G., Li H., Li J., Li M., Li N., Li Q., Li R., Li S., Li T., Li W., Li X., Li Y., Li Z., Liang H., Liao J., Limphirat A., Lin G. -L., Lin S., Lin T., Ling J., Ling X., Lippi I., Liu C., Liu F., Liu H., Liu J., Liu M., Liu Q., Liu R., Liu S., Liu X., Liu Y., Liu Z., Lokhov A., Lombardi P., Lombardo C., Loo K., Lu C., Lu H., Lu J., Lu P., Lu S., Lubsandorzhiev B., Lubsandorzhiev S., Ludhova L., Lukanov A., Luo D., Luo F., Luo G., Luo J., Luo S., Luo W., Luo X., Lyashuk V., Ma B., Ma Q., Ma S., Ma X., Maalmi J., Magoni M., Mai J., Malyshkin Y., Mandujano R. C., Mantovani F., Mao X., Mao Y., Mari S. M., Marini F., Martini A., Mayer M., Mayilyan D., Mednieks I., Meng Y., Meraviglia A., Meregaglia A., Meroni E., Meyhofer D., Miramonti L., Mohan N., Montini P., Montuschi M., Muller A., Nastasi M., Naumov D. V., Naumova E., Navas-Nicolas D., Nemchenok I., Thi M. T. N., Nikolaev A., Ning F., Ning Z., Nunokawa H., Oberauer L., Ochoa-Ricoux J. P., Olshevskiy A., Orestano D., Ortica F., Othegraven R., Paoloni A., Parmeggiano S., Pei Y., Pelicci L., Peng A., Peng H., Peng Y., Peng Z., Perrot F., Petitjean P. -A., Petrucci F., Pilarczyk O., Rico L. F. P., Popov A., Poussot P., Previtali E., Qi F., Qi M., Qi X., Qian S., Qian X., Qian Z., Qiao H., Qin Z., Qiu S., Ranucci G., Rasheed R., Re A., Rebii A., Redchuk M., Ren B., Ren J., Ricci B., Rifai M., Roche M., Rodphai N., Romani A., Roskovec B., Ruan X., Rybnikov A., Sadovsky A., Saggese P., Sandanayake D., Sanfilippo S., Sangka A., Sawangwit U., Schever M., Schwab C., Schweizer K., Selyunin A., Serafini A., Settimo M., Sharov V., Shaydurova A., Shi J., Shi Y., Shutov V., Sidorenkov A., Simkovic F., Singhal A., Sirignano C., Siripak J., Sisti M., Smirnov M., Smirnov O., Sogo-Bezerra T., Sokolov S., Songwadhana J., Soonthornthum B., Sotnikov A., Sramek O., Sreethawong W., Stahl A., Stanco L., Stankevich K., Steiger H., Steinmann J., Sterr T., Stock M. R., Strati V., Studenikin A., Su J., Sun S., Sun X., Sun Y., Sun Z., Suwonjandee N., Szelezniak M., Takenaka A., Tang J., Tang Q., Tang X., Hariharan V. T., Theisen E., Tietzsch A., Tkachev I., Tmej T., Torri M. D. C., Tortorici F., Treskov K., Triossi A., Triozzi R., Trzaska W., Tung Y. -C., Tuve C., Ushakov N., Vedin V., Verde G., Vialkov M., Viaud B., Vollbrecht C. M., von Sturm K., Vorobel V., Voronin D., Votano L., Walker P., Wang C., Wang C. -H., Wang E., Wang G., Wang J., Wang L., Wang M., Wang R., Wang S., Wang W., Wang X., Wang Y., Wang Z., Watcharangkool A., Wei W., Wei Y., Wen K., Wen L., Weng J., Wiebusch C., Wirth R., Wonsak B., Wu D., Wu Q., Wu Y., Wu Z., Wurm M., Wurtz J., Wysotzki C., Xi Y., Xia D., Xiao X., Xie X., Xie Y., Xie Z., Xin Z., Xing Z., Xu B., Xu C., Xu D., Xu F., Xu H., Xu J., Xu M., Xu Y., Yan B., Yan Q., Yan T., Yan X., Yan Y., Yang C., Yang J., Yang L., Yang X., Yang Y., Yao H., Ye J., Ye M., Ye Z., Yermia F., You Z., Yu B., Yu C., Yu G., Yu H., Yu M., Yu X., Yu Z., Yuan C., Yuan Y., Yuan Z., Yue B., Zafar N., Zavadskyi V., Zeng S., Zeng T., Zeng Y., Zhan L., Zhang A., Zhang B., Zhang F., Zhang H., Zhang J., Zhang M., Zhang P., Zhang Q., Zhang S., Zhang T., Zhang X., Zhang Y., Zhang Z., Zhao J., Zhao R., Zhao S., Zheng D., Zheng H., Zheng Y., Zhong W., Zhou J., Zhou L., Zhou N., Zhou S., Zhou T., Zhou X., Zhu J., Zhu K., Zhu Z., Zhuang B., Zhuang H., Zong L., Zou J., Zufle J., and Zwickel S.
- Abstract
The Jiangmen Underground Neutrino Observatory (JUNO), the first multi-kton liquid scintillator detector, which is under construction in China, will have a unique potential to perform a real-time measurement of solar neutrinos well below the few MeV threshold typical of Water Cherenkov detectors. JUNO’s large target mass and excellent energy resolution are prerequisites for reaching unprecedented levels of precision. In this paper, we provide estimation of the JUNO sensitivity to 7Be, pep, and CNO solar neutrinos that can be obtained via a spectral analysis above the 0.45 MeV threshold. This study is performed assuming different scenarios of the liquid scintillator radiopurity, ranging from the most optimistic one corresponding to the radiopurity levels obtained by the Borexino experiment, up to the minimum requirements needed to perform the neutrino mass ordering determination with reactor antineutrinos — the main goal of JUNO. Our study shows that in most scenarios, JUNO will be able to improve the current best measurements on 7Be, pep, and CNO solar neutrino fluxes. We also perform a study on the JUNO capability to detect periodical time variations in the solar neutrino flux, such as the day-night modulation induced by neutrino flavor regeneration in Earth, and the modulations induced by temperature changes driven by helioseismic waves.
- Published
- 2023
44. Turnover rates of hepatic collagen and circulating collagen-associated proteins in humans with chronic liver disease
- Author
-
Peters, Marion, Decaris, ML, Emson, CL, Li, K, Gatmaitan, M, Luo, F, Cattin, J, Nakamura, C, Holmes, WE, Angel, TE, and Peters, MG
- Abstract
© 2015 Decaris et al.Accumulation and degradation of scar tissue in fibrotic liver disease occur slowly, typically over many years. Direct measurement of fibrogenesis, the rate of scar tissue deposition, may provide valuable therapeutic and prognostic info
- Published
- 2015
45. The End of the CMSSM Coannihilation Strip is Nigh
- Author
-
Citron, M., Ellis, J., Luo, F., Marrouche, J., Olive, K. A., and de Vries, K. J.
- Subjects
High Energy Physics - Phenomenology ,High Energy Physics - Experiment - Abstract
A recent global fit to the CMSSM incorporating current constraints on supersymmetry, including missing transverse energy searches at the LHC, BR(B_s to mu+ mu-) and the direct XENON100 search for dark matter, favours points towards the end of the stau-neutralino (stau_1- chi) coannihilation strip with relatively large m_1/2 and 10 < tan beta < 40 and points in the H/A rapid-annihilation funnel with tan beta ~ 50. The coannihilation points typically have m_stau_1-m_chi < 5 GeV, and a significant fraction, including the most-favoured point, has m_stau_1-m_chi < m_tau. In such a case, the stau_1 lifetime would be so long that the stau_1 would be detectable as a long-lived massive charged particle that may decay inside or outside the apparatus. We show that CMSSM scenarios close to the tip of the coannihilation strip for tan beta < 40 are already excluded by LHC searches for massive charged particles, and discuss the prospects for their detection in the CMS and ATLAS detectors via time-of-flight measurements, anomalous heavy ionization or decays into one or more soft charged particles., Comment: 33 pages, 19 pdf figures
- Published
- 2012
- Full Text
- View/download PDF
46. Construction of the center-of-mass free space for the SU(3) no-core shell model
- Author
-
Luo, F. Q., Caprio, M. A., and Dytrych, T.
- Subjects
Nuclear Theory - Abstract
We address the removal of states with center-of-mass excitation from the SU(3) no-core shell model [SU(3)-NCSM] space, i.e., construction of the nonspurious subspace. A procedure is formulated based on solution of the null-space problem for the center-of-mass harmonic oscillator lowering operator Bcm, operating at the level of SU(3) irreducible representations. Isolation of the center-of-mass free subspace for the SU(3)-NCSM provides the foundation for exact removal of center-of-mass dynamics in the proposed Sp(3,R) symplectic no-core shell model. We outline the construction process for the matrix representation of Bcm, present the algorithm for obtaining the nonspurious space, and examine the dimensions obtained for center-of-mass free SU(3) subspaces in representative light nuclei., Comment: 14 pages, 5 figures; to be published in Nucl. Phys. A
- Published
- 2012
- Full Text
- View/download PDF
47. Generalized seniority for the shell model with realistic interactions
- Author
-
Caprio, M. A., Luo, F. Q., Cai, K., Hellemans, V., and Constantinou, C.
- Subjects
Nuclear Theory - Abstract
The generalized seniority scheme has long been proposed as a means of dramatically reducing the dimensionality of nuclear shell model calculations, when strong pairing correlations are present. However, systematic benchmark calculations, comparing results obtained in a model space truncated according to generalized seniority with those obtained in the full shell model space, are required to assess the viability of this scheme. Here, a detailed comparison is carried out, for semimagic nuclei taken in a full major shell and with realistic interactions. The even-mass and odd-mass Ca isotopes are treated in the generalized seniority scheme, for generalized seniority v<=3. Results for level energies, orbital occupations, and electromagnetic observables are compared with those obtained in the full shell model space., Comment: 13 pages, 8 figures; published in Phys. Rev. C
- Published
- 2012
- Full Text
- View/download PDF
48. Recursive calculation of matrix elements for the generalized seniority shell model
- Author
-
Luo, F. Q. and Caprio, M. A.
- Subjects
Nuclear Theory - Abstract
A recursive calculational scheme is developed for matrix elements in the generalized seniority scheme for the nuclear shell model. Recurrence relations are derived which permit straightforward and efficient computation of matrix elements of one-body and two-body operators and basis state overlaps., Comment: 19 pages, 1 figure; published in Nucl. Phys. A
- Published
- 2011
- Full Text
- View/download PDF
49. Computing Quasiconformal Maps on Riemann surfaces using Discrete Curvature Flow
- Author
-
Zeng, W., Lui, L. M., Luo, F., Liu, J. S., Chan, T. F., Yau, S. T., and Gu, X. F.
- Subjects
Mathematics - Numerical Analysis ,Mathematics - Metric Geometry - Abstract
Surface mapping plays an important role in geometric processing. They induce both area and angular distortions. If the angular distortion is bounded, the mapping is called a {\it quasi-conformal} map. Many surface maps in our physical world are quasi-conformal. The angular distortion of a quasi-conformal map can be represented by Beltrami differentials. According to quasi-conformal Teichm\"uller theory, there is an 1-1 correspondence between the set of Beltrami differentials and the set of quasi-conformal surface maps. Therefore, every quasi-conformal surface map can be fully determined by the Beltrami differential and can be reconstructed by solving the so-called Beltrami equation. In this work, we propose an effective method to solve the Beltrami equation on general Riemann surfaces. The solution is a quasi-conformal map associated with the prescribed Beltrami differential. We firstly formulate a discrete analog of quasi-conformal maps on triangular meshes. Then, we propose an algorithm to compute discrete quasi-conformal maps. The main strategy is to define a discrete auxiliary metric of the source surface, such that the original quasi-conformal map becomes conformal under the newly defined discrete metric. The associated map can then be obtained by using the discrete Yamabe flow method. Numerically, the discrete quasi-conformal map converges to the continuous real solution as the mesh size approaches to 0. We tested our algorithm on surfaces scanned from real life with different topologies. Experimental results demonstrate the generality and accuracy of our auxiliary metric method.
- Published
- 2010
50. A novel FGFR1-binding peptide attenuates the degeneration of articular cartilage in adult mice
- Author
-
Tan, Q., Chen, B., Wang, Q., Xu, W., Wang, Y., Lin, Z., Luo, F., Huang, S., Zhu, Y., Su, N., Jin, M., Li, C., Kuang, L., Qi, H., Ni, Z., Wang, Z., Luo, X., Jiang, W., Chen, H., Chen, S., Li, F., Zhang, B., Huang, J., Zhang, R., Jin, K., Xu, X., Deng, C., Du, X., Xie, Y., and Chen, L.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.